
<html lang="en"     class="pb-page"  data-request-id="897cbb57-1ae1-48fb-86e6-4b2dbb103507"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2018.61.issue-13;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.8b00243"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Antitumorigenic Properties of Omega-3 Endocannabinoid Epoxides" /></meta><meta name="dc.Creator" content="Jahnabi  Roy" /></meta><meta name="dc.Creator" content="Josephine E.  Watson" /></meta><meta name="dc.Creator" content="In Sup  Hong" /></meta><meta name="dc.Creator" content="Timothy M.  Fan" /></meta><meta name="dc.Creator" content="Aditi  Das" /></meta><meta name="dc.Description" content="Accumulating studies have linked inflammation to tumor progression. Dietary omega-3 fatty acids, such as docosahexaenoic acid (DHA), have been shown to suppress tumor growth through their conversio..." /></meta><meta name="Description" content="Accumulating studies have linked inflammation to tumor progression. Dietary omega-3 fatty acids, such as docosahexaenoic acid (DHA), have been shown to suppress tumor growth through their conversio..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 1, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00243" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00243" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00243" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00243" /></link>
        
    
    

<title>Antitumorigenic Properties of Omega-3 Endocannabinoid Epoxides | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00243" /></meta><meta property="og:title" content="Antitumorigenic Properties of Omega-3 Endocannabinoid Epoxides" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/large/jm-2018-002437_0004.jpeg" /></meta><meta property="og:description" content="Accumulating studies have linked inflammation to tumor progression. Dietary omega-3 fatty acids, such as docosahexaenoic acid (DHA), have been shown to suppress tumor growth through their conversion to epoxide metabolites. Alternatively, DHA is converted enzymatically into docosahexaenoylethanolamide (DHEA), an endocannabinoid with antiproliferative activity. Recently, we reported a novel class of anti-inflammatory DHEA-epoxide derivative called epoxydocospentaenoic-ethanolamide (EDP-EA) that contain both ethanolamide and epoxide moieties. Herein, we study the antitumorigenic properties of EDP-EAs in an osteosarcoma (OS) model. First, we show ∼80% increase in EDP-EAs in metastatic versus normal lungs of mice. We found significant differences in the apoptotic and antimigratory potencies of the different EDP-EA regioisomers, which were partially mediated through cannabinoid receptor 1 (CB1). Next, we synthesized derivatives of the most pro-apoptotic regioisomer. These derivatives had reduced hydrolytic susceptibility to fatty acid amide hydrolase (FAAH) and increased CB1-selective binding. Collectively, we report a novel class of EDP-EAs that exhibit antiangiogenic, antitumorigenic, and antimigratory properties in OS." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00243"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00243">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00243&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00243&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00243&amp;href=/doi/10.1021/acs.jmedchem.8b00243" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 5569-5579</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00143" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00292" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Antitumorigenic Properties of Omega-3 Endocannabinoid Epoxides</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Jahnabi Roy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jahnabi Roy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry; ; ; ; , University of Illinois, Urbana-Champaign, Urbana, Illinois 61802, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jahnabi++Roy">Jahnabi Roy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Josephine E. Watson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Josephine E. Watson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry; ; ; ; , University of Illinois, Urbana-Champaign, Urbana, Illinois 61802, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Josephine+E.++Watson">Josephine E. Watson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">In Sup Hong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">In Sup Hong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry; ; ; ; , University of Illinois, Urbana-Champaign, Urbana, Illinois 61802, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=In+Sup++Hong">In Sup Hong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Timothy M. Fan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Timothy M. Fan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Veterinary Clinical Medicine; ; ; ; , University of Illinois, Urbana-Champaign, Urbana, Illinois 61802, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+M.++Fan">Timothy M. Fan</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Aditi Das</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aditi Das</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Comparative Biosciences,  Department of Biochemistry,  Beckman Institute for Advanced Science, Division of Nutritional Sciences, Neuroscience Program, and Department of Bioengineering,  ; ; ; ; , University of Illinois, Urbana-Champaign, Urbana, Illinois 61802, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#71101518051815100231181d1d181f1e18025f141504"><span class="__cf_email__" data-cfemail="7d1c19140914191c0e3d141111141312140e53181908">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aditi++Das">Aditi Das</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6731-6726" title="Orcid link">http://orcid.org/0000-0002-6731-6726</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00243&amp;href=/doi/10.1021%2Facs.jmedchem.8b00243" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 5569–5579</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 1, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 February 2018</li><li><span class="item_label"><b>Published</b> online</span>1 June 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 July 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00243" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00243</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5569%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJahnabi%2BRoy%252C%2BJosephine%2BE.%2BWatson%252C%2BIn%2BSup%2BHong%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D13%26contentID%3Dacs.jmedchem.8b00243%26title%3DAntitumorigenic%2BProperties%2Bof%2BOmega-3%2BEndocannabinoid%2BEpoxides%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5579%26publicationDate%3DJuly%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00243"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1555</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00243" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Antitumorigenic Properties of Omega-3 Endocannabinoid Epoxides&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jahnabi&quot;,&quot;last_name&quot;:&quot;Roy&quot;},{&quot;first_name&quot;:&quot;Josephine&quot;,&quot;last_name&quot;:&quot;E. Watson&quot;},{&quot;first_name&quot;:&quot;In&quot;,&quot;last_name&quot;:&quot;Sup Hong&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;M. Fan&quot;},{&quot;first_name&quot;:&quot;Aditi&quot;,&quot;last_name&quot;:&quot;Das&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;5569-5579&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00243&quot;},&quot;abstract&quot;:&quot;Accumulating studies have linked inflammation to tumor progression. Dietary omega-3 fatty acids, such as docosahexaenoic acid (DHA), have been shown to suppress tumor growth through their conversion to epoxide metabolites. Alternatively, DHA is converted enzymatically into docosahexaenoylethanolamide (DHEA), an endocannabinoid with antiproliferative activity. Recently, we reported a novel class of anti-inflammatory DHEA-epoxide derivative called epoxydocospentaenoic-ethanolamide (EDP-EA) that contain both ethanolamide and epoxide moieties. Herein, we study the antitumorigenic properties of EDP-EAs in an osteosarcoma (OS) model. First, we show ∼80% increase in EDP-EAs in metastatic versus normal lungs of mice. We found significant differences in the apoptotic and antimigratory potencies of the different EDP-EA regioisomers, which were partially mediated through cannabinoid receptor 1 (CB1). Next, we synthesized derivatives of the most pro-apoptotic regioisomer. These derivatives had reduced hydrolytic suscepti&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00243&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00243" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00243&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00243" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00243&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00243" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00243&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00243&amp;href=/doi/10.1021/acs.jmedchem.8b00243" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00243" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00243" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00243%26sid%3Dliteratum%253Aachs%26pmid%3D29856219%26genre%3Darticle%26aulast%3DRoy%26date%3D2018%26atitle%3DAntitumorigenic%2BProperties%2Bof%2BOmega-3%2BEndocannabinoid%2BEpoxides%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D13%26spage%3D5569%26epage%3D5579%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (4)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=291285" title="Ethers">Ethers</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/jmcmar.2018.61.issue-13/20180712/jmcmar.2018.61.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/medium/jm-2018-002437_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/large/jm-2018-002437_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00243&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Accumulating studies have linked inflammation to tumor progression. Dietary omega-3 fatty acids, such as docosahexaenoic acid (DHA), have been shown to suppress tumor growth through their conversion to epoxide metabolites. Alternatively, DHA is converted enzymatically into docosahexaenoylethanolamide (DHEA), an endocannabinoid with antiproliferative activity. Recently, we reported a novel class of anti-inflammatory DHEA-epoxide derivative called epoxydocospentaenoic-ethanolamide (EDP-EA) that contain both ethanolamide and epoxide moieties. Herein, we study the antitumorigenic properties of EDP-EAs in an osteosarcoma (OS) model. First, we show ∼80% increase in EDP-EAs in metastatic versus normal lungs of mice. We found significant differences in the apoptotic and antimigratory potencies of the different EDP-EA regioisomers, which were partially mediated through cannabinoid receptor 1 (CB1). Next, we synthesized derivatives of the most pro-apoptotic regioisomer. These derivatives had reduced hydrolytic susceptibility to fatty acid amide hydrolase (FAAH) and increased CB1-selective binding. Collectively, we report a novel class of EDP-EAs that exhibit antiangiogenic, antitumorigenic, and antimigratory properties in OS.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61874" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61874" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Recent studies in cancer focus on understanding the role of inflammation in tumor initiation and malignant progression. Inflammatory conditions have been previously studied to promote oncogenic transformation. In addition, the carcinogenic milieu can generate an inflammatory microenvironment, which in turn favors tumor progression.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> Dietary omega-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been shown to suppress tumor growth and progression by their conversion into anti-inflammatory, pro-resolving, and antitumorigenic lipids.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7">(4−7)</a> As inflammation is capable of promoting tumor initiation, proliferation, and progression, omega-3 fatty acid derived lipid metabolites have also been hypothesized to prevent tumor formation and metastasis in a multifaceted manner.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Hence, there are biological and clinical justifications to discover potential omega-3 fatty acid derived lipid metabolites that possess antitumorigenic and anti-inflammatory properties.</div><div class="NLM_p">Cytochrome P450 (CYP) epoxygenases convert omega-3 fatty acids into epoxides that exhibit anticancer properties. Specifically, EPA-epoxides, also known as epoxyeicosatetraenoic acid (EEQs), have been studied to be antiproliferative.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In addition, the terminal epoxide of EPA, 17,18-EEQ, decreases endothelial-cell proliferation, interrupts the cell cycle in S-phase, and down-regulates the cyclin D1–cyclin-dependent kinase (CDK)-4 complex. The corresponding DHA-epoxide, epoxydocosapentaenoic acid (EDP), inhibits metastasis and tumor growth.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Furthermore, the actions of the DHA and EPA-epoxides are attenuated in the absence of a soluble-epoxide-hydrolase (sEH) inhibitor, indicating that the functional epoxide moiety is key for their antitumorigenic properties.</div><div class="NLM_p">Omega-3 fatty acids are enzymatically converted into docosahexaenoyl ethanolamide (DHEA) and eicosapentaenoyl ethanolamide (EPEA) through the <i>N</i>-acyl ethanolamine synthesis pathway, similar to the conversion of the omega-6 fatty acid arachidonic acid (AA) to arachidonoyl ethanolamide (AEA, anandamide).<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> These ethanolamide derivatives are collectively termed endocannabinoids (eCBs) because they elicit similar physiological effects as cannabinoids found in cannabis. The eCB system consists of biosynthetic and degradative enzymes, such as diacylglycerol lipase (DAG) and FAAH;<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> omega-6 eCBs, AEA and 2-arachidonylglycerol (2-AG); and cannabinoids receptors 1 and 2 (CB1 and CB2).<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> CB1 is predominantly found in the central nervous system (CNS), CB2 is found in immune cells.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> CB receptors interact with various eCBs to exert their physiological activities.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> CB1 and CB2 interact with the active components of cannabis and are responsible for cannabis’s psychoactive and anti-inflammatory properties, respectively. Phytocannabinoids, such as Δ<sup>9</sup>-tetrahydrocannabinol (Δ<sup>9</sup>-THC), and cannabidiol (CBD), are two specific components of cannabis that have been shown to induce apoptosis in hepatocellular carcinoma, breast cancer, and colon cancer.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> As a whole, phytocannabinoids and eCBs have been shown to play a powerful role in cancer-cell proliferation, apoptosis, inflammation, and immunomodulation.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a></div><div class="NLM_p">The most studied eCBs in the human body are AEA and 2-AG, which are derived from AA. AEA was shown to have antitumorigenic effects on breast cancer, colorectal cancer, and OS.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23">(20−23)</a> 2-AG has been shown to induce apoptosis in prostate cancer.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The omega-3-derived eCBs, DHEA and EPEA, have shown greater antiproliferative activity than their parent counterparts in prostate-cancer cells.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Additionally, it was also shown that the activity of eCBs in cancer cells was increased in the presence of a FAAH inhibitor, indicating that the ethanolamide eCBs, AEA, DHEA, and EPEA, contribute to the increased pro-apoptotic and antiproliferative activity.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a></div><div class="NLM_p">Recently, we showed that a novel class of eCB epoxides are generated from the cross-talk of the NAPE-PLD pathway and CYP-epoxygenase pathways, which were found in various tissues<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a). These bifunctional metabolites contain both ethanolamide and epoxide motifs that function through different signaling pathways lead to several overlapping physiological outcomes. Both the eCB and epoxyeicosanoid pathways have been implicated in cancer, as described above.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> Hence, we wanted to evaluate the antitumorigenic properties of dual-functional eCB epoxides in a cancer model. These lipid metabolites, termed EPEA epoxide (i.e., epoxyeicosatetraenoic-ethanolamide (EEQ-EA)) and DHEA-epoxide (i.e., epoxydocosapentaenoic-ethanolamide (EDP-EA)), are synthesized from EPEA and DHEA by cytochrome P450s and are anti-inflammatory and vasodilatory in nature. More importantly, DHEA-epoxides are widely distributed throughout the body. Additionally, we show that there is an ∼80% increase in these levels in metastatic lungs (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b and <a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf" class="ext-link">S1</a>) compared to levels in normal lungs of mice. This indicates that they might play a physiological role in tumorigenesis and cancer metastasis.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/medium/jm-2018-002437_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/large/jm-2018-002437_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Endogenous synthesis of DHEA-epoxide regioisomers (EDP-EAs), 19,20- (<b>5</b>), 16,17- (<b>4</b>), 13,14- (<b>3</b>), 10,11- (<b>2</b>), and 7,8-EDP-EA (<b>1</b>). (B) Levels of endocannabinoid epoxides of DHEA and DHEA in normal lungs and lungs of mice with tumor metastasis. The lungs in the images were infused with India ink, and white lesions represent metastatic-tumor burden. (C) Percentage cell viability as measured by cell-titer blue assay with various regioisomers at 5, 12.5, and 25 μM. (D) Apoptosis induced in HOS, 143B, and MG63 cells by 12.5 μM concentrations of 13,14-EDP-EA (crisscross), 10,11-EDP-EA (checkered), and 7,8-EDP-EA (dots). (E) Wound-healing scratch shown at 0 and 10 h in the 143B cell line with 13,14-EDP-EA, 10,11-EDP-EA, and 7,8-EDP-EA at 5 μM concentrations. (F) Wound healing represented as a ratio of wound remaining in the treatment group to the wound remaining in the control group after 10 h in three cell lines, (i) HOS, (ii) 143B, and (iii) MG63, with 5 μM concentrations of 13,14-EDP-EA (crisscross), 10,11-EDP-EA (checkered), and 7,8-EDP-EA (dots).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/large/jm-2018-002437_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00243&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Herein, we investigate the antitumorigenic activities of the different regioisomers of DHEA-epoxides on OS cell lines. OS is the most common primary bone cancer in humans and presents high rates of invasion and metastasis. The cannabinoid-receptor agonist WIN-55212 has been shown to potentiate the antitumorigenic properties of drugs like adriamycin in OS.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Additionally, the administration of cannabinoid-receptor agonists have been shown to reduce bone loss in bone-tumor models and cannabinoid-receptor-mediated nociceptive pain.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> Taken together, we will show that DHEA-epoxide regioisomers and their stable derivatives exhibit antitumorigenic activities in OS, and therefore, can potentially reduce bone-cancer pain through receptor-selective activation.</div><div class="NLM_p">In order to examine the antitumorigenic properties of DHEA-epoxides, we first tested the apoptotic potential of the different regioisomers of DHEA-epoxides using an annexin V staining assay in three different OS cell lines (metastatic OS cell lines, MG63 and 143B, and the nonmetastatic cell line HOS) and identified the most potent DHEA-epoxide regioisomer. We further tested the antimigratory potential of the DHEA-epoxides via a wound-healing assay in all three cell lines.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Interestingly, we observed significant differences between the DHEA-epoxide regioisomers tested with respect to their pro-apoptotic and antimigratory properties that were uniform across the different OS cell lines chosen for the studies, indicating that the specific isomers of these lipid metabolites triggered common signaling pathways.</div><div class="NLM_p">Furthermore, we synthesized stable derivatives of the most pro-apoptotic regioisomer of DHEA-epoxide, 10,11-EDP-EA, to reduce its hydrolytic susceptibility to FAAH and increase its binding to CB1. 10,11-EDP-EA and its stable derivatives were further tested for their antitumorigenic and antimigratory properties and for susceptibility to FAAH hydrolysis.</div><div class="NLM_p last">Collectively, we report a novel class of DHEA-epoxides and their stable derivatives that exhibit anti-inflammatory,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> antiangiogenic, antitumorigenic, and antimigratory properties. By virtue of their ability to bind cannabinoid receptors, DHEA-epoxides and its analogues may reduce nociceptive bone pain in OS. OS is commonly accompanied by inflammation and pain; these molecules could aid in alleviating both.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73282" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73282" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Endogenous Production of DHEA-Epoxides in Metastatic-Osteosarcoma Lung Tissues</h3><div class="NLM_p">We developed a targeted lipidomics method using LC-MS/MS in multiple-reaction-monitoring (MRM) mode to identify and quantitate DHEA-epoxide regioisomers (19,20-, 16,17-, 13,14-, 10,11-, and 7,8-EDP-EA).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In order to quantify basal levels of endogenous EDP-EA regioisomers in metastatic and non-tumor containing lungs, we measured these metabolites in mice with OS and those without. We used a metastatic-tumor animal model. 10<sup>6</sup> K7M2 cells (murine OS cells) were prepared in HBSS and intravenously injected into the tail veins of 6–8 week old female BALB/c mice in 200 μL volumes. Lungs from ten mice, five mice with lungs absent of tumors and five with lung-metastasized OS tumors, were isolated. The eCBs were extracted from the lungs and quantified by LC-MS/MS as described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. As indicated in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b and <a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf" class="ext-link">S1</a>, both tumor-free lungs without OS and tumor-present lungs in mice produced several-fold fewer eCB-epoxides compared to the levels of DHEA, the parent molecule. There was an increase of ∼87% in the terminal DHEA-epoxide, 19,20-EDP-EA, a 66% increase in 16,17-EDP-EA, a 72% increase in 13,14-EDP-EA, and a 49% increase in 10,11-EDP-EA in lungs with a metastatic-tumor burden, whereas DHEA levels did not change in lung tissue with a metastatic burden compared to the levels in healthy lungs with no tumors. The increase of these metabolites in the metastasized lungs warranted further investigation to determine whether they were promoting tumor growth or exhibiting antitumorigenic properties.</div><div class="NLM_p last">In order to investigate the effects of eCB epoxides on OS, all five regioisomers were synthesized as described previously.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a>meta-chloroperoxybenzoic acid (mCPBA) was used to oxidize DHA and the epoxide regioisomers formed were purified using reverse- and normal-phase HPLC. The individual regioisomers were coupled to ethanolamine and purified by reverse-phase chromatography. The compounds were quantified using synthesized standards and used for further studies.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Effects of DHEA-Epoxide (EDP-EA) Regioisomers on Cell Viability</h3><div class="NLM_p last">To evaluate the effects of EDP-EA regioisomers on the cellular viability of OS cells, a cell-titer blue (CTB) assay was performed on 143B metastatic OS cells at 5 μM concentrations. The CTB assay measures cellular viability by measuring the conversion of the dye reazurin into the fluorescent end product resorufin by living cells. The fluorescence produced is directly proportional to the amount of viable cells. As seen in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>c, only 13,14-, 10,11-, and 7,8-EDP-EA reduced total cell viability at 12.5 μM concentrations, while 19,20- and 16,17-EDP-EA were less effective. All regioisomers were tested for their effects on 143B cell viability by CTB assays at various concentrations, as seen in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf" class="ext-link">Figure S2</a>. However, at 25 μM concentrations, complete reduction of cell viability was observed for all EDP-EA isomers. Because 7,8-, 10,11-, and 13,14-EDP-EA were more effective at reducing cell viability than the other two regioisomers at lower concentrations, their apoptotic and antimigratory potentials were further evaluated. In order to evaluate if the decrease in cell viability due to the three different DHEA-epoxide regioisomers was the result of cell death or a check in cell proliferation, we performed apoptosis and wound healing assays.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Induction of Apoptosis in Metastatic-OS Cells by DHEA-Epoxide (EDP-EA) Regioisomers</h3><div class="NLM_p last">The apoptotic potential of 7,8-EDP-EA, 10,11-EDP-EA, and 13,14-EDP-EA were tested in three different cell lines, HOS, 143B, and MG63 cells, using the annexin V/PI staining assay at 12.5 μM concentrations. This concentration was chosen to reflect the point in the CTB assay where cell viability was reduced but not completely diminished. The annexin V/PI binding assay measures apoptotic cells by binding labeled annexin V to phosphatidylserine (PS) species. PS is an inner-leaflet lipid that flips to the outer leaflet of the plasma membrane in apoptotic cells. Fluorescence by annexin V is proportional to apoptotic cells. PI binds to DNA in necrotic cells. A signal from both annexin V and PI indicate cells in late apoptosis. As seen in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>d, all three regioisomers induced apoptosis in all the cell lines at the concentration of 12.5 μM. Specifically, in the 143B cell line (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf" class="ext-link">Supplementary Table ST3</a>), 7,8-EDP-EA induced 8.75 ± 0.15% apoptosis (<i>p</i> = 0.001), 10,11-EDP-EA induced 17.92 ± 3.32% (<i>p</i> = 0.05) apoptosis, and 13,14-EDP-EA induced 9.95 ± 1.88% apoptosis (<i>p</i> = 0.09). Similar to these results, in MG63 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf" class="ext-link">Table ST4</a>), 7,8-EDP-EA induced 16.4 ± 1.4% apoptosis (<i>p</i> = 0.011), 10,11-EDP-EA induced 26.6 ± 3.5% apoptosis (<i>p</i> = 0.027), and 13,14-EDP-EA induced 16.9 ± 2.3% apoptosis (<i>p</i> = 0.04). In HOS cells (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf" class="ext-link">Table ST2</a>), the trend followed, and 7,8-EDP-EA induced 17.1 ± 0.5% apoptosis (<i>p</i> = 0.023 compared to the control), 10,11-EDP-EA induced 31.1 ± 2.3% apoptosis (<i>p</i> = 0.007), and 13,14-EDP-EA induced 19.6 ± 3.5% apoptosis (<i>p</i> = 0.027). In contrast to these results, treatment of all three different cell lines with AA, AEA, DHA, and DHEA at 12.5 μM concentrations showed no induction of apoptosis compared to the no-treatment control (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf" class="ext-link">Table ST1</a>).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Inhibition of Migration of Cancer Cells by DHEA-Epoxides As Determined Using a Wound-Healing Assay</h3><div class="NLM_p">The wound-healing assay has been shown to be an effective measure for the directional migration of cells in vivo.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(30)</a> This assay measures the migration of cells across a scratch or wound over time as an indicator of cell migratory potential. A wound-healing assay was performed for 7,8-EDP-EA, 10,11-EDP-EA, and 13,14-EDP-EA at 5 μM. This concentration was chosen to reflect a concentration at which the compounds are not significantly pro-apoptotic, and the reduction in wound healing would be due to the compounds’ antimigratory properties only. <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>e is representative of the effects of 7,8-EDP-EA, 10,11-EDP-EA, and 13,14-EDP-EA on wound closure in 143B cells. <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>f represents the ratio of wound remaining in the treatment to the wound remaining in the no-treatment control at three time points (0, 6, and 10 h). Therefore, a ratio of 1 indicates that the same percentage areas of wound remain in the treatment and control, and thus the treatment is no different from control. A ratio higher than 1 indicates that the treatment has a higher percentage area of wound remaining and thus is a compound that restricts migration. As seen from the data in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>f, in HOS cells, all three compounds inhibit cell migration to an extent. For 7,8-EDP-EA (at 6 h, <i>p</i> = 0.07, and at 10 h, <i>p</i> = 0.35) and 13,14-EDP-EA (at 6 h, <i>p</i> = 0.5, and at 10 h, <i>p</i> = 0.4) the difference in wound closure at 10 h is not significant. For 10,11-EDP-EA, the wound closure at 10 h is 1.5 times better than in the control (at 6 h, <i>p</i> = 0.08, and at 10 h, <i>p</i> = 0.17). In 143B cells (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>f), 7,8-EDP-EA and 13,14-EDP-EA do not inhibit wound healing at 10 h. However, 10,11-EDP-EA inhibits wound closure significantly at 10 h (at 6 h, <i>p</i> = 0.21, and at 10 h, <i>p</i> = 0.05). In the MG63 cell lines (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>f), all three isomers restrict wound healing, and at 10 h, 10,11-EDP-EA inhibited wound closure twice as much as the control (at 6 h, <i>p</i> = 0.38, and at 10 h, <i>p</i> = 0.06). For 13,14-EDP-EA, wound healing was restricted at 10 h but not at 6 h (at 6 h, <i>p</i> = 0.018, and at 10 h, <i>p</i> = 0.015). For 7,8-EDP-EA, a similar trend was seen, with <i>p</i> = 0.23 at 6 h, and <i>p</i> = 0.23 at 10 h. Thus, although all three isomers in most conditions demonstrate variable capacity to restrict wound healing and thereby show antimigratory potential, the directional-trend effect is greatest in 10,11-EDP-EA.</div><div class="NLM_p last">From our apoptosis and wound-healing assays, 10,11-EDP-EA was the most potent regioisomer. This was partly mediated through cannabinoid receptor 1, as the reduction of cell migration by 10,11-EDP-EA in the 143B cell line was completely abolished by using the CB1-receptor antagonist rimonabant (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf" class="ext-link">Figure S4</a>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(31)</a></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Synthesis of Amide Derivatives of 10,11-DHEA Epoxide (10,11-EDP-EA)</h3><div class="NLM_p">The eCB epoxides are dual-functional molecules. As the amide bond is susceptible to FAAH, we designed more stable analogues of 10,11-EDP-EA. Derivatives were made with different amide modifications at the carboxylate end to reduce susceptibility to hydrolysis by FAAH as well as to increase binding to CB1 and CB2, the purported receptors for apoptotic activity.</div><div class="NLM_p">The current literature has mainly focused on AEA and AEA derivatives, because AEA is a biological ligand of the CB1 and CB2 receptors. It has been previously shown that introduction of a methyl group at the 1′ position of the amide results in increased metabolic stability of AEA while affecting the CB1 binding ability.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(32)</a> It was shown that the <i>R</i>-isomer has 4-fold higher CB1 binding and the <i>S</i>-isomer has 2-fold lower binding compared to AEA. Thus, the <i>R</i>-1′-methyl isomer was the first modification made to 10,11-EDP, resulting in 10,11-EDP-IA (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a). Next, the cyclopropyl derivative of AEA has been shown to have modest FAAH inhibition, with an IC<sub>50</sub> value of 4.1 ± 2.0 μM and significantly increased CB1 binding;<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(33)</a> thus, 10,11-EDP-CA was prepared. Finally, the <i>n</i>-propyl derivative of AEA was made to assess the effect of acyl-chain length on FAAH hydrolysis. It has also been shown to have better affinity for CB1 as compared with that of AEA, thus 10,11-EDP-NA was prepared.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(34,35)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/medium/jm-2018-002437_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/large/jm-2018-002437_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Synthetic scheme for the EDP-EA analogues (<b>6</b>–<b>8</b>). (B) Fatty acid amide hydrolase (FAAH)-dependent hydrolysis of amide derivatives. (C) Apoptotic potentials of 10,11-EDP-EA (checkered), 10,11-EDP-NA (<b>7</b>, dots), 10,11-EDP-IA (<b>8</b>, horizontal stripes), and 10,11-EDP-CA (<b>6</b>, vertical stripes) compared to the control measured by an annexin V apoptosis assay. (D) Antimigratory properties of 10,11-EDP-EA, 10,11-EDP-NA, 10,11-EDP-IA, and 10,11-EDP-CA compared to the control measured by a wound-healing scratch assay on HOS, 143B, and MG63 cell lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/large/jm-2018-002437_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00243&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The synthesis of these analogues is outlined in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> and shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a and is similar to the synthesis of 10,11-EDP-EA. Briefly, 10,11-EDP was incubated with NHS and EDC in acetonitrile for 20 min at 37 °C, followed by the addition of the corresponding amine, and stirred overnight at room temperature. The amines were purified by reverse-phase HPLC and quantified in a similar manner to 10,11-EDP-EA.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Susceptibility of 10,11-DHEA-Epoxide and Its Amide Derivatives to FAAH Hydrolysis</h3><div class="NLM_p last">Fatty acid amide hydrolase (FAAH) is a ubiquitously expressed protein in various mammals, and the sequence of the protein has been shown to be highly conserved in humans,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(36)</a> mice,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(36)</a> and pigs.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(37)</a> For our studies, we used pig-brain-membrane preparations to analyze the effect of FAAH on 10,11-EDP-EA as well as the three amino-derived modifications.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(38)</a> The products of hydrolysis were measured by LC-MS/MS as indicated in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. Previously, 19,20-EDP-EA, the rate of hydrolysis was 150 pmol/min per milligram of protein.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> As observed from <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b, there was significant reduction of hydrolytic potential in all three derivatives as compared with that of 10,11-EDP-EA (<i>p</i> < 0.01). Whereas the rate of hydrolysis of 10,11-EDP-EA to 10,11-EDP was 30.0 ± 0.3 pmol/min per milligram of protein, the rates of hydrolysis for derivatives 10,11-EDP-NA, 10,11-EDP-IA, and 10,11-EDP-CA were 0.09 ± 0.01, 0.99 ± 0.04, and 5.17 ± 0.06 pmol/min per milligram of protein, respectively. Because the three derivatives show significantly reduced hydrolytic susceptibility, they could have higher bioavailability, and thus their apoptotic and antimigratory potentials were further evaluated.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Apoptosis Induced by Amino-Modified Derivatives of 10,11 DHEA Epoxide (10,11-EDP-EA)</h3><div class="NLM_p last">All three amino-modified derivatives of 10,11-EDP were tested for their apoptotic activity by an annexin V/PI binding assay. All three compounds showed increased apoptotic potential compared to the no-treatment vehicle control (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>c). The 10,11-EDP-CA analogue had the highest pro-apoptotic potential among the three derivatives. In HOS, MG63, and 143B cells, it increased apoptosis to 27.2 ± 4.1% (<i>p</i> = 0.036 compared to the control), 17.1 ± 4.4% (<i>p</i> = 0.078), and 21.3 ± 1.9% (<i>p</i> = 0.01), respectively. The 10,11-EDP-IA analogue was the second most effective in HOS and MG63 cells, with apoptotic potentials of 20.2 ± 1.8% (<i>p</i> = 0.016) and 17.5 ± 2.8% (<i>p</i> = 0.033), respectively; in 143B cells, it was only 18.8 ± 0.3% (<i>p</i> = 0.0004) for 10,11-EDP-IA, compared to 25.7 ± 0.4% (<i>p</i> = 0.0002) for 10,11-EDP-NA. However, 10,11-EDP-NA was least effective in HOS and MG63 cells, with only 17.1 ± 1.4% (<i>p</i> = 0.017) and 15.2 ± 3.3% (<i>p</i> = 0.06), respectively. Overall, all the derivatives showed pro-apoptotic potentials similar to the parent compound without discernible differences.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Wound-Healing Assay to Determine the Potential to Inhibit Cell Migration by Amino-Modified Derivatives of 10,11 DHEA-Epoxide (10,11-EDP-EA)</h3><div class="NLM_p last">A wound-healing assay was used to analyze the antimigratory properties of the three derivatives. The data in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>d are represented as ratios, by compound, of the percentage areas remaining in the wounds to that of the control. As seen in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>d, in all the cell lines, all the 10,11-EDP derivatives restrict wound healing at 10 h. Among the derivatives, 10,11-EDP-CA shows significantly greater potency at the 6 and 10 h time points, inhibiting migration 4.5–6 times more than vehicle control (at 6 h, <i>p</i> = 0.19 for 143B cells and <i>p</i> = 0.57 for HOS cells, and at 10 h, <i>p</i> = 0.11 for 143B cells and <i>p</i> = 0.37 for HOS cells). Similarly, as seen in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>d, in the 143B and HOS cells, wound healing was 1–1.9 times more restricted by 10,11-EDP-EA (for HOS cells, <i>p</i> = 0.08 at 6 h and <i>p</i> = 0.17 at 10 h, and for 143B cells, <i>p</i> = 0.21 at 6 h and <i>p</i> = 0.05 at 10 h), 1–1.47 times more restricted by 10,11-EDP-NA (for HOS cells, <i>p</i> = 0.39 at 6 h and <i>p</i> = 0.44 at 10 h, and for 143B cells, <i>p</i> = 0.4 at 6 h and <i>p</i> = 0.0002 at 10 h), and 1–3.9 times more restricted by 10,11-EDP-IA (for HOS cells, <i>p</i> = 0.58 at 6 h and <i>p</i> = 0.99 at 10 h, and for 143B cells, <i>p</i> = 0.059 at 6 h and <i>p</i> = 0.002 at 10 h). Finally, in the MG63 cell line (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>d), wound healing was 1–2 times more restricted by 10,11-EDP-EA (at 6 h, <i>p</i> = 0.38, and at 10 h, <i>p</i> = 0.06) compared to the control. 10,11-EDP-NA (at 6 h, <i>p</i> = 0.7, and at 10 h, <i>p</i> = 0.94) and 10,11-EDP-IA (at 6 h, <i>p</i> = 0.57, and at 10 h, <i>p</i> = 0.34) were slightly poorer than the control in restricting cell migration. 10,11-EDP-CA (at 6 h, <i>p</i> = 0.12, and at 10 h, <i>p</i> = 0.09 compared to the vehicle control, and <i>p</i> > 0.9 compared to 10,11-EDP-EA) was comparable to 10,11-EDP-EA in the MG63 cell line in restricting cell migration. As observed from the various results, it was concluded that 10,11-EDP-CA was the most potent in inhibiting wound healing in 143B and HOS cells and comparable to the parent molecule in MG63 cells.</div></div><div id="sec2_8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Cell-Cycle Analysis of 10,11-EDP-EA and Its Analogues</h3><div class="NLM_p">The effects of 10,11-EDP-EA and its analogues on cell-cycle progression were tested by treating cells with the compounds for 24 h, staining them with propidium iodide, and then analyzing them with flow cytometry. Staining with PI reflects the percentage of cells in G1, S, and G2 stages of the cell cycle. As seen in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, in 143B cells, there does not appear to be a significant effect on the cell cycle except a slight suppression in S phase with 10,11-EDP-NA. However, with the HOS cell lines, there is an increase in G1 phase with all compounds and a suppression in S phase. Finally, with MG63, there is an increase in G1 phase and a suppression in S phase with 10,11-EDP-IA.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Percentage of Cells Treated with 10,11-EDP-EA, 10,11-EDP-NA, 10,11-EDP-IA and 10,11-EDP-CA in Each Stage of the Cell Cycle As Monitored by Propidium Iodide Staining<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center" char="±">untreated</th><th class="colsep0 rowsep0" align="center" char="±">10,11-EDP-EA</th><th class="colsep0 rowsep0" align="center" char="±">10,11-EDP-NA</th><th class="colsep0 rowsep0" align="center" char="±">10,11-EDP-IA</th><th class="colsep0 rowsep0" align="center" char="±">10,11-EDP-CA</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center">143B</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">G1</td><td class="colsep0 rowsep0" align="char" char="±">56.2 ± 2.7</td><td class="colsep0 rowsep0" align="char" char="±">50.7 ± 2.03</td><td class="colsep0 rowsep0" align="char" char="±">52.2 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">50.1 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">54.2 ± 0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">S</td><td class="colsep0 rowsep0" align="char" char="±">26.6 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">28.9 ± 3.9</td><td class="colsep0 rowsep0" align="char" char="±">24.0 ± 0.3*</td><td class="colsep0 rowsep0" align="char" char="±">41.8 ± 3.7</td><td class="colsep0 rowsep0" align="char" char="±">22.9 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">G2</td><td class="colsep0 rowsep0" align="char" char="±">17.2 ± 2.3</td><td class="colsep0 rowsep0" align="char" char="±">21.1 ± 1.9</td><td class="colsep0 rowsep0" align="char" char="±">23.7 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">8.1 ± 3.7</td><td class="colsep0 rowsep0" align="char" char="±">22.9 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center">HOS</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">G1</td><td class="colsep0 rowsep0" align="char" char="±">47.8 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="±">67.2 ± 0.6**<sup>,#</sup></td><td class="colsep0 rowsep0" align="char" char="±">62.2 ± 0.4**</td><td class="colsep0 rowsep0" align="char" char="±">55.8 ± 5.0</td><td class="colsep0 rowsep0" align="char" char="±">54.4 ± 1.4*<sup>,#</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">S</td><td class="colsep0 rowsep0" align="char" char="±">37.1 ± 1.6</td><td class="colsep0 rowsep0" align="char" char="±">20.3 ± 0.9*</td><td class="colsep0 rowsep0" align="char" char="±">20.7 ± 2.1*</td><td class="colsep0 rowsep0" align="char" char="±">24.3 ± 1.4*</td><td class="colsep0 rowsep0" align="char" char="±">30.5 ± 1.8<sup>#</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">G2</td><td class="colsep0 rowsep0" align="char" char="±">15.1 ± 0.97</td><td class="colsep0 rowsep0" align="char" char="±">12.4 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">17.1 ± 1.7</td><td class="colsep0 rowsep0" align="char" char="±">20.0 ± 3.7</td><td class="colsep0 rowsep0" align="char" char="±">15.1 ± 0.4<sup>#</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center">MG63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">G1</td><td class="colsep0 rowsep0" align="char" char="±">62.9 ± 1.8</td><td class="colsep0 rowsep0" align="char" char="±">67.7 ± 2.2</td><td class="colsep0 rowsep0" align="char" char="±">63.5 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">76.7 ± 0.1*</td><td class="colsep0 rowsep0" align="char" char="±">59.6 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">S</td><td class="colsep0 rowsep0" align="char" char="±">20.2 ± 1.8</td><td class="colsep0 rowsep0" align="char" char="±">17.9 ± 2.1</td><td class="colsep0 rowsep0" align="char" char="±">19.0 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">10.8 ± 0.3*</td><td class="colsep0 rowsep0" align="char" char="±">23.1 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">G2</td><td class="colsep0 rowsep0" align="char" char="±">16.9 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">14.4 ± 0.2**</td><td class="colsep0 rowsep0" align="char" char="±">17.5 ± 0.4<sup>#</sup></td><td class="colsep0 rowsep0" align="char" char="±">12.5 ± 0.4**<sup>,#</sup></td><td class="colsep0 rowsep0" align="char" char="±">16.9 ± 0.1<sup>##</sup></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup><sup>a</sup></sup><p class="last">All experiments were done in triplicate. *<i>p</i> < 0.05, **<i>p</i> < 0.01 compared to the untreated control. <sup>#</sup><i>p</i> < 0.05, <sup>##</sup><i>p</i> < 0.01 compared to 10,11-EDP-EA.</p></div></div></div></div><div id="sec2_8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Prevention of Angiogenesis in HUVEC Cells by 10,11-EDP-EA and Its Analogues</h3><div class="NLM_p">Increased angiogenesis is one of the hallmarks of cancer. The development of neovascularization is key for the adequate supply of nutrients and oxygen to the site of metastasis.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(39)</a> Endothelial-tube formation on a matrix has been established as a cellular model for angiogenesis.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(40)</a> Endothelial HUVEC cells form a networks of tubes when plated on matrigel, and tube formation in presence and absence of treatment can be quantified as a measure of restricted angiogenic potential. Briefly, endothelial HUVEC cells were grown on a matrix and treated with the vehicle control, 0.5 or 1 μM concentrations of the compounds. Tube formation was assessed by ImageJ analysis. As seen in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a,b, the 0.5 and 1 μM concentrations restricted tube formation significantly compared to the vehicle control. We also verified that the 1 μM concentrations of the treatments did not reduce cell viability in HUVEC cells, as seen in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf" class="ext-link">Figure S5</a>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/medium/jm-2018-002437_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/large/jm-2018-002437_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Restriction of tube formation in endothelial HUVEC cells on matrigel by 10,11-EDP-EA, 10,11-EDP-NA, 10,11-EDP-IA, and 10,11-EDP-CA at 0.5 and 1 μM. (B) Quantification of angiogenesis reduction by all amide derivatives as represented by number of branches per unit area. (C) PRESTO–Tango-assay measurement of the activation of CB1 and CB2 by the amide derivatives. (D) EC<sub>50</sub> values of all amide derivatives with CB1 and CB2 as determined by the PRESTO–Tango assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/large/jm-2018-002437_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00243&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Expression of CB1 and CB2 Receptors in Model Cell Lines</h3><div class="NLM_p last">Literature evidence suggests that DHEA is an agonist of CB1 and CB2 receptors.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Therefore, we investigated whether the effect of DHEA is mediated by the CB1–CB2-pathway . Additionally, CB receptors have been shown to be overexpressed in various cancers, including osteosarcoma.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(41)</a> We first determined the expression of CB1 and CB2 receptors in all three cell lines, HOS, 143B, and MG63, by qRT-PCR, which quantifies receptor expression by measuring corresponding mRNA levels and comparing them with those of a control marker like β-actin. As seen in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf" class="ext-link">Figure S6</a>, all three cell lines expressed CB1 and CB2 at similar levels. Additionally, the expression of CB1 and CB2 was significantly higher in 143B cells compared to expression levels in HOS cells (<i>p</i> = 0.023 and 0.021 for CB1 and CB2, respectively) as well as MG63 cells (<i>p</i> = 0.033 and <i>p</i> = 0.027 for CB1 and CB2, respectively).</div></div><div id="sec2_8_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Activation of CB1 and CB2 by 10,11-EDP-EA and Its Amide Analogues</h3><div class="NLM_p last">To investigate whether 10,11-EDP-EA and its amide-modified analogues activated the cannabinoid receptors, a β-arrestin-recruitment PRESTO–Tango assay was performed in a dose-dependent manner for these compounds.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(42)</a> PRESTO–Tango is an open-source resource developed by the Roth group that allows the interrogation of the human GPCRome by drugs and endogenous ligands. In this assay, ligand binding to a specific G-protein-coupled receptor (GPCR) triggers desensitization mediated by the recruitment of protease-tagged arrestin proteins to the activated receptor. This protease-tagged arrestin then cleaves a protease site fused to the C-terminus of the GPCR that is being studied, thus releasing a non-native transcription factor (TF). This TF regulates the transcription of a luciferase reporter construct, which is measured upon the addition of the luminogenic substrate. The activation of the reporter gene by the ligand or drug provides a quantifiable measurement of the degree of interaction between the target receptor and the protease-tagged arrestin partner. Briefly, HTLA cells transfected with either CNR1-Tango or CNR2-Tango were incubated with the appropriate treatment, and subsequently, luminescence was measured as an indicator of receptor activation (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>c,d). CP55940 was used as a control for this experiment, and its EC<sub>50</sub> values were observed to be 0.9 for CB1 and 1.73 nM for CB2, which are in agreement with the literature.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(43)</a> As observed in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>c, a dose–response curve was obtained for 10,11-EDP-EA and its analogues. 10,11-EDP-EA has EC<sub>50</sub> values of 0.43 and 22.5 nM for CB1 and CB2, respectively. This indicates that it shows higher activation of CB1 than CB2. A similar trend was observed for all 10,11-EDP-EA analogues. 10,11-EDP-NA had EC<sub>50</sub> values of 0.19 and 7.3 nM, respectively for CB1 and CB2. 10,11-EDP-CA had EC<sub>50</sub> values of 0.03 and 0.46 nM for CB1 and CB2, respectively. Finally, 10,11-EDP-IA showed the smallest differences in the activation of CB1 and CB2, with EC<sub>50</sub> values of 0.07 and 0.08 nM, respectively. Therefore, all amide analogues had increased activation of both CB1 and CB2 compared to the parent compound, 10,11-EDP-EA, and all activated CB1 better than CB2. As observed in this data, 10,11-EDP-CA is the best activator of CB1. The cannabinoid-receptor-mediated reduction of cancer-cell migration has been reported in the literature,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and it can be hypothesized that 10,11-EDP-CA has increased antimigratory potential as a result of its increased activation of CB1.</div></div><div id="sec2_8_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Apoptotic Effect of DHEA-Epoxides in the Presence of CB1 and CB2 Antagonists</h3><div class="NLM_p last">As an initial investigation into the mechanism of action for these eCBs, we assessed their apoptotic activity in the presence of the CB1 and CB2 antagonists, rimonabant and AM 630, respectively. As seen from <a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf" class="ext-link">Supplementary Tables ST2–4</a>, rimonabant and AM 630 exhibit very limited apoptotic activity compared to the control. However, the blocking of CB1 and CB2 has a very limited effect on the apoptotic potential of the eCB epoxides. In the HOS cell line (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf" class="ext-link">Table ST2</a>), the decrease in apoptosis in the presence of the CB1 antagonist, the CB2 antagonist, or both is modest with all three regioisomers, indicating this is not the primary pathway of action for the eCB epoxides. In 143B cells (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf" class="ext-link">Table ST3</a>), when the CB1 and CB2 antagonists were incubated with 7,8-EDP-EA, there were slight increases in apoptotic activity of 14.6 ± 1.82 and 10.1 ± 1.4%, respectively. A similar result was seen for 13,14-EDP-EA, where the treatment and the CB1 antagonist showed 13.03 ± 3.63%. The treatment and the CB2 antagonist showed no difference in apoptosis compared to the treatment alone at 9.2 ± 0.8%. For 10,11-EDP-EA, there was slight suppression of apoptotic activity with both antagonists. The slight increase in apoptosis might be a combinatorial effect of the treatment with the antagonist. Finally, as seen in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf" class="ext-link">Table ST4</a>, the effects of the CB1 and CB2 antagonists on MG63 cells were similar to those observed in 143B cells. Alternatively, because the molecules have two different reactive centers, an epoxide and an amide, they likely act through two different receptor classes: the cannabinoid receptor and the unknown receptor for the epoxy fatty acids. It is possible that the blocking of the CB1 or CB2 receptors shuttles the molecules to the second epoxide-receptor pathway, thereby increasing the apoptotic activity. Finally, 10,11-EDP-EA showed a decrease in apoptotic potential with the CB1 and CB2 antagonists at 7.44 ± 2.19 and 10.9 ± 0.08%, indicating that this molecule mainly goes through the CB1 and CB2 receptors.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78770" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78770" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Lipid metabolites that are generated from omega-3 fatty acids, such as DHA, have been shown to exert anti-inflammatory, pro-resolving,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and antitumorigenic effects through various mechanisms.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5−7)</a> In one mechanism, DHA is converted by CYP epoxygenase to DHA-epoxides (EDPs) that have been shown to exhibit antitumorigenic properties. Alternatively, DHA can be converted to DHEA, an eCB that has shown antiproliferative efficiency in prostate-cancer cells.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Previously, we have shown that CYPs convert DHEA into DHEA-epoxides (EDP-EA), which are dual-functional molecules containing both ethanolamide and epoxide moieties<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a), and both the eCB and epoxyeicosanoid pathways have been separately implicated in cancer.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> Previously, 19,20 EDP-EA, was shown to exhibit anti-inflammatory properties.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Herein, we evaluated the antitumorigenic properties of all the different regioisomers of EDP-EAs.</div><div class="NLM_p">To ascertain the biological relevance of endocannabinoid epoxides in the tumor microenvironment, we induced tumors in mice and extracted total eCBs from lung-metastasized tumors, which showed that the DHEA-epoxides were increased 20–80%, depending on the regioisomer (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b), in the metastatic mice with OS tumors compared to mice with normal lungs. Bioactive lipids, such as EDP-EAs, are generated by various cell types, including immune cells. We hypothesize that the upregulation of cytochrome P450s in these tumor tissues and surrounding immune cells leads to the rapid synthesis of these EDP-EAs, which are anti-inflammatory,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> antiangiogenic, antimetastatic, and potentially pro-resolving. It has been shown before that pro-resolving mediators help in the reduction of inflammation and modify the tumor microenvironment.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(44)</a> We tested all five epoxide regioisomers of EDP-EA for their ability to induce apoptosis in three human OS cell lines: 143B, MG63, and HOS. We further show that the EDP-EAs result in reduction of the migratory potentials of cancer cells and moderately increase apoptosis in OS cell lines.</div><div class="NLM_p">In all three cell lines, the various regioisomers show apoptotic effects and antimigratory effects that are significantly higher than those of the parent molecules, DHA and DHEA. However, these effects are differential among the various EDP-EA regioisomers. For instance, 10,11-EDP-EA emerges as the most potent regioisomer in reducing cell migration. Interestingly, this effect was mediated via the CB1 receptor; when a CB1 antagonist was used, the antimigratory potential of 10,11-EDP-EA was significantly reduced (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf" class="ext-link">Figure S4</a>).</div><div class="NLM_p">Because 10,11-EDP-EA showed the greatest potency in our assays, we wanted to characterize the molecule and explore its therapeutic potential in vivo. However, EDP-EAs have two hydrolytically susceptible groups. The amide group is hydrolyzed by FAAH, and the epoxide group is hydrolyzed by sEH. Thus, we prepared synthetic analogues that demonstrated similar apoptotic and migratory potentials (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>c,d) compared to 10,11-EDP-EA, but with a markedly reduced susceptibility to FAAH hydrolysis (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b).</div><div class="NLM_p last">Finally, cannabinoid-receptor-mediated apoptosis has been characterized in the literature and is thought to be mediated through ceramide synthesis.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(45)</a> The CB1-mediated restriction of cell migration has also been studied.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(46)</a> In our studies, we show that although all eCB epoxides and their derivatives activate both cannabinoid receptors, their activity is not completely mediated through these receptors. Therefore, their activity could also be mediated through other receptors, including the uncharacterized receptor for epoxy fatty acids, PPAR, and TRPV.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(47)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31553" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31553" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Taking the findings all together, we demonstrate a novel class of eCB epoxides, and their stable derivatives exhibit anti-inflammatory,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> antiangiogenic, antitumorigenic, and antimigratory properties. These molecules particularly reduced the migratory ability of OS cells and therefore may be of greater therapeutic significance to prevent metastasis of tumors. By virtue of their ability to bind CB receptors, these molecules might also exhibit antinociceptive activity . As OS and other forms of cancer are accompanied by inflammation and pain, these molecules might aid in alleviating both conditions. These molecules are naturally occurring and their levels increase ∼80% in OS metastatic lungs, and increasing their levels in vivo using FAAH and sEH dual inhibition will be an effective adjuvant therapy for OS.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(48,49)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26582" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26582" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Materials</h3><div class="NLM_p last">An annexin V/PI kit was purchased from BD Biosciences (556547). HUVEC cells were procured from Thermo Fisher (C0035C), and endothelial-cell media was obtained from Lonza (EGM2 bullet kit CC-3162). An angiogenesis kit was purchased from Abcam (ab204726).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Synthesis of EDP-EAs (<b>1</b>–<b>5</b>)</h3><div class="NLM_p">EDP-EA synthesis was performed in a two-step approach. First, a nonspecific epoxidation reaction with 50 mg of DHA dissolved in 2 mL of dichloromethane (DCM) with 2 mol equiv of metachloroperoxybenzoic acid (mCPBA) was reacted for 1 h at room temperature. The reaction was stopped with an equal volume of 10% aqueous NaHCO<sub>3</sub> to remove mCPBA from the organic layer, and the aqueous layer was re-extracted thrice with equal volumes of DCM; the combined organic layer was dried in vacuo. Purification of regioisomers was achieved using normal-phase HPLC (NP-HPLC) using a Zorbax-NH<sub>2</sub> semipreparative column (5 μm, 9.4 × 250 mm, Agilent, PN880952-208) with an isocratic gradient (hexane/isopropanol/acetic acid, 90:10:0.1) coupled to an HPLC system. For coeluting regioisomers of DHA-epoxides (19,20-EDP and 13,14-EDP), the mixtures were further purified on the same system using reverse-phase HPLC (RP-HPLC), a Sun Fire Prep C18 column (5 μm, 19 × 50 mm, PN 186002566; Waters), a mobile system composed of solvent A (H<sub>2</sub>O/acetonitrile/acetic acid, 95:5:0.1) and solvent B (H<sub>2</sub>O/acetonitrile/acetic acid, 5:95:0.1), and a linear gradient from 50 to 0% A in 50 min.</div><div class="NLM_p last">In the second step, the coupling of the purified EDP regioisomer to ethanolamine was achieved by dissolving the epoxide in acetonitrile and incubating it at 37 °C for 20 min with 1-ethyl-3-(3-(dimethylamino)propyl) carbodiimide (EDC) and <i>N</i>-hydroxysuccinimide (NHS). Ethanolamine was subsequently added, and the mixture was stirred overnight at room temperature. The resulting EDP-EA regioisomers were purified by RP-HPLC using a Sun Fire Prep C18 column (5 μm, 19 × 50 mm, PN 186002566; Waters), a mobile system composed of solvent A (H<sub>2</sub>O/acetonitrile/acetic acid, 95:5:0.1) and solvent B (H<sub>2</sub>O/acetonitrile/acetic acid, 5:95:0.1), and a linear gradient from 50 to 0% A in 50 min.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Isolation of Endocannabinoids from Tissue Samples: K7M2 Experimental Metastatic-Tumor Models of Osteosarcoma</h3><div class="NLM_p last">All animal-experimental procedures were reviewed and approved by the University of Illinois Institutional Animal Care and Use Committee (Protocol 15120). K7M2 cells (1,000,000) were prepared in HBSS and intravenously injected into the tail veins of 6–8 week old female BALB/c mice (day 0) in 200 μL volumes. After 14 days, the mice were sacrificed, the lung tissue was isolated and weighed, and total endocannabinoids were extracted. The tissue was mechanically homogenized on ice with a BioHomogenizer (BioSpec) in a 1:1 ratio with PBS supplemented with sEH inhibitor 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA, 30 μm; Cayman Chemical) and FAAH inhibitor, phenylmethylsulfonyl fluoride (PMSF,1 mM) until a homogeneous slurry was formed. Tissue (1 g) was homogenized with 40 mL of ethyl acetate/hexane (9:1) using a BioHomogenizer (BioSpec) at room temperature and then sonicated for 1 min. The resulting solution was washed with a 30% volume of water and centrifuged for the layers to separate. The organic layer was removed, and the aqueous layer was extracted with an equal volume of ethyl acetate/hexane (9:1) twice. The total organic layer was concentrated in vacuo using a Buchi 120 rotary evaporator and reconstituted in 1 mL of chloroform. The metabolites of interest were isolated by solid-phase extraction (SPE) using a 1 mL silica-gel column (no. 214477, Sigma). The reconstituted samples were added to the silica column, washed in three column volumes of chloroform, and consequently eluted with four column volumes of methanol/chloroform (1:9). The eluent was dried, and samples were reconstituted in ethanol for analysis via LC-MS/MS.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Liquid-Chromatography–Mass-Spectrometry Analysis</h3><div class="NLM_p last">The LC separation was performed on an Agilent Eclipse XDB-C18 (4.6 × 150 mm, 5 μm) with mobile phase A (0.1% formic acid in water) and mobile phase B (0.1% formic acid in acetonitrile). The flow rate was 0.4 mL/min. The linear gradient was as follows: 0–2 min, 90% A; 8 min, 55% A; 13–25 min, 40% A; 30 min, 30% A; 35 min, 25% A; 40–47 min, 20% A; and 47.5–54 min, 90% A. The autosampler was set at 5 °C. The injection volume was 10 μL. Positive mass spectra were acquired with an ion-spray voltage of 5500 V under electrospray ionization (ESI). The source temperature was 450 °C. The curtain gas, ion-source gas 1, and ion-source gas 2 were 32, 60, and 60 psi, respectively. Multiple-reaction monitoring (MRM) was used for quantitation: <i>m</i>/<i>z</i> 388.1–62.1 for 19,20-EDP-EA and 7,8-EDP-EA; <i>m</i>/<i>z</i> 388.1–370.1 for 16,17-EDP-EA, 13,14-EDP-EA, and 10,11-EDP-EA; <i>m</i>/<i>z</i> 372.4–62.1 for DHEA; and <i>m</i>/<i>z</i> 348.3–62.1 for anandamide. Internal standards were monitored at <i>m</i>/<i>z</i> 376.4–66.1 for DHEA-<i>d</i><sub>4</sub>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Cell Culture</h3><div class="NLM_p last">Human cell lines HOS, MG63, and 143B were cultured in DMEM (Gibco, Invitrogen) supplemented with 10% fetal bovine serum (FBS) and 1 mg/mL penicillin–streptomycin (Gibco, Invitrogen) at 37 °C and 5% CO<sub>2</sub> in a humidified incubator.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Cell-Titer Blue Assay</h3><div class="NLM_p last">In 96-well plates, 20,000 cells were plated per well and allowed to adhere overnight. In the morning, the cell media was aspirated and replaced with 100 μL of fresh cell media, after which the cells were incubated with a compound or the DMSO vehicle control (1 μL) at 37 °C and 5% CO<sub>2</sub> in a humidified incubator for 24 h. Cell-titer blue reagent (24 μL) was added, and the plate was incubated for 1 h before the fluorescence was read using a plate reader with excitation at 534 nm and emission at 590 nm.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Annexin V Assay</h3><div class="NLM_p last">An annexin V kit from BD Biosciences was used. Briefly, cells were scraped and collected with the dead cells. They were washed with ice cold 2× PBS twice, resuspended in 1× binding buffer, and incubated with annexin V–FITC and propidium iodide for 15 min, followed by flow cytometry with a BD Accuri C6 instrument. The annexin V–PI assay was performed as per the manufacturer’s instructions. Briefly, cells were trypsinized and collected for analysis. Dead cells in the media were collected for testing along with the rest of the sample. The total cell sample was washed twice with cold PBS and then resuspended in 100 μL of binding buffer. Annexin V and PI (5 μL each) were added, and the cells were vortexed and incubated in the dark for 15 min. The cells were then diluted with 400 μL of binding buffer and analyzed with a BD Accuri flow cytometer within 1 h. The treated samples were compared with both negative- and positive-stained samples and with the vehicle control.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Wound-Healing Assay</h3><div class="NLM_p last">Cells were grown to a confluent monolayer in 12-well plates, a scratch was made across the center of the plate with a pipet tip, and images were taken. The media was replaced with fresh media, and a treatment or the vehicle control was added to the wells. The cells were maintained at 37 °C and 5% CO<sub>2</sub> in a humidified incubator, and images were taken every 2 h. The images were processed using ImageJ via the wound-healing plugin and normalized to 100% area at time 0.</div></div><div id="sec5_8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Synthesis of Amine EDP-EAs and Analogues (<b>1</b>–<b>8</b>)</h3><div class="NLM_p last">To a solution of epoxide in acetonitrile, a solution of 1-ethyl-3-(3-(dimethylamino)propyl) carbodiimide (EDC, 10 mg/mL in acetonitrile) and <i>N</i>-hydroxysuccinimide (NHS, 10 mg/mL in acetonitrile) in a ratio of 1:50:50 was added and incubated at 37 °C for 20 min. To this, we added the amine solution (2 mg/mL in acetonitrile) in a ratio of 1:50 with epoxide, and this was stirred at room temperature overnight. The acetonitrile was removed under reduced pressure. The sample was reconstituted in ethanol and purified via HPLC. Purification of the 10,11-EDP derivatives was performed using a reverse-phase HPLC (RP-HPLC), Sun Fire Prep C18 column (5 μm, 19 × 50 mm, PN 186002566; Waters) and a mobile system composed of solvent A (H<sub>2</sub>O/acetonitrile/acetic acid, 95:5:0.1) and solvent B (H<sub>2</sub>O/acetonitrile/acetic acid, 5:95:0.1) and a linear gradient from 50 to 0% A in 50 min. Compounds <b>1</b>−<b>5</b> have been previously synthesized and characterized. The HR-ESI and <sup>1</sup>H NMR characterization performed is detailed below, and <sup>1</sup>H NMR spectra are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf" class="ext-link">Figures S7–10</a>. All compounds showed >95% purity by <sup>1</sup>H NMR analysis.</div></div><div id="sec5_8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (4<i>Z</i>,7<i>Z</i>)-<i>N</i>-(2-Hydroxyethyl)-9-(3-((2<i>Z</i>,5<i>Z</i>,8<i>Z</i>)-undeca-2,5,8-trien-1-yl)oxiran-2-yl)nona-4,7-dienamide (10,11-EDP-EA, <b>2</b>)</h3><div class="NLM_p">Synthesis was performed as mentioned in the previous section using 10,11-EDP and ethanolamine. HR-ESI-MS (<i>m</i>/<i>z</i>) found: 387.2821, [M + H]<sup>+</sup> calculated (C<sub>24</sub>H<sub>38</sub>NO<sub>3</sub>): 387.28.</div><div class="NLM_p last"><sup>1</sup>H NMR: 5.58–5.27 (m, 10H), 3.77–3.62 (m, 3H), 3.45–3.32 (m, 2H), 3.29–3.22 (t, 2H), 3.21–3.15 (d, 1H), 3.03–2.94 (m, 2H), 2.88–2.75 (m, 4H), 2.75–2.65 (t, 1H), 2.32–2.22 (m, 5H), 1.15–1.09 (t, 3H), 1.00–0.94 (t, 3H).</div></div><div id="sec5_8_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (4<i>Z</i>,7<i>Z</i>)-<i>N</i>-Cyclopropyl-9-(3-((2<i>Z</i>,5<i>Z</i>,8<i>Z</i>)-undeca-2,5,8-trien-1-yl)oxiran-2-yl)nona-4,7-dienamide (10,11-EDP-CA, <b>6</b>)</h3><div class="NLM_p">Synthesis was performed as mentioned in the previous section using 10,11-EDP and cyclopropylamine. HR-ESI-MS (<i>m</i>/<i>z</i>) found: 384.2910, [M + H]<sup>+</sup> calculated C<sub>25</sub>H<sub>38</sub>NO<sub>3</sub>: 383.58.</div><div class="NLM_p last"><sup>1</sup>H NMR: 5.57–5.22 (m, 10H), 3.30–3.24 (t, 2H), 3.24–3.14 (q, 2H), 2.99–2.93 (m, 1H), 2.87–2.77 (m, 6H), 2.73–2.66 (m, 1H), 2.42–2.36 (m, 3H), 2.20–2.14 (t, 2H), 2.12–2.05 (t, 2H), 1.87–79 (t, 2H), 1.00–0.92 (t, 3H), 0.88–0.84 (t, 3H).</div></div><div id="sec5_8_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (4<i>Z</i>,7<i>Z</i>)-<i>N</i>-(3-Hydroxypropyl)-9-(3-((2<i>Z</i>,5<i>Z</i>,8<i>Z</i>)-undeca-2,5,8-trien-1-yl)oxiran-2-yl)nona-4,7-dienamide (10,11-EDP-NA, <b>7</b>)</h3><div class="NLM_p">Synthesis was performed as mentioned in the previous section using 10,11-EDP and 3-amino-1-propanol. HR-ESI-MS (<i>m</i>/<i>z</i>) found [M + Na]: 424.2891, [M + H]<sup>+</sup> calculated C<sub>25</sub>H<sub>40</sub>NO<sub>3</sub>: 401.29.</div><div class="NLM_p last"><sup>1</sup>H NMR: 5.59–5.27 (m, 10H), 3.88–2.79 (t, 1H), 3.75–3.69 (q, 2H), 3.66–3.59 (m, 2H), 3.45–3.38 (m, 2H), 3.28–2.23 (t, 1H), 3.22–3.15 (m, 1H),3.04–2.95 (m, 2 H), 2.91–2.72 (m, 4H), 2.67–2.63 (s, 1H), 2.62–2.58 (t, 1H), 2.48–2.40 (m, 1H), 2.31–2.21 (m, 2H), 1.28–1.22 (m, 4H), 1.15–1.10 (t, 2H), 1.00–0.95 (t, 2H).</div></div><div id="sec5_8_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (4<i>Z</i>,7<i>Z</i>)-<i>N</i>-(1-Hydroxypropan-2-yl)-9-(3-((2<i>Z</i>,5<i>Z</i>,8<i>Z</i>)-undeca-2,5,8-trien-1-yl)oxiran-2-yl)nona-4,7-dienamide (10,11-EDP-IA, <b>8</b>)</h3><div class="NLM_p">Synthesis was performed as mentioned in the previous section using 10,11-EDP and <i>R</i>-(−)2-amino-1-propanol. HR-ESI-MS (<i>m</i>/<i>z</i>) found: 402.2901, [M + H]<sup>+</sup> calculated C<sub>25</sub>H<sub>40</sub>NO<sub>3</sub>: 401.29.</div><div class="NLM_p last"><sup>1</sup>H NMR: 5.57–5.26 (m, 10H), 4.16–3.98 (m, 3H), 3.71–3.57 (m, 2H), 3.57–3.44 (m, 3H), 3.09–2.98 (m, 1H), 2.89–2.75 (m, 4H), 2.46–2.33 (m, 4 H), 2.22–2.21 (m, 3H), 2.11–1.99 (m, 2H), 0.99–0.94 (t, 3H), 0.89–0.85 (t, 3H).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Cell-Cycle Analysis</h3><div class="NLM_p last">Confluent cells (80%) in a 12-well plate were treated for 24 h with the appropriate treatment and harvested. Cells were washed twice with PBS and fixed with 70% ethanol on ice for 30 min with vortexing to prevent clumping. The cells were washed twice with PBS and incubated with 50 μL of a 100 μg/mL RNase solution for 30 min on ice; this was followed by the addition of 200 μL of a 50 μg/mL propidium iodide solution, after which they were analyzed with a BD LSR II flow cytometer and FCS software.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> FAAH Hydrolysis</h3><div class="NLM_p last">The preparation of pig-forebrain membranes was achieved using dounce homogenization in buffer (50 mM Tris, pH 7.4, 1 mM EDTA, and 3 mM MgCl<sub>2</sub>) and membrane pelleting, as previously described.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(38)</a> Incubations contained 5 μg of forebrain protein in a 0.5 mL reaction containing 50 mM Tris (pH 7.4), 1 mM EDTA, 3 mM MgCl<sub>2</sub>, and 20 μM amide. After 40 min, the reactions were quenched with methanol containing 1 mM PMSF and centrifuged to pellet the protein (10,000<i>g</i>, 10 min). The supernatant was collected and analyzed via LC-MS/MS as outlined below.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Analysis of 10,11-EDP by LC-MS/MS</h3><div class="NLM_p last">Analyses were performed using the 5500 QTRAP LC-MS/MS system (AB Sciex) in the Metabolomics Lab of Roy J. Carver Biotechnology Center, University of Illinois at Urbana-Champaign. The 1200 series HPLC system (Agilent Technologies) includes a degasser, an autosampler, and a binary pump, and this system was used to separate the metabolites. LC separation was performed on an Agilent Eclipse XDB-C18 (4.6 × 150 mm, 5 μm) with mobile phase A (0.1% formic acid in water) and mobile phase B (0.1% formic acid in acetonitrile) at a flow rate was 0.4 mL/min. The linear gradient was as follows: 0–2 min, 90% A; 8 min, 55% A; 13–25 min, 40% A; 30 min, 30% A; 35 min, 25% A; 40 min, 20% A; 45–47 min, 15% A; and 48–54 min, 90% A. The autosampler was set at 5 °C. The injection volume was 10 μL. Negative mass spectra were acquired with an ion-spray voltage of −4500 V under electrospray ionization (ESI). The source temperature was 450 °C. The curtain gas, ion source gas 1, and ion source gas 2 were 32, 50, and 55 psi, respectively. Multiple-reaction monitoring (MRM) was used for quantitation: <i>m</i>/<i>z</i> 343.0 for 10,11-EDP.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> PRESTO–Tango β-Arrestin-Recruitment Assay</h3><div class="NLM_p last">The PRESTO–Tango β-arrestin recruitment assay was used for the measurement of CB1 (CNR1) and CB2 (CNR2) GPCR activation as previously described.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> HTLA cells and CNR1-Tango (Addgene #66254) and CNR2-Tango (Addgene #66255) plasmids were a generous gift from the Roth laboratory (University of North Carolina, Chapel Hill). HTLA cells were maintained in DMEM with 10% FBS containing 2 μg/mL puromycin and 100 μg/mL hygromycin B at 37 °C in a 5% CO<sub>2</sub> humidified-air atmosphere and grown to 80–90% confluency. Cells were resuspended in DMEM with 10% FBS containing 1% penicillin/ streptomycin and were seeded at 20,000 cells per 100 μL into a poly-<span class="smallcaps smallerCapital">l</span>-lysine-coated 96-well plate. After 18–24 h, cells were transfected with the CNR1 and CNR2 plasmids (0.1 μg per well) using Calfectin (0.4 μL) as the transfection reagent in a 4:1 reagent-to-plasmid ratio (final well volumes of 110 μL). Transfection media was replaced after 12–18 h with fresh serum media and maintained for 36–48 h. On the day of the assay, serum media was replaced with 100 μL of media containing 1% dialyzed FBS for 4 h; then, the compound was further diluted with media containing 1% dialyzed FBS, added in a logarithmic-dose manner (final well volumes of 200 μL), and incubated for 8–14 h. For epoxygenated metabolites, serum media was replaced with 100 μL of media containing 1% dialyzed FBS and 1 μM AUDA for 30 min; then, the compound was further diluted with media containing 1% dialyzed FBS, added in a logarithmic-dose manner (final well volumes of 200 μL including the media supplemented with AUDA), and incubated for 8–14 h. The following day, the media was removed, and 40 μL of diluted Bright-Glo solution (Promega) was added to each well; the plate was incubated in the dark for 20 min at room temperature before luminescence recordings. Relative-luminescence-unit (RLU) values were normalized to percent of receptor response, plotted as a function of compound concentration, and analyzed using “DoseResp” in OriginPro.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Angiogenesis Assay</h3><div class="NLM_p last">Angiogenesis in endothelial HUVEC cells was measured using an Abcam angiogenesis kit (ab204726). Briefly, HUVEC cells at passage 2 (<i>p</i> = 2) were grown to 80% confluency. The matrigel provided was thawed overnight, and 50 μL was put into each well of a 96-well plate that had been chilled overnight in a −20 °C freezer. The plate was rocked slightly and then allowed to incubate at 37 °C for 1 h. HUVEC cells (15,000) were then plated into the wells and treated with the vehicle control or 0.5 or 1 μM concentrations of a compound. A no-matrix control and a control with vinblastine (an inhibitor of angiogenesis) were also performed. All wells were performed in duplicate. The plates were then incubated for 5 h at 37 °C. The incubation medium was removed, and the cells were washed with 100 μL of wash buffer. Staining dye (100 μL) was added to each well, and incubated for 30 min at 37 °C. The wells were imaged using a fluorescent microscope and analyzed using ImageJ with the Angiogenesis Analyzer Plugin.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00243" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83107" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83107" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00243" class="ext-link">10.1021/acs.jmedchem.8b00243</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Endocannabinoid fold change in normal versus metastatic lungs; full-range CTB assay; apoptosis assay with parent fatty acids, 7,8-EDP-EA, 10,11-EDP-EA, and 13,14-EDP-EA in the presence of CB1 and CB2 inhibitors in all three cell lines; scratch assay in 143B cells; CTB assay with HUVEC cells; qRT-PCR for CB1 and CB2; NMR spectra of 10,11-EDP-NA, 10,11-EDP-IA, and 10,11-EDP-CA; scratch assay of 10,11-EDP-CA in 143B cells with CB1 and CB2 antagonists; and angiogenesis assay with 10,11-EDP-EA and its analogues in HUVEC cells (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES strings and the corresponding biological data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">EDP-EA regioisomers (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_003.cdx" class="ext-link">CDX</a>)</p></li><li><p class="inline">10,11-EDP-NA, 10,11-EDP-CA, and 10,11-EDP-IA (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_004.cdx" class="ext-link">CDX</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf">jm8b00243_si_001.pdf (1.31 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_002.csv">jm8b00243_si_002.csv (1.57 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_003.cdx">jm8b00243_si_003.cdx (15.72 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_004.cdx">jm8b00243_si_004.cdx (8.47 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00243" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84246" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84246" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aditi Das</span> - <span class="hlFld-Affiliation affiliation">Department
of Comparative Biosciences, 
    Department of Biochemistry, 
    Beckman Institute for Advanced Science,
Division of Nutritional Sciences, Neuroscience Program, and Department
of Bioengineering, 
    ; ; ; ; , University of Illinois,
Urbana-Champaign, Urbana, Illinois 61802, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6731-6726" title="Orcid link">http://orcid.org/0000-0002-6731-6726</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1b7a7f726f727f7a685b7277777275747268357e7f6e"><span class="__cf_email__" data-cfemail="39585d504d505d584a79505555505756504a175c5d4c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jahnabi Roy</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry; ; ; ; , University of Illinois,
Urbana-Champaign, Urbana, Illinois 61802, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Josephine E. Watson</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry; ; ; ; , University of Illinois,
Urbana-Champaign, Urbana, Illinois 61802, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">In Sup Hong</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry; ; ; ; , University of Illinois,
Urbana-Champaign, Urbana, Illinois 61802, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy M. Fan</span> - <span class="hlFld-Affiliation affiliation">Department of Veterinary Clinical
Medicine; ; ; ; , University of Illinois,
Urbana-Champaign, Urbana, Illinois 61802, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.D. and J.R. conceived the paper; J.R., J.E.W., and I.H. performed the experiments; A.D. and J.R. analyzed the data; J.E.W. performed the PRESTO–Tango assay; I.H. contributed to compounds synthesis; and A.D., J.R., and T.F. wrote and edited the paper.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e1651-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32824" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32824" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Partially supported by American Heart Association Scientist Development Grant 15SDG25760064 (A.D.), National Institutes of Health (NIH) Grant R01 GM1155884 (A.D.), and NIH Grant R03 DA042365. The authors greatly appreciate the contributions of Dr. Z. Li at the Metabolomics Laboratory of Roy J. Carver Biotechnology Center, University of Illinois at Urbana-Champaign. We thank H. Pondenis, Dr. K. Wycislo, and Nicole Sidebotham for helpful discussion.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">AA</td><td class="NLM_def"><p class="first last">arachidonic acid</p></td></tr><tr><td class="NLM_term">EPA</td><td class="NLM_def"><p class="first last">eicosapentaenoic acid</p></td></tr><tr><td class="NLM_term">EEQ</td><td class="NLM_def"><p class="first last">epoxyeicosatrienoic acid</p></td></tr><tr><td class="NLM_term">EEQ-EA</td><td class="NLM_def"><p class="first last">epoxyeicosatrienoic-ethanolamide</p></td></tr><tr><td class="NLM_term">DHA</td><td class="NLM_def"><p class="first last">docosahexaenic acid</p></td></tr><tr><td class="NLM_term">EDP</td><td class="NLM_def"><p class="first last">epoxydocosapentaenoic acid</p></td></tr><tr><td class="NLM_term">EDP-EA</td><td class="NLM_def"><p class="first last">epoxydocosapentaenoic-ethanolamide</p></td></tr><tr><td class="NLM_term">sEH</td><td class="NLM_def"><p class="first last">soluble epoxide hydrolase</p></td></tr><tr><td class="NLM_term">FAAH</td><td class="NLM_def"><p class="first last">fatty acid amide hydrolase</p></td></tr><tr><td class="NLM_term">LC-MS/MS</td><td class="NLM_def"><p class="first last">liquid chromatography–tandem mass spectrometry</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36016" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36016" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 49 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mantovani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allavena, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balkwill, F.</span></span> <span> </span><span class="NLM_article-title">Cancer-related inflammation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>454</i></span>,  <span class="NLM_fpage">436</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1038/nature07205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1038%2Fnature07205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=18650914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovV2mtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=454&publication_year=2008&pages=436-444&author=A.+Mantovaniauthor=P.+Allavenaauthor=A.+Sicaauthor=F.+Balkwill&title=Cancer-related+inflammation&doi=10.1038%2Fnature07205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-related inflammation</span></div><div class="casAuthors">Mantovani, Alberto; Allavena, Paola; Sica, Antonio; Balkwill, Frances</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">454</span>
        (<span class="NLM_cas:issue">7203</span>),
    <span class="NLM_cas:pages">436-444</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mediators and cellular effectors of inflammation are important constituents of the local environment of tumors.  In some types of cancer, inflammatory conditions are present before a malignant change occurs.  Conversely, in other types of cancer, an oncogenic change induces an inflammatory microenvironment that promotes the development of tumors.  Regardless of its origin, 'smoldering' inflammation in the tumor microenvironment has many tumor-promoting effects.  It aids in the proliferation and survival of malignant cells, promotes angiogenesis and metastasis, subverts adaptive immune responses, and alters responses to hormones and chemotherapeutic agents.  The mol. pathways of this cancer-related inflammation are now being unravelled, resulting in the identification of new target mols. that could lead to improved diagnosis and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMShCOkqk0ArVg90H21EOLACvtfcHk0lgyHsDCTfcWZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovV2mtbg%253D&md5=488ad8afac066b6330d0468ebb65d941</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnature07205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07205%26sid%3Dliteratum%253Aachs%26aulast%3DMantovani%26aufirst%3DA.%26aulast%3DAllavena%26aufirst%3DP.%26aulast%3DSica%26aufirst%3DA.%26aulast%3DBalkwill%26aufirst%3DF.%26atitle%3DCancer-related%2520inflammation%26jtitle%3DNature%26date%3D2008%26volume%3D454%26spage%3D436%26epage%3D444%26doi%3D10.1038%2Fnature07205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allavena, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantovani, A.</span></span> <span> </span><span class="NLM_article-title">Cancer related inflammation: the macrophage connection</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2008.03.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2Fj.canlet.2008.03.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=18448242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovF2hsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2008&pages=204-215&author=A.+Sicaauthor=P.+Allavenaauthor=A.+Mantovani&title=Cancer+related+inflammation%3A+the+macrophage+connection&doi=10.1016%2Fj.canlet.2008.03.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer related inflammation: The macrophage connection</span></div><div class="casAuthors">Sica, Antonio; Allavena, Paola; Mantovani, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">204-215</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. macrophages (TAM) are key regulators of the link between inflammation and cancer.  In the tumor microenvironment neoplastic cells shape the differentiation and functional orientation of TAM which, in turn, express several pro-tumoral functions, including secretion of growth factors and matrix-proteases, promotion of angiogenesis, and suppression of adaptive immunity.  This review analyzes the current knowledge of TAM and their involvement in tumor development and progression.  The interplay between TAM and neoplastic cells represents a promising target of future therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgrC1ceAH1C7Vg90H21EOLACvtfcHk0lgyHsDCTfcWZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovF2hsLk%253D&md5=c780e82b622ace9f918e109ce12c1c6d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2008.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2008.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DSica%26aufirst%3DA.%26aulast%3DAllavena%26aufirst%3DP.%26aulast%3DMantovani%26aufirst%3DA.%26atitle%3DCancer%2520related%2520inflammation%253A%2520the%2520macrophage%2520connection%26jtitle%3DCancer%2520Lett.%26date%3D2008%26volume%3D267%26spage%3D204%26epage%3D215%26doi%3D10.1016%2Fj.canlet.2008.03.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardoll, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jove, R.</span></span> <span> </span><span class="NLM_article-title">STATs in cancer inflammation and immunity: a leading role for STAT3</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">798</span>– <span class="NLM_lpage">809</span>, <span class="refDoi"> DOI: 10.1038/nrc2734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1038%2Fnrc2734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=19851315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSjur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=798-809&author=H.+Yuauthor=D.+Pardollauthor=R.+Jove&title=STATs+in+cancer+inflammation+and+immunity%3A+a+leading+role+for+STAT3&doi=10.1038%2Fnrc2734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">STATs in cancer inflammation and immunity: a leading role for STAT3</span></div><div class="casAuthors">Yu, Hua; Pardoll, Drew; Jove, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">798-809</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Commensurate with their roles in regulating cytokine-dependent inflammation and immunity, signal transducer and activator of transcription (STAT) proteins are central in detg. whether immune responses in the tumor microenvironment promote or inhibit cancer.  Persistently activated STAT3 and, to some extent, STAT5 increase tumor cell proliferation, survival and invasion while suppressing anti-tumor immunity.  The persistent activation of STAT3 also mediates tumor-promoting inflammation.  STAT3 has this dual role in tumor inflammation and immunity by promoting pro-oncogenic inflammatory pathways, including nuclear factor-κB (NF-κB) and interleukin-6 (IL-6)-GP130-Janus kinase (JAK) pathways, and by opposing STAT1- and NF-κB-mediated T helper 1 anti-tumor immune responses.  Consequently, STAT3 is a promising target to redirect inflammation for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYvEMN5YrxbbVg90H21EOLACvtfcHk0lgruFOphk7dwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSjur%252FP&md5=e431d0bd9eabd8f1ef703211be3d5cc9</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc2734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2734%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DPardoll%26aufirst%3DD.%26aulast%3DJove%26aufirst%3DR.%26atitle%3DSTATs%2520in%2520cancer%2520inflammation%2520and%2520immunity%253A%2520a%2520leading%2520role%2520for%2520STAT3%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D798%26epage%3D809%26doi%3D10.1038%2Fnrc2734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaudszus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watzl, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ness, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lochner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahreis, G.</span></span> <span> </span><span class="NLM_article-title">Evaluation of suppressive and pro-resolving effects of EPA and DHA in human primary monocytes and T-helper cells</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">935</span>, <span class="refDoi"> DOI: 10.1194/jlr.P031260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1194%2Fjlr.P031260" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=923-935&author=A.+Jaudszusauthor=M.+Gruenauthor=B.+Watzlauthor=C.+Nessauthor=A.+Rothauthor=A.+Lochnerauthor=D.+Barzauthor=H.+Gabrielauthor=M.+Rotheauthor=G.+Jahreis&title=Evaluation+of+suppressive+and+pro-resolving+effects+of+EPA+and+DHA+in+human+primary+monocytes+and+T-helper+cells&doi=10.1194%2Fjlr.P031260"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1194%2Fjlr.P031260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.P031260%26sid%3Dliteratum%253Aachs%26aulast%3DJaudszus%26aufirst%3DA.%26aulast%3DGruen%26aufirst%3DM.%26aulast%3DWatzl%26aufirst%3DB.%26aulast%3DNess%26aufirst%3DC.%26aulast%3DRoth%26aufirst%3DA.%26aulast%3DLochner%26aufirst%3DA.%26aulast%3DBarz%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DH.%26aulast%3DRothe%26aufirst%3DM.%26aulast%3DJahreis%26aufirst%3DG.%26atitle%3DEvaluation%2520of%2520suppressive%2520and%2520pro-resolving%2520effects%2520of%2520EPA%2520and%2520DHA%2520in%2520human%2520primary%2520monocytes%2520and%2520T-helper%2520cells%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2013%26volume%3D54%26spage%3D923%26epage%3D935%26doi%3D10.1194%2Fjlr.P031260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laviano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rianda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molfino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanelli, F. R.</span></span> <span> </span><span class="NLM_article-title">Omega-3 fatty acids in cancer</span>. <i>Curr. Opin. Clin. Nutr. Metab. Care</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">156</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1097/MCO.0b013e32835d2d99</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1097%2FMCO.0b013e32835d2d99" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=23299701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1egtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2013&pages=156-161&author=A.+Lavianoauthor=S.+Riandaauthor=A.+Molfinoauthor=F.+R.+Fanelli&title=Omega-3+fatty+acids+in+cancer&doi=10.1097%2FMCO.0b013e32835d2d99"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Omega-3 fatty acids in cancer</span></div><div class="casAuthors">Laviano, Alessandro; Rianda, Serena; Molfino, Alessio; Fanelli, Filippo Rossi</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Clinical Nutrition and Metabolic Care</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">156-161</span>CODEN:
                <span class="NLM_cas:coden">COCMF3</span>;
        ISSN:<span class="NLM_cas:issn">1363-1950</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: Significant achievements have been obtained in cancer treatment, but the clin. relevance of drug approach in daily practice remains questionable due to the high costs, limited efficacy, and negligible influence on quality of life.  A new concept is emerging which is based on the early combination of chemotherapy and nutrition therapy.  Recent findings: Inflammation dictates tumor initiation, progression and growth.  Omega-3 fatty acids exert anti-inflammatory effects, and therefore recent studies investigated their role in cancer prevention, in cancer cachexia treatment and in enhancement of antitumor therapies.  Limited evidence suggests a role for omega-3 fatty acid supplementation in cancer prevention, but they have been shown to preserve muscle mass and function in cancer patients even during active treatment.  During chemotherapy, omega-3 fatty acids may contribute to a reduced inflammatory response, but whether cancer treatment toxicity can be prevented remains to be assessed.  Finally, small studies showed that omega-3 fatty acids increase response rate to chemotherapy.  Summary: Combination of chemotherapy and omega-3 supplementation appears an effective strategy to enhance the clin. outcome of cancer patients in their curative and palliative clin. trajectory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJhg1I1lPH9bVg90H21EOLACvtfcHk0lgruFOphk7dwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1egtb0%253D&md5=f9395b88d331289390ebefe80b1c7e16</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1097%2FMCO.0b013e32835d2d99&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMCO.0b013e32835d2d99%26sid%3Dliteratum%253Aachs%26aulast%3DLaviano%26aufirst%3DA.%26aulast%3DRianda%26aufirst%3DS.%26aulast%3DMolfino%26aufirst%3DA.%26aulast%3DFanelli%26aufirst%3DF.%2BR.%26atitle%3DOmega-3%2520fatty%2520acids%2520in%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Clin.%2520Nutr.%2520Metab.%2520Care%26date%3D2013%26volume%3D16%26spage%3D156%26epage%3D161%26doi%3D10.1097%2FMCO.0b013e32835d2d99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rose, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, J. M.</span></span> <span> </span><span class="NLM_article-title">Omega-3 fatty acids as cancer chemopreventive agents</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1016/S0163-7258(99)00026-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2FS0163-7258%2899%2900026-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10576293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADyaK1MXmtVyitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1999&pages=217-244&author=D.+P.+Roseauthor=J.+M.+Connolly&title=Omega-3+fatty+acids+as+cancer+chemopreventive+agents&doi=10.1016%2FS0163-7258%2899%2900026-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Omega-3 fatty acids as cancer chemopreventive agents</span></div><div class="casAuthors">Rose, David P.; Connolly, Jeanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">217-244</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 291 refs.  There is both epidemiol. and exptl. evidence that the long-chain ω-3 fatty acids (FAs), which occur at high levels in some fish oils, exert protective effects against some common cancers, notably breast, colon, and prostate cancer.  Multiple mechanisms are involved in this chemopreventive activity, including suppression of neoplastic transformation, cell growth inhibition, enhanced apoptosis, and antiangiogenicity.  A common feature of most of these biol. effects is the inhibition of eicosanoid prodn. from ω-6 FA precursors.  Several risk factors for breast and colon cancer may be favorably modified by dietary ω-3 FA supplementation.  Implementation of clin. chemoprevention trials is now feasible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvzw5ib3DJGbVg90H21EOLACvtfcHk0lh0Dtmgek0anA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtVyitLY%253D&md5=d6ebfa872f856260fd1e0491c56799c4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2899%2900026-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252899%252900026-1%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DD.%2BP.%26aulast%3DConnolly%26aufirst%3DJ.%2BM.%26atitle%3DOmega-3%2520fatty%2520acids%2520as%2520cancer%2520chemopreventive%2520agents%26jtitle%3DPharmacol.%2520Ther.%26date%3D1999%26volume%3D83%26spage%3D217%26epage%3D244%26doi%3D10.1016%2FS0163-7258%2899%2900026-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Eliseo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velotti, F.</span></span> <span> </span><span class="NLM_article-title">Omega-3 Fatty Acids and Cancer Cell Cytotoxicity: Implications for Multi-Targeted Cancer Therapy</span>. <i>J. Clin. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">15</span>, <span class="refDoi"> DOI: 10.3390/jcm5020015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.3390%2Fjcm5020015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmt1GgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=15&author=D.+D%E2%80%99Eliseoauthor=F.+Velotti&title=Omega-3+Fatty+Acids+and+Cancer+Cell+Cytotoxicity%3A+Implications+for+Multi-Targeted+Cancer+Therapy&doi=10.3390%2Fjcm5020015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Omega-3 fatty acids and cancer cell cytotoxicity: implications for multi-targeted cancer therapy</span></div><div class="casAuthors">D'Eliseo, Donatella; Velotti, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">15/1-15/29</span>CODEN:
                <span class="NLM_cas:coden">JCMOHK</span>;
        ISSN:<span class="NLM_cas:issn">2077-0383</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Cancer is a major disease worldwide.  Despite progress in cancer therapy, conventional cytotoxic therapies lead to unsatisfactory long-term survival, mainly related to development of drug resistance by tumor cells and toxicity towards normal cells. n-3 polyunsatd. fatty acids (PUFAs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), can exert anti-neoplastic activity by inducing apoptotic cell death in human cancer cells either alone or in combination with conventional therapies.  Indeed, n-3 PUFAs potentially increase the sensitivity of tumor cells to conventional therapies, possibly improving their efficacy esp. against cancers resistant to treatment.  Moreover, in contrast to traditional therapies, n-3 PUFAs appear to cause selective cytotoxicity towards cancer cells with little or no toxicity on normal cells.  This review focuses on studies investigating the cytotoxic activity of n-3 PUFAs against cancer cells via apoptosis, analyzing the mol. mechanisms underlying this effective and selective activity.  Here, we highlight the multiple mols. potentially targeted by n-3 PUFAs to trigger cancer cell apoptosis.  This anal. can allow a better comprehension of the potential cytotoxic therapeutic role of n-3 PUFAs against cancer, providing specific information and support to design future pre-clin. and clin. studies for a better use of n-3 PUFAs in cancer therapy, mainly combinational therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHpM3IA5Wv_rVg90H21EOLACvtfcHk0lh0Dtmgek0anA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmt1GgsLc%253D&md5=6f0c1a747d3112158c37313958f30ff7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3390%2Fjcm5020015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcm5020015%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Eliseo%26aufirst%3DD.%26aulast%3DVelotti%26aufirst%3DF.%26atitle%3DOmega-3%2520Fatty%2520Acids%2520and%2520Cancer%2520Cell%2520Cytotoxicity%253A%2520Implications%2520for%2520Multi-Targeted%2520Cancer%2520Therapy%26jtitle%3DJ.%2520Clin.%2520Med.%26date%3D2016%26volume%3D5%26spage%3D15%26doi%3D10.3390%2Fjcm5020015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, M.</span></span> <span> </span><span class="NLM_article-title">The omega-3 epoxide of eicosapentaenoic acid inhibits endothelial cell proliferation by p38 MAP kinase activation and cyclin D1/CDK4 down-regulation</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">1143</span>– <span class="NLM_lpage">1155</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.01113.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1111%2Fj.1476-5381.2010.01113.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=21077851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhslWgs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2011&pages=1143-1155&author=P.+H.+Cuiauthor=N.+Petrovicauthor=M.+Murray&title=The+omega-3+epoxide+of+eicosapentaenoic+acid+inhibits+endothelial+cell+proliferation+by+p38+MAP+kinase+activation+and+cyclin+D1%2FCDK4+down-regulation&doi=10.1111%2Fj.1476-5381.2010.01113.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The ω-3 epoxide of eicosapentaenoic acid inhibits endothelial cell proliferation by p38 MAP kinase activation and cyclin D1/CDK4 down-regulation</span></div><div class="casAuthors">Cui, Pei H.; Petrovic, Nenad; Murray, Michael</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1143-1155</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Dietary intake of ω-3 polyunsatd. fatty acids (ω-3 PUFAs) like eicosapentaenoic acid (EPA) decreases cancer risk, while arachidonic acid and other ω-6 PUFAs increase risk, but the underlying mechanisms are unclear.  Cytochrome P 450 (CYP)-derived epoxides contribute to enhanced tumorigenesis due to ω-6 PUFA intake.  Thus, ω-6 arachidonic acid epoxides (EETs) inhibit apoptosis and stimulate proliferation by up-regulating cyclin D1 expression in cells.  The present study evaluated the corresponding ω-3 PUFA epoxides and assessed their role in the regulation of cell proliferation.  Four chem. stable EPA epoxides (formed at the 8,9-, 11,12-, 14,15- and 17,18-olefinic bonds) were synthesized and tested against growth-related signaling pathways in brain microvascular endothelial bEND.3 cells.  Cell cycle distribution was detd. by flow cytometry and cyclin gene expression by immunoblotting and real-time PCR.  The role of the p38 mitogen-activated protein (MAP) kinase in cyclin D1 dysregulation was assessed using specific inhibitors and dominant-neg. expression plasmids.  The ω-3 17,18-epoxide of EPA decreased cell proliferation, interrupted the cell cycle in S-phase and down-regulated the cyclin D1/cyclin-dependent kinase (CDK)-4 complex, whereas the 8,9-, 11,12-, and 14,15-epoxides were either inactive or enhanced proliferation.  Cyclin D1 down-regulation by 17,18-epoxy-EPA was mediated by activation of the growth-suppressing p38 MAP kinase, but the alternate EPA-epoxides were inactive.  The present findings suggest that the epoxide formed by CYP enzymes at the ω-3 olefinic bond may contribute to the beneficial effects of ω-3 PUFA by down-regulating cyclin D1 and suppressing cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpp3uX9jlKaLVg90H21EOLACvtfcHk0lh0Dtmgek0anA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhslWgs7o%253D&md5=67e943c96c12a2371ceab81be6b64aa5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.01113.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.01113.x%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DP.%2BH.%26aulast%3DPetrovic%26aufirst%3DN.%26aulast%3DMurray%26aufirst%3DM.%26atitle%3DThe%2520omega-3%2520epoxide%2520of%2520eicosapentaenoic%2520acid%2520inhibits%2520endothelial%2520cell%2520proliferation%2520by%2520p38%2520MAP%2520kinase%2520activation%2520and%2520cyclin%2520D1%252FCDK4%2520down-regulation%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D162%26spage%3D1143%26epage%3D1155%26doi%3D10.1111%2Fj.1476-5381.2010.01113.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigrahy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahakian, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephen
Lee, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettersten, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingham, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieran, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">6530</span>– <span class="NLM_lpage">6535</span>, <span class="refDoi"> DOI: 10.1073/pnas.1304321110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1073%2Fpnas.1304321110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=6530-6535&author=G.+Zhangauthor=D.+Panigrahyauthor=L.+M.+Mahakianauthor=J.+Yangauthor=J.+Y.+Liuauthor=K.+S.+Stephen%0ALeeauthor=H.+I.+Wetterstenauthor=A.+Uluauthor=X.+Huauthor=S.+Tamauthor=S.+H.+Hwangauthor=E.+S.+Inghamauthor=M.+W.+Kieranauthor=R.+H.+Weissauthor=K.+W.+Ferraraauthor=B.+D.+Hammock&title=Epoxy+metabolites+of+docosahexaenoic+acid+%28DHA%29+inhibit+angiogenesis%2C+tumor+growth%2C+and+metastasis&doi=10.1073%2Fpnas.1304321110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1304321110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1304321110%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DPanigrahy%26aufirst%3DD.%26aulast%3DMahakian%26aufirst%3DL.%2BM.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DStephen%2BLee%26aufirst%3DK.%2BS.%26aulast%3DWettersten%26aufirst%3DH.%2BI.%26aulast%3DUlu%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DIngham%26aufirst%3DE.%2BS.%26aulast%3DKieran%26aufirst%3DM.%2BW.%26aulast%3DWeiss%26aufirst%3DR.%2BH.%26aulast%3DFerrara%26aufirst%3DK.%2BW.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DEpoxy%2520metabolites%2520of%2520docosahexaenoic%2520acid%2520%2528DHA%2529%2520inhibit%2520angiogenesis%252C%2520tumor%2520growth%252C%2520and%2520metastasis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D6530%26epage%3D6535%26doi%3D10.1073%2Fpnas.1304321110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascio, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotondo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heys, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahle, K. W.</span></span> <span> </span><span class="NLM_article-title">Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators</span>. <i>Prog. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1016/j.plipres.2012.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2Fj.plipres.2012.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=23103355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFensg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=80-109&author=I.+Brownauthor=M.+G.+Cascioauthor=D.+Rotondoauthor=R.+G.+Pertweeauthor=S.+D.+Heysauthor=K.+W.+Wahle&title=Cannabinoids+and+omega-3%2F6+endocannabinoids+as+cell+death+and+anticancer+modulators&doi=10.1016%2Fj.plipres.2012.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators</span></div><div class="casAuthors">Brown, Iain; Cascio, Maria G.; Rotondo, Dino; Pertwee, Roger G.; Heys, Steven D.; Wahle, Klaus W. J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-109</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Cannabinoids-endocannaboids are possible preventatives of common diseases including cancers.  Cannabinoid receptors (CB1/2, TRPV1) are central components of the system.  Many disease-ameliorating effects of cannabinoids-endocannabinoids are receptor mediated, but many are not, indicating non-CBR signaling pathways.  Cannabinoids-endocannabinoids are anti-inflammatory, anti-proliferative, anti-invasive, anti-metastatic and pro-apoptotic in most cancers, in vitro and in vivo in animals.  They signal through p38, MAPK, JUN, PI3, AKT, ceramide, caspases, MMPs, PPARs, VEGF, NF-κB, p8, CHOP, TRB3 and pro-apoptotic oncogenes (p53,p21 waf1/cip1) to induce cell cycle arrest, autophagy, apoptosis and tumor inhibition.  Paradoxically they are pro-proliferative and anti-apoptotic in some cancers.  Differences in receptor expression and concns. of cannabinoids in cancer and immune cells can elicit anti- or pro-cancer effects through different signal cascades (p38MAPK or PI3/AKT).  Similarities between effects of cannabinoids-endocannabinoids, omega-3 LCPUFA and CLAs/CLnAs as anti-inflammatory, antiangiogenic, anti-invasive anti-cancer agents indicate common signaling pathways.  Evidence in vivo and in vitro shows EPA and DHA can form endocannabinoids that: (i) are ligands for CB1/2 receptors and possibly TRPV-1, (ii) have non-receptor mediated bioactivity, (iii) induce cell cycle arrest, (iii) increase autophagy and apoptosis, and (iv) augment chemotherapeutic actions in vitro.  They can also form bioactive, eicosanoid-like products that appear to be non-CBR ligands but have effects on PPARs and NF-kB transcription factors.  The use of cannabinoids in cancer treatment is currently limited to chemo- and radio-therapy-assocd. nausea and cancer-assocd. pain apart from one trial on brain tumors in patients.  Further clin. studies are urgently required to det. the true potential of these intriguing, low toxicity compds. in cancer therapy.  Particularly in view of their synergistic effects with chemotherapeutic agents similar to that obsd. for n-3 LCPUFA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0MNRYHO3XzLVg90H21EOLACvtfcHk0lilF40kwIJlVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFensg%253D%253D&md5=faf1b468db28bb0d84c1df1be7e7cbbe</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2012.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2012.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DI.%26aulast%3DCascio%26aufirst%3DM.%2BG.%26aulast%3DRotondo%26aufirst%3DD.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DHeys%26aufirst%3DS.%2BD.%26aulast%3DWahle%26aufirst%3DK.%2BW.%26atitle%3DCannabinoids%2520and%2520omega-3%252F6%2520endocannabinoids%2520as%2520cell%2520death%2520and%2520anticancer%2520modulators%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2013%26volume%3D52%26spage%3D80%26epage%3D109%26doi%3D10.1016%2Fj.plipres.2012.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascio, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahle, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smoum, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heys, S. D.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1584</span>– <span class="NLM_lpage">1591</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgq151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1093%2Fcarcin%2Fbgq151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=20660502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaitLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=1584-1591&author=I.+Brownauthor=M.+G.+Cascioauthor=K.+W.+Wahleauthor=R.+Smoumauthor=R.+Mechoulamauthor=R.+A.+Rossauthor=R.+G.+Pertweeauthor=S.+D.+Heys&title=Cannabinoid+receptor-dependent+and+-independent+anti-proliferative+effects+of+omega-3+ethanolamides+in+androgen+receptor-positive+and+-negative+prostate+cancer+cell+lines&doi=10.1093%2Fcarcin%2Fbgq151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines</span></div><div class="casAuthors">Brown, Iain; Cascio, Maria G.; Wahle, Klaus W. J.; Smoum, Reem; Mechoulam, Raphael; Ross, Ruth A.; Pertwee, Roger G.; Heys, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1584-1591</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The omega-3 fatty acid ethanolamides, docosahexaenoyl ethanolamide (DHEA) and eicosapentaenoyl ethanolamide (EPEA), displayed greater anti-proliferative potency than their parent omega-3 fatty acids, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), in LNCaP and PC3 prostate cancer cells.  DHEA and EPEA activated cannabinoid CB1 and CB2 receptors in vitro with significant potency, suggesting that they are endocannabinoids.  Both LNCaP and PC3 cells expressed CB1 and CB2 receptors, and the CB1- and CB2-selective antagonists, AM281 and AM630, administered sep. or together, reduced the anti-proliferative potencies of EPEA and EPA but not of DHEA or DHA in PC3 cells and of EPA but not of EPEA, DHEA or DHA in LNCaP cells.  Even so, EPEA and EPA may not have inhibited PC3 or LNCaP cell proliferation via cannabinoid receptors since the anti-proliferative potency of EPEA was well below the potency it displayed as a CB1 or CB2 receptor agonist.  Indeed, these receptors may mediate a protective effect because the anti-proliferative potency of DHEA in LNCaP and PC3 cells was increased by sep. or combined administration of AM281 and AM630.  The anandamide-metabolizing enzyme, fatty acid amide hydrolase (FAAH), was highly expressed in LNCaP but not PC3 cells.  Evidence was obtained that FAAH metabolizes EPEA and DHEA and that the anti-proliferative potencies of these ethanolamides in LNCaP cells can be enhanced by inhibiting this enzyme.  Our findings suggest that the expression of cannabinoid receptors and of FAAH in some tumor cells could well influence the effectiveness of DHA and EPA or their ethanolamide derivs. as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXVmDGbUYUjbVg90H21EOLACvtfcHk0lilF40kwIJlVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaitLvO&md5=782181896032c0d8fce5f0252c67c4fc</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgq151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgq151%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DI.%26aulast%3DCascio%26aufirst%3DM.%2BG.%26aulast%3DWahle%26aufirst%3DK.%2BW.%26aulast%3DSmoum%26aufirst%3DR.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DRoss%26aufirst%3DR.%2BA.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DHeys%26aufirst%3DS.%2BD.%26atitle%3DCannabinoid%2520receptor-dependent%2520and%2520-independent%2520anti-proliferative%2520effects%2520of%2520omega-3%2520ethanolamides%2520in%2520androgen%2520receptor-positive%2520and%2520-negative%2520prostate%2520cancer%2520cell%2520lines%26jtitle%3DCarcinogenesis%26date%3D2010%26volume%3D31%26spage%3D1584%26epage%3D1591%26doi%3D10.1093%2Fcarcin%2Fbgq151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Marzo, V.</span></span> <span> </span><span class="NLM_article-title">Endocannabinoids: synthesis and degradation</span>. <i>Rev. Physiol., Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1007/112_0505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1007%2F112_0505" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2006&pages=1-24&author=V.+Di%0AMarzo&title=Endocannabinoids%3A+synthesis+and+degradation&doi=10.1007%2F112_0505"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2F112_0505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F112_0505%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DEndocannabinoids%253A%2520synthesis%2520and%2520degradation%26jtitle%3DRev.%2520Physiol.%252C%2520Biochem.%2520Pharmacol.%26date%3D2006%26volume%3D160%26spage%3D1%26epage%3D24%26doi%3D10.1007%2F112_0505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skaper, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span> <span> </span><span class="NLM_article-title">Endocannabinoids in nervous system health and disease: the big picture in a nutshell</span>. <i>Philos. Trans. R. Soc., B</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>367</i></span>,  <span class="NLM_fpage">3193</span>– <span class="NLM_lpage">3200</span>, <span class="refDoi"> DOI: 10.1098/rstb.2012.0313</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1098%2Frstb.2012.0313" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=23108539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKgtLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=3193-3200&author=S.+D.+Skaperauthor=V.+Di+Marzo&title=Endocannabinoids+in+nervous+system+health+and+disease%3A+the+big+picture+in+a+nutshell&doi=10.1098%2Frstb.2012.0313"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoids in nervous system health and disease: the big picture in a nutshell</span></div><div class="casAuthors">Skaper, Stephen D.; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical Transactions of the Royal Society, B: Biological Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">1607</span>),
    <span class="NLM_cas:pages">3193-3200</span>CODEN:
                <span class="NLM_cas:coden">PTRBAE</span>;
        ISSN:<span class="NLM_cas:issn">0962-8436</span>.
    
            (<span class="NLM_cas:orgname">Royal Society</span>)
        </div><div class="casAbstract">A review.  The psychoactive component of the cannabis resin and flowers, delta9-tetrahydrocannabinol (THC), was first isolated in 1964, and at least 70 other structurally related 'phytocannabinoid' compds. have since been identified.  The serendipitous identification of a G-protein-coupled cannabinoid receptor at which THC is active in the brain heralded an explosion in cannabinoid research.  Elements of the endocannabinoid system (ECS) comprise the cannabinoid receptors, a family of nascent lipid ligands, the 'endocannabinoids' and the machinery for their biosynthesis and metab.  The function of the ECS is thus defined by modulation of these receptors, in particular, by two of the best-described ligands, 2-arachidonoyl glycerol and anandamide (arachidonylethanolamide).  Research on the ECS has recently aroused enormous interest not only for the physiol. functions, but also for the promising therapeutic potentials of drugs interfering with the activity of cannabinoid receptors.  Many of the former relate to stress-recovery systems and to the maintenance of homeostatic balance.  Among other functions, the ECS is involved in neuroprotection, modulation of nociception, regulation of motor activity, neurogenesis, synaptic plasticity and the control of certain phases of memory processing.  In addn., the ECS acts to modulate the immune and inflammatory responses and to maintain a pos. energy balance.  This theme issue aims to provide the reader with an overview of ECS pharmacol., followed by discussions on the pivotal role of this system in the modulation of neurogenesis in the developing and adult organism, memory processes and synaptic plasticity, as well as in pathol. pain and brain ageing.  The vol. will conclude with discussions that address the proposed therapeutic applications of targeting the ECS for the treatment of neurodegeneration, pain and mental illness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqytAYy2FAN-LVg90H21EOLACvtfcHk0lilF40kwIJlVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKgtLzI&md5=dc601d67ca629e093ff1d85b422be36a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1098%2Frstb.2012.0313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2012.0313%26sid%3Dliteratum%253Aachs%26aulast%3DSkaper%26aufirst%3DS.%2BD.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DEndocannabinoids%2520in%2520nervous%2520system%2520health%2520and%2520disease%253A%2520the%2520big%2520picture%2520in%2520a%2520nutshell%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%252C%2520B%26date%3D2012%26volume%3D367%26spage%3D3193%26epage%3D3200%26doi%3D10.1098%2Frstb.2012.0313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correia-da-Silva, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixeira, N. A.</span></span> <span> </span><span class="NLM_article-title">Endogenous cannabinoids revisited: a biochemistry perspective</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>102–103</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2013.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2Fj.prostaglandins.2013.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkt12qurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102%E2%80%93103&publication_year=2013&pages=13-30&author=B.+M.+Fonsecaauthor=M.+A.+Costaauthor=M.+Almadaauthor=G.+Correia-da-Silvaauthor=N.+A.+Teixeira&title=Endogenous+cannabinoids+revisited%3A+a+biochemistry+perspective&doi=10.1016%2Fj.prostaglandins.2013.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous cannabinoids revisited: A biochemistry perspective</span></div><div class="casAuthors">Fonseca, B. M.; Costa, M. A.; Almada, M.; Correia-da-Silva, G.; Teixeira, N. A.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins and Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">102-103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-30</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Marijuana is the most commonly used illegal drug, particularly in Western societies.  The discovery of an endogenous cannabinoid system (ECS) highlighted new mols. in various physiol. processes.  The ECS consists of G-protein-coupled cannabinoid receptors that can be activated by small lipid mediators, termed endocannabinoids (eCBs) and cannabis-derived drugs, plus the assocd. biochem. machinery (precursors, synthesis and degradative enzymes, and transporters).  Several biochem., pharmacol. and physiol. studies have shown that endocannabinoid system elements are widely distributed throughout the body, with regional variations and organ-specific actions.  This review portrays the endocannabinoid "family" on new studies concerning eCB storage, release and functional roles and on the growing importance of its bioactive metabolites.  Those findings reinforce and confirm the importance of ECS.  Strategies for manipulating the system for the treatment of human disease will require a thorough understanding of the roles of the different eCBs and their sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWoSuyAKTrl7Vg90H21EOLACvtfcHk0lj1gikmxRjs3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkt12qurk%253D&md5=d069aa267e2de467a1ae2a86c901fc6a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2013.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2013.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca%26aufirst%3DB.%2BM.%26aulast%3DCosta%26aufirst%3DM.%2BA.%26aulast%3DAlmada%26aufirst%3DM.%26aulast%3DCorreia-da-Silva%26aufirst%3DG.%26aulast%3DTeixeira%26aufirst%3DN.%2BA.%26atitle%3DEndogenous%2520cannabinoids%2520revisited%253A%2520a%2520biochemistry%2520perspective%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2013%26volume%3D102%25E2%2580%2593103%26spage%3D13%26epage%3D30%26doi%3D10.1016%2Fj.prostaglandins.2013.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, M.</span></span> <span> </span><span class="NLM_article-title">The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration</span>. <i>Current Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.2174/157015907780866884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.2174%2F157015907780866884" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=73-80&author=J.+C.+Ashtonauthor=M.+Glass&title=The+cannabinoid+CB2+receptor+as+a+target+for+inflammation-dependent+neurodegeneration&doi=10.2174%2F157015907780866884"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F157015907780866884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157015907780866884%26sid%3Dliteratum%253Aachs%26aulast%3DAshton%26aufirst%3DJ.%2BC.%26aulast%3DGlass%26aufirst%3DM.%26atitle%3DThe%2520cannabinoid%2520CB2%2520receptor%2520as%2520a%2520target%2520for%2520inflammation-dependent%2520neurodegeneration%26jtitle%3DCurrent%2520Neuropharmacology%26date%3D2007%26volume%3D5%26spage%3D73%26epage%3D80%26doi%3D10.2174%2F157015907780866884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Onaivi, E. S.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications</span>. <i>Int. Rev. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1016/S0074-7742(09)88012-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2FS0074-7742%2809%2988012-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=19897083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt1Omsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2009&pages=335-369&author=E.+S.+Onaivi&title=Cannabinoid+receptors+in+brain%3A+pharmacogenetics%2C+neuropharmacology%2C+neurotoxicology%2C+and+potential+therapeutic+applications&doi=10.1016%2FS0074-7742%2809%2988012-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications</span></div><div class="casAuthors">Onaivi, Emmanuel S.</div><div class="citationInfo"><span class="NLM_cas:title">International Review of Neurobiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">New Concepts of Psychostimulants Induced Neurotoxicity</span>),
    <span class="NLM_cas:pages">335-369</span>CODEN:
                <span class="NLM_cas:coden">IRNEAE</span>;
        ISSN:<span class="NLM_cas:issn">0074-7742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Much progress has been achieved in cannabinoid research.  A major breakthrough in marijuana-cannabinoid research has been the discovery of a previously unknown but elaborate endogenous endocannabinoid system (ECS), complete with endocannabinoids and enzymes for their biosynthesis and degrdn. with genes; encoding two distinct cannabinoid (CB1 and CB2) receptors (CBRs) that are activated by endocannabinoids, cannabinoids, and marijuana use.  Phys. and genetic localization of the CBR genes CNR1 and CNR2 have been mapped to chromosome 6 and 1, resp.  A no. of variations in CBR genes have been assocd. with human disorders including osteoporosis, attention deficit hyperactivity disorder (ADHD), posttraumatic stress disorder (PTSD), drug dependency, obesity, and depression.  Other family of lipid receptors including vanilloid (VR1) and lysophosphatidic acid (LPA) receptors appear to be related to the CBRs at the phylogenetic level.  The ubiquitous abundance and differential distribution of the ECS in the human body and brain along with the coupling to many signal transduction pathways may explain the effects in most biol. system and the myriad behavioral effects assocd. with smoking marijuana.  The neuropharmacol. and neuroprotective features of phytocannabinoids and endocannabinoid assocd. neurogenesis have revealed roles for the use of cannabinoids in neurodegenerative pathologies with less neurotoxicity.  The remarkable progress in understanding the biol. actions of marijuana and cannabinoids have provided much richer results than previously appreciated cannabinoid genomics and raised a no. of crit. issues on the mol. mechanisms of cannabinoid induced behavioral and biochem. alterations.  These advances will allow specific therapeutic targeting of the different components of the ECS in health and disease.  This review focuses on these recent advances in cannabinoid genomics and the surprising new fundamental roles that the ECS plays in the retrograde signaling assocd. with cannabinoid inhibition of neurotransmitter release to the genetic basis of the effects of marijuana use and pharmacotherpeutic applications and limitations.  Much evidence is provided for the complex GNR1 and CNR2 gene structures and their assocd. regulatory elements.  Thus, understanding the ECS in the human body and brain will contribute to elucidating this natural regulatory mechanism in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Ei-jnghXtLVg90H21EOLACvtfcHk0lj1gikmxRjs3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt1Omsg%253D%253D&md5=bb945ecc35b936bd0de1edfa0588103d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0074-7742%2809%2988012-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0074-7742%252809%252988012-4%26sid%3Dliteratum%253Aachs%26aulast%3DOnaivi%26aufirst%3DE.%2BS.%26atitle%3DCannabinoid%2520receptors%2520in%2520brain%253A%2520pharmacogenetics%252C%2520neuropharmacology%252C%2520neurotoxicology%252C%2520and%2520potential%2520therapeutic%2520applications%26jtitle%3DInt.%2520Rev.%2520Neurobiol.%26date%3D2009%26volume%3D88%26spage%3D335%26epage%3D369%26doi%3D10.1016%2FS0074-7742%2809%2988012-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salazar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olea-Herrero, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Laviada, I.</span></span> <span> </span><span class="NLM_article-title">Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1099</span>– <span class="NLM_lpage">1111</span>, <span class="refDoi"> DOI: 10.1038/cdd.2011.32</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1038%2Fcdd.2011.32" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=21475304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVShtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1099-1111&author=D.+Varaauthor=M.+Salazarauthor=N.+Olea-Herreroauthor=M.+Guzmanauthor=G.+Velascoauthor=I.+Diaz-Laviada&title=Anti-tumoral+action+of+cannabinoids+on+hepatocellular+carcinoma%3A+role+of+AMPK-dependent+activation+of+autophagy&doi=10.1038%2Fcdd.2011.32"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy</span></div><div class="casAuthors">Vara, D.; Salazar, M.; Olea-Herrero, N.; Guzman, M.; Velasco, G.; Diaz-Laviada, I.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1099-1111</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is the third cause of cancer-related death worldwide.  When these tumors are in advanced stages, few therapeutic options are available.  Therefore, it is essential to search for new treatments to fight this disease.  In this study, we investigated the effects of cannabinoids - a novel family of potential anticancer agents - on the growth of HCC.  We found that Δ9-tetrahydrocannabinol (Δ9-THC, the main active component of Cannabis sativa) and JWH-015 (a cannabinoid receptor 2 (CB2) cannabinoid receptor-selective agonist) reduced the viability of the human HCC cell lines HepG2 (human hepatocellular liver carcinoma cell line) and HuH-7 (hepatocellular carcinoma cells), an effect that relied on the stimulation of CB2 receptor.  We also found that Δ9-THC- and JWH-015-induced autophagy relies on tribbles homolog 3 (TRB3) upregulation, and subsequent inhibition of the serine-threonine kinase Akt/mammalian target of rapamycin C1 axis and adenosine monophosphate-activated kinase (AMPK) stimulation.  Pharmacol. and genetic inhibition of AMPK upstream kinases supported that calmodulin-activated kinase kinase β was responsible for cannabinoid-induced AMPK activation and autophagy.  In vivo studies revealed that Δ9-THC and JWH-015 reduced the growth of HCC s.c. xenografts, an effect that was not evident when autophagy was genetically of pharmacol. inhibited in those tumors.  Moreover, cannabinoids were also able to inhibit tumor growth and ascites in an orthotopic model of HCC xenograft.  Our findings may contribute to the design of new therapeutic strategies for the management of HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUstctG4ZkZbVg90H21EOLACvtfcHk0lj1gikmxRjs3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVShtLg%253D&md5=670cf2a3687e9ea926f9ec346c9ae009</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2011.32&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2011.32%26sid%3Dliteratum%253Aachs%26aulast%3DVara%26aufirst%3DD.%26aulast%3DSalazar%26aufirst%3DM.%26aulast%3DOlea-Herrero%26aufirst%3DN.%26aulast%3DGuzman%26aufirst%3DM.%26aulast%3DVelasco%26aufirst%3DG.%26aulast%3DDiaz-Laviada%26aufirst%3DI.%26atitle%3DAnti-tumoral%2520action%2520of%2520cannabinoids%2520on%2520hepatocellular%2520carcinoma%253A%2520role%2520of%2520AMPK-dependent%2520activation%2520of%2520autophagy%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2011%26volume%3D18%26spage%3D1099%26epage%3D1111%26doi%3D10.1038%2Fcdd.2011.32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ladin, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soliman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dross, R.</span></span> <span> </span><span class="NLM_article-title">Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">361</span>, <span class="refDoi"> DOI: 10.3389/fphar.2016.00361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.3389%2Ffphar.2016.00361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=27774065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptl2lsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=361&author=D.+A.+Ladinauthor=E.+Solimanauthor=L.+Griffinauthor=R.+Van+Dross&title=Preclinical+and+Clinical+Assessment+of+Cannabinoids+as+Anti-Cancer+Agents&doi=10.3389%2Ffphar.2016.00361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical and clinical assessment of cannabinoids as anti-cancer agents</span></div><div class="casAuthors">Ladin, Daniel A.; Soliman, Eman; Griffin, LaToya; Van Dross, Rukiyah</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">361/1-361/18</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Cancer is the second leading cause of death in the United States with 1.7 million new cases estd. to be diagnosed in 2016.  This disease remains a formidable clin. challenge and represents a substantial financial burden to the US health care system.  Therefore, research and development of novel therapeutics for the treatment of cancer is of high priority.  Cannabinoids and their derivs. have been utilized for their medicinal and therapeutic properties throughout history.  Cannabinoid activity is regulated by the endocannabinoid system (ECS), which is comprised of cannabinoid receptors, transporters, and enzymes involved in cannabinoid synthesis and breakdown.  More recently, cannabinoids have gained special attention for their role in cancer cell proliferation and death.  However, many studies investigated these effects using in vitro models which may not adequately mimic tumor growth and metastasis.  As such, this article aims to review study results which evaluated effects of cannabinoids from plant, synthetic and endogenous origins on cancer development in preclin. animal models and to examine the current standing of cannabinoids that are being tested in human cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3Nc9bhtVzW7Vg90H21EOLACvtfcHk0lgQ9h0j-ebh8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptl2lsQ%253D%253D&md5=46fb9ae53781f1a50ea578ceddc28560</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2016.00361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2016.00361%26sid%3Dliteratum%253Aachs%26aulast%3DLadin%26aufirst%3DD.%2BA.%26aulast%3DSoliman%26aufirst%3DE.%26aulast%3DGriffin%26aufirst%3DL.%26aulast%3DVan%2BDross%26aufirst%3DR.%26atitle%3DPreclinical%2520and%2520Clinical%2520Assessment%2520of%2520Cannabinoids%2520as%2520Anti-Cancer%2520Agents%26jtitle%3DFront.%2520Pharmacol.%26date%3D2016%26volume%3D7%26spage%3D361%26doi%3D10.3389%2Ffphar.2016.00361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guindon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, A. G.</span></span> <span> </span><span class="NLM_article-title">The endocannabinoid system and cancer: therapeutic implication</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">1447</span>– <span class="NLM_lpage">1463</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01327.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1111%2Fj.1476-5381.2011.01327.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=21410463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC3MXps1Sju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2011&pages=1447-1463&author=J.+Guindonauthor=A.+G.+Hohmann&title=The+endocannabinoid+system+and+cancer%3A+therapeutic+implication&doi=10.1111%2Fj.1476-5381.2011.01327.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The endocannabinoid system and cancer: therapeutic implication</span></div><div class="casAuthors">Guindon, Josee; Hohmann, Andrea G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1447-1463</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The endocannabinoid system is implicated in a variety of physiol. and pathol. conditions (inflammation, immunomodulation, analgesia, cancer and others).  The main active ingredient of cannabis, Δ9-tetrahydrocannabinol (Δ9-THC), produces its effects through activation of CB1 and CB2 receptors.  CB1 receptors are expressed at high levels in the central nervous system (CNS), whereas CB2 receptors are concd. predominantly, although not exclusively, in cells of the immune system.  Endocannabinoids are endogenous lipid-signaling mols. that are generated in the cell membrane from phospholipid precursors.  The 2 best characterized endocannabinoids identified to date are anandamide (AEA) and 2-arachidonoylglycerol (2-AG).  Here we review the relationship between the endocannabinoid system and anti-tumor actions (inhibition of cell proliferation and migration, induction of apoptosis, redn. of tumor growth) of the cannabinoids in different types of cancer.  This review will focus on examg. how activation of the endocannabinoid system impacts breast, prostate and bone cancers in both in vitro and in vivo systems.  The therapeutic potential of cannabinoids for cancer, as identified in clin. trials, is also discussed.  Identification of safe and effective treatments to manage and improve cancer therapy is crit. to improve quality of life and reduce unnecessary suffering in cancer patients.  In this regard, cannabis-like compds. offer therapeutic potential for the treatment of breast, prostate and bone cancer in patients.  Further basic research on anti-cancer properties of cannabinoids as well as clin. trials of cannabinoid therapeutic efficacy in breast, prostate and bone cancer is therefore warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_omB4D6NVN7Vg90H21EOLACvtfcHk0lgQ9h0j-ebh8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXps1Sju7g%253D&md5=fb5ec332b401d12e51c229d291c1909d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01327.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01327.x%26sid%3Dliteratum%253Aachs%26aulast%3DGuindon%26aufirst%3DJ.%26aulast%3DHohmann%26aufirst%3DA.%2BG.%26atitle%3DThe%2520endocannabinoid%2520system%2520and%2520cancer%253A%2520therapeutic%2520implication%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D163%26spage%3D1447%26epage%3D1463%26doi%3D10.1111%2Fj.1476-5381.2011.01327.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, B.</span></span> <span> </span><span class="NLM_article-title">Targeting the endocannabinoid system as a potential anticancer approach</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1080/03602532.2018.1428344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1080%2F03602532.2018.1428344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=29390896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1aiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2018&pages=26-53&author=R.+Schwarzauthor=R.+Ramerauthor=B.+Hinz&title=Targeting+the+endocannabinoid+system+as+a+potential+anticancer+approach&doi=10.1080%2F03602532.2018.1428344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the endocannabinoid system as a potential anticancer approach</span></div><div class="casAuthors">Schwarz, Rico; Ramer, Robert; Hinz, Burkhard</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-53</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The endocannabinoid system is currently under intense investigation due to the therapeutic potential of cannabinoid-based drugs as treatment options for a broad variety of diseases including cancer.  Besides the canonical endocannabinoid system that includes the cannabinoid receptors CB1 and CB2 and the endocannabinoids N-arachidonoylethanolamine (anandamide) and 2-arachidonoylglycerol, recent investigations suggest that other fatty acid derivs., receptors, enzymes, and lipid transporters likewise orchestrate this system as components of the endocannabinoid system when defined as an extended signaling network.  As such, fatty acids acting at cannabinoid receptors (e.g. 2-arachidonoyl glyceryl ether [noladin ether], N-arachidonoyldopamine) as well as endocannabinoid-like substances that do not elicit cannabinoid receptor activation (e.g. N-palmitoylethanolamine, N-oleoylethanolamine) have raised interest as anticancerogenic substances.  Furthermore, the endocannabinoid-degrading enzymes fatty acid amide hydrolase and monoacylglycerol lipase, lipid transport proteins of the fatty acid binding protein family, addnl. cannabinoid-activated G protein-coupled receptors, members of the transient receptor potential family as well as peroxisome proliferator-activated receptors have been considered as targets of antitumoral cannabinoid activity.  Therefore, this review focused on the antitumorigenic effects induced upon modulation of this extended endocannabinoid network.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6gqyQZreVWrVg90H21EOLACvtfcHk0lgQ9h0j-ebh8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1aiur0%253D&md5=2a17e53ac39a2a376a82098d3e1aae01</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1080%2F03602532.2018.1428344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F03602532.2018.1428344%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarz%26aufirst%3DR.%26aulast%3DRamer%26aufirst%3DR.%26aulast%3DHinz%26aufirst%3DB.%26atitle%3DTargeting%2520the%2520endocannabinoid%2520system%2520as%2520a%2520potential%2520anticancer%2520approach%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2018%26volume%3D50%26spage%3D26%26epage%3D53%26doi%3D10.1080%2F03602532.2018.1428344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jan, C. R.</span></span> <span> </span><span class="NLM_article-title">Anandamide-induced Ca2+ elevation leading to p38 MAPK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells</span>. <i>Toxicology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>231</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/j.tox.2006.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2Fj.tox.2006.11.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=2007&pages=21-29&author=S.+S.+Hsuauthor=C.+J.+Huangauthor=H.+H.+Chengauthor=C.+T.+Chouauthor=H.+Y.+Leeauthor=J.+L.+Wangauthor=I.+S.+Chenauthor=S.+I.+Liuauthor=Y.+C.+Luauthor=H.+T.+Changauthor=J.+K.+Huangauthor=J.+S.+Chenauthor=C.+R.+Jan&title=Anandamide-induced+Ca2%2B+elevation+leading+to+p38+MAPK+phosphorylation+and+subsequent+cell+death+via+apoptosis+in+human+osteosarcoma+cells&doi=10.1016%2Fj.tox.2006.11.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.tox.2006.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tox.2006.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DHsu%26aufirst%3DS.%2BS.%26aulast%3DHuang%26aufirst%3DC.%2BJ.%26aulast%3DCheng%26aufirst%3DH.%2BH.%26aulast%3DChou%26aufirst%3DC.%2BT.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DWang%26aufirst%3DJ.%2BL.%26aulast%3DChen%26aufirst%3DI.%2BS.%26aulast%3DLiu%26aufirst%3DS.%2BI.%26aulast%3DLu%26aufirst%3DY.%2BC.%26aulast%3DChang%26aufirst%3DH.%2BT.%26aulast%3DHuang%26aufirst%3DJ.%2BK.%26aulast%3DChen%26aufirst%3DJ.%2BS.%26aulast%3DJan%26aufirst%3DC.%2BR.%26atitle%3DAnandamide-induced%2520Ca2%252B%2520elevation%2520leading%2520to%2520p38%2520MAPK%2520phosphorylation%2520and%2520subsequent%2520cell%2520death%2520via%2520apoptosis%2520in%2520human%2520osteosarcoma%2520cells%26jtitle%3DToxicology%26date%3D2007%26volume%3D231%26spage%3D21%26epage%3D29%26doi%3D10.1016%2Fj.tox.2006.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Petrocellis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmisano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisogno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laezza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bifulco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span> <span> </span><span class="NLM_article-title">The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">8375</span>– <span class="NLM_lpage">8380</span>, <span class="refDoi"> DOI: 10.1073/pnas.95.14.8375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1073%2Fpnas.95.14.8375" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=8375-8380&author=L.+De%0APetrocellisauthor=D.+Melckauthor=A.+Palmisanoauthor=T.+Bisognoauthor=C.+Laezzaauthor=M.+Bifulcoauthor=V.+Di+Marzo&title=The+endogenous+cannabinoid+anandamide+inhibits+human+breast+cancer+cell+proliferation&doi=10.1073%2Fpnas.95.14.8375"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.14.8375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.14.8375%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26aulast%3DMelck%26aufirst%3DD.%26aulast%3DPalmisano%26aufirst%3DA.%26aulast%3DBisogno%26aufirst%3DT.%26aulast%3DLaezza%26aufirst%3DC.%26aulast%3DBifulco%26aufirst%3DM.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DThe%2520endogenous%2520cannabinoid%2520anandamide%2520inhibits%2520human%2520breast%2520cancer%2520cell%2520proliferation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D8375%26epage%3D8380%26doi%3D10.1073%2Fpnas.95.14.8375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patsos, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenhough, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paraskeva, C.</span></span> <span> </span><span class="NLM_article-title">The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1741</span>– <span class="NLM_lpage">1750</span>, <span class="refDoi"> DOI: 10.1136/gut.2005.073403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1136%2Fgut.2005.073403" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=1741-1750&author=H.+A.+Patsosauthor=D.+J.+Hicksauthor=R.+R.+Dobsonauthor=A.+Greenhoughauthor=N.+Woodmanauthor=J.+D.+Laneauthor=A.+C.+Williamsauthor=C.+Paraskeva&title=The+endogenous+cannabinoid%2C+anandamide%2C+induces+cell+death+in+colorectal+carcinoma+cells%3A+a+possible+role+for+cyclooxygenase+2&doi=10.1136%2Fgut.2005.073403"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1136%2Fgut.2005.073403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgut.2005.073403%26sid%3Dliteratum%253Aachs%26aulast%3DPatsos%26aufirst%3DH.%2BA.%26aulast%3DHicks%26aufirst%3DD.%2BJ.%26aulast%3DDobson%26aufirst%3DR.%2BR.%26aulast%3DGreenhough%26aufirst%3DA.%26aulast%3DWoodman%26aufirst%3DN.%26aulast%3DLane%26aufirst%3DJ.%2BD.%26aulast%3DWilliams%26aufirst%3DA.%2BC.%26aulast%3DParaskeva%26aufirst%3DC.%26atitle%3DThe%2520endogenous%2520cannabinoid%252C%2520anandamide%252C%2520induces%2520cell%2520death%2520in%2520colorectal%2520carcinoma%2520cells%253A%2520a%2520possible%2520role%2520for%2520cyclooxygenase%25202%26jtitle%3DGut%26date%3D2005%26volume%3D54%26spage%3D1741%26epage%3D1750%26doi%3D10.1136%2Fgut.2005.073403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nithipatikom, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endsley, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isbell, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillard, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span> <span> </span><span class="NLM_article-title">2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">8826</span>– <span class="NLM_lpage">8830</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-3136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1158%2F0008-5472.CAN-04-3136" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=8826-8830&author=K.+Nithipatikomauthor=M.+P.+Endsleyauthor=M.+A.+Isbellauthor=J.+R.+Falckauthor=Y.+Iwamotoauthor=C.+J.+Hillardauthor=W.+B.+Campbell&title=2-arachidonoylglycerol%3A+a+novel+inhibitor+of+androgen-independent+prostate+cancer+cell+invasion&doi=10.1158%2F0008-5472.CAN-04-3136"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-3136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-3136%26sid%3Dliteratum%253Aachs%26aulast%3DNithipatikom%26aufirst%3DK.%26aulast%3DEndsley%26aufirst%3DM.%2BP.%26aulast%3DIsbell%26aufirst%3DM.%2BA.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DIwamoto%26aufirst%3DY.%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26atitle%3D2-arachidonoylglycerol%253A%2520a%2520novel%2520inhibitor%2520of%2520androgen-independent%2520prostate%2520cancer%2520cell%2520invasion%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D8826%26epage%3D8830%26doi%3D10.1158%2F0008-5472.CAN-04-3136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDougle, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdeen, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adili, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caputo, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krapf, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilian, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holinstat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, A.</span></span> <span> </span><span class="NLM_article-title">Anti-inflammatory omega-3 endocannabinoid epoxides</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E6034</span>, <span class="refDoi"> DOI: 10.1073/pnas.1610325114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1073%2Fpnas.1610325114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E6034&author=D.+R.+McDougleauthor=J.+E.+Watsonauthor=A.+A.+Abdeenauthor=R.+Adiliauthor=M.+P.+Caputoauthor=J.+E.+Krapfauthor=R.+W.+Johnsonauthor=K.+A.+Kilianauthor=M.+Holinstatauthor=A.+Das&title=Anti-inflammatory+omega-3+endocannabinoid+epoxides&doi=10.1073%2Fpnas.1610325114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1610325114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1610325114%26sid%3Dliteratum%253Aachs%26aulast%3DMcDougle%26aufirst%3DD.%2BR.%26aulast%3DWatson%26aufirst%3DJ.%2BE.%26aulast%3DAbdeen%26aufirst%3DA.%2BA.%26aulast%3DAdili%26aufirst%3DR.%26aulast%3DCaputo%26aufirst%3DM.%2BP.%26aulast%3DKrapf%26aufirst%3DJ.%2BE.%26aulast%3DJohnson%26aufirst%3DR.%2BW.%26aulast%3DKilian%26aufirst%3DK.%2BA.%26aulast%3DHolinstat%26aufirst%3DM.%26aulast%3DDas%26aufirst%3DA.%26atitle%3DAnti-inflammatory%2520omega-3%2520endocannabinoid%2520epoxides%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3DE6034%26doi%3D10.1073%2Fpnas.1610325114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sha, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nie, T. H.</span></span> <span> </span><span class="NLM_article-title">Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212–2</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2415</span>– <span class="NLM_lpage">2421</span>, <span class="refDoi"> DOI: 10.3892/ol.2015.3525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.3892%2Fol.2015.3525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=26622862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltlGksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=2415-2421&author=F.+Niuauthor=S.+Zhaoauthor=C.+Y.+Xuauthor=H.+Shaauthor=G.+B.+Biauthor=L.+Chenauthor=L.+Yeauthor=P.+Gongauthor=T.+H.+Nie&title=Potentiation+of+the+antitumor+activity+of+adriamycin+against+osteosarcoma+by+cannabinoid+WIN-55%2C212%E2%80%932&doi=10.3892%2Fol.2015.3525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2</span></div><div class="casAuthors">Niu, Feng; Zhao, Song; Xu, Chang-Yan; Sha, Hui; Bi, Gui-Bin; Chen, Lin; Ye, Long; Gong, Ping; Nie, Tian-Hong</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2415-2421</span>CODEN:
                <span class="NLM_cas:coden">OLNEB5</span>;
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Osteosarcoma is the most frequent primary malignant bone tumor that occurs in children and adolescents.  The present study aimed to identify novel therapeutic strategies for osteosarcoma, by assessing the antitumor activity of the cannabinoid WIN-55,212-2 and its combined effect with adriamycin (ADM) against the MG-63 human osteosarcoma cell line.  To evaluate the antiproliferative action of these mols., a Cell Counting kit-8 (CCK-8) assay was used.  The ability of cannabinoid to inhibit the migration, invasion and angiogenic activity of MG-63 cells were assessed by scratch, Transwell chamber and angiogenesis assays, resp., in vitro.  To examine the alterations in expression of targeted genes, quant. polymerase chain reaction and western blot anal. were used.  The administration of cannabinoid combined with ADM was demonstrated to inhibit the growth of MG-63 cells, resulting in a cell viability of 32.12 ± 3.13%, which was significantly lower (P<0.05) compared with the cell viability following treatment with cannabinoid (70.86 ± 7.55%) and ADM (62.87 ± 5.98%) alone.  Greater antimetastasis and antiangiogenic activities were also obsd. following the coadministration of the two agents compared with individual treatments and controls.  In addn., the expression levels of Notch-1, matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in MG-63 cells were downregulated following the treatments with cannabinoid alone or in combination with ADM.  In conclusion, the present findings demonstrated that cannabinoid WIN-55,212-2 may significantly potentiate the antiproliferative, antimetastasis and antiangiogenic effects of ADM against MG-63 cells via the downregulation of Notch-1, MMP-2 and VEGF.  These findings may offer a novel strategy for the treatment of osteosarcoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1RaPlUUcAnrVg90H21EOLACvtfcHk0ljMgRVsaN-lug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltlGksbs%253D&md5=162b54a5116cf2ad8d190b879cfe0175</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3892%2Fol.2015.3525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2015.3525%26sid%3Dliteratum%253Aachs%26aulast%3DNiu%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DC.%2BY.%26aulast%3DSha%26aufirst%3DH.%26aulast%3DBi%26aufirst%3DG.%2BB.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DGong%26aufirst%3DP.%26aulast%3DNie%26aufirst%3DT.%2BH.%26atitle%3DPotentiation%2520of%2520the%2520antitumor%2520activity%2520of%2520adriamycin%2520against%2520osteosarcoma%2520by%2520cannabinoid%2520WIN-55%252C212%25E2%2580%25932%26jtitle%3DOncol.%2520Lett.%26date%3D2015%26volume%3D10%26spage%3D2415%26epage%3D2421%26doi%3D10.3892%2Fol.2015.3525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hald, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egerod, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konradsen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atalay, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjerrum, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heegaard, A. M.</span></span> <span> </span><span class="NLM_article-title">Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212–2 in experimental models of bone cancer pain and neuropathic pain</span>. <i>Pharmacol., Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1016/j.pbb.2008.04.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2Fj.pbb.2008.04.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2008&pages=38-46&author=A.+Haldauthor=M.+Dingauthor=K.+Egerodauthor=R.+R.+Hansenauthor=D.+Konradsenauthor=S.+G.+Jorgensenauthor=B.+Atalayauthor=A.+Nasserauthor=O.+J.+Bjerrumauthor=A.+M.+Heegaard&title=Differential+effects+of+repeated+low+dose+treatment+with+the+cannabinoid+agonist+WIN+55%2C212%E2%80%932+in+experimental+models+of+bone+cancer+pain+and+neuropathic+pain&doi=10.1016%2Fj.pbb.2008.04.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2008.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2008.04.021%26sid%3Dliteratum%253Aachs%26aulast%3DHald%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DM.%26aulast%3DEgerod%26aufirst%3DK.%26aulast%3DHansen%26aufirst%3DR.%2BR.%26aulast%3DKonradsen%26aufirst%3DD.%26aulast%3DJorgensen%26aufirst%3DS.%2BG.%26aulast%3DAtalay%26aufirst%3DB.%26aulast%3DNasser%26aufirst%3DA.%26aulast%3DBjerrum%26aufirst%3DO.%2BJ.%26aulast%3DHeegaard%26aufirst%3DA.%2BM.%26atitle%3DDifferential%2520effects%2520of%2520repeated%2520low%2520dose%2520treatment%2520with%2520the%2520cannabinoid%2520agonist%2520WIN%252055%252C212%25E2%2580%25932%2520in%2520experimental%2520models%2520of%2520bone%2520cancer%2520pain%2520and%2520neuropathic%2520pain%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2008%26volume%3D91%26spage%3D38%26epage%3D46%26doi%3D10.1016%2Fj.pbb.2008.04.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lozano-Ondoua, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vardanyan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Largent-Milnes, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Andrade, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantyh, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderah, T. W.</span></span> <span> </span><span class="NLM_article-title">A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">653</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2010.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2Fj.lfs.2010.02.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2010&pages=646-653&author=A.+N.+Lozano-Ondouaauthor=C.+Wrightauthor=A.+Vardanyanauthor=T.+Kingauthor=T.+M.+Largent-Milnesauthor=M.+Nelsonauthor=J.+M.+Jimenez-Andradeauthor=P.+W.+Mantyhauthor=T.+W.+Vanderah&title=A+cannabinoid+2+receptor+agonist+attenuates+bone+cancer-induced+pain+and+bone+loss&doi=10.1016%2Fj.lfs.2010.02.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2010.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2010.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DLozano-Ondoua%26aufirst%3DA.%2BN.%26aulast%3DWright%26aufirst%3DC.%26aulast%3DVardanyan%26aufirst%3DA.%26aulast%3DKing%26aufirst%3DT.%26aulast%3DLargent-Milnes%26aufirst%3DT.%2BM.%26aulast%3DNelson%26aufirst%3DM.%26aulast%3DJimenez-Andrade%26aufirst%3DJ.%2BM.%26aulast%3DMantyh%26aufirst%3DP.%2BW.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26atitle%3DA%2520cannabinoid%25202%2520receptor%2520agonist%2520attenuates%2520bone%2520cancer-induced%2520pain%2520and%2520bone%2520loss%26jtitle%3DLife%2520Sci.%26date%3D2010%26volume%3D86%26spage%3D646%26epage%3D653%26doi%3D10.1016%2Fj.lfs.2010.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luu, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montag, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peabody, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haydon, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinker-Schaeffer, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, T. C.</span></span> <span> </span><span class="NLM_article-title">An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis</span>. <i>Clin. Exp. Metastasis</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.1007/s10585-005-0365-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1007%2Fs10585-005-0365-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=16170668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A280%3ADC%252BD2Mvps12gsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2005&pages=319-329&author=H.+H.+Luuauthor=Q.+Kangauthor=J.+K.+Parkauthor=W.+Siauthor=Q.+Luoauthor=W.+Jiangauthor=H.+Yinauthor=A.+G.+Montagauthor=M.+A.+Simonauthor=T.+D.+Peabodyauthor=R.+C.+Haydonauthor=C.+W.+Rinker-Schaefferauthor=T.+C.+He&title=An+orthotopic+model+of+human+osteosarcoma+growth+and+spontaneous+pulmonary+metastasis&doi=10.1007%2Fs10585-005-0365-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis</span></div><div class="casAuthors">Luu Hue H; Kang Quan; Park Jong Kyung; Si Weike; Luo Qing; Jiang Wei; Yin Hong; Montag Anthony G; Simon Michael A; Peabody Terrance D; Haydon Rex C; Rinker-Schaeffer Carrie W; He Tong-Chuan</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & experimental metastasis</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">319-29</span>
        ISSN:<span class="NLM_cas:issn">0262-0898</span>.
    </div><div class="casAbstract">Osteosarcoma is the most common primary malignancy of bone and patients often develop pulmonary metastases.  In order to investigate the pathogenesis of human osteosarcoma, there is a great need to develop a clinically relevant animal model.  Here we report the development of an osteosarcoma animal model using three related human osteosarcoma lines, the parental TE-85 and two derivative lines MNNG/HOS and 143B.  In vitro characterization demonstrated that the 143B line had the greatest cell migration and the least cell adhesion activities among the three lines.  The 143B line also exhibited the greatest ability for anchorage independent growth.  When GFP-tagged osteosarcoma cells were injected into the proximal tibia of athymic mice, we found that 143B cells were highly tumorigenic and metastatic, and MNNG/HOS cells were tumorigenic but significantly less metastatic.  TE85 cells were neither tumorigenic nor metastatic.  The number of pulmonary metastases was found 50-fold higher in 143B injected animals than that in MNNG/HOS injected mice.  No pulmonary metastases were detected in TE85 injected animals for up to 8 weeks.  Primary tumors formed by MNNG/HOS and 143B cells could be visualized by whole body fluorescence imaging, while the pulmonary metastases were visualized on the necropsied samples.  The GFP tagged 143B cells (and to a lesser extent, MNNG/HOS cells) were readily recovered from lung metastases.  This clinically relevant model of human osteosarcoma provides varying degrees of tumor growth at the primary site and metastatic potential.  Thus, this orthotopic model should be a valuable tool to investigate factors that promote or inhibit osteosarcoma growth and/or metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXRi-dKHz0zkh5eUSa2oe_fW6udTcc2eaa_OMVwcWkibntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mvps12gsQ%253D%253D&md5=3bc41704831cd6b329d783262bac338e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs10585-005-0365-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10585-005-0365-9%26sid%3Dliteratum%253Aachs%26aulast%3DLuu%26aufirst%3DH.%2BH.%26aulast%3DKang%26aufirst%3DQ.%26aulast%3DPark%26aufirst%3DJ.%2BK.%26aulast%3DSi%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DMontag%26aufirst%3DA.%2BG.%26aulast%3DSimon%26aufirst%3DM.%2BA.%26aulast%3DPeabody%26aufirst%3DT.%2BD.%26aulast%3DHaydon%26aufirst%3DR.%2BC.%26aulast%3DRinker-Schaeffer%26aufirst%3DC.%2BW.%26aulast%3DHe%26aufirst%3DT.%2BC.%26atitle%3DAn%2520orthotopic%2520model%2520of%2520human%2520osteosarcoma%2520growth%2520and%2520spontaneous%2520pulmonary%2520metastasis%26jtitle%3DClin.%2520Exp.%2520Metastasis%26date%3D2005%26volume%3D22%26spage%3D319%26epage%3D329%26doi%3D10.1007%2Fs10585-005-0365-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, J. L.</span></span> <span> </span><span class="NLM_article-title">In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.1038/nprot.2007.30</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1038%2Fnprot.2007.30" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=17406593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGntbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=329-333&author=C.+C.+Liangauthor=A.+Y.+Parkauthor=J.+L.+Guan&title=In+vitro+scratch+assay%3A+a+convenient+and+inexpensive+method+for+analysis+of+cell+migration+in+vitro&doi=10.1038%2Fnprot.2007.30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro</span></div><div class="casAuthors">Liang, Chun-Chi; Park, Ann Y.; Guan, Jun-Lin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">329-333</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The in vitro scratch assay is an easy, low-cost and well-developed method to measure cell migration in vitro.  The basic steps involve creating a "scratch" in a cell monolayer, capturing the images at the beginning and at regular intervals during cell migration to close the scratch, and comparing the images to quantify the migration rate of the cells.  Compared to other methods, the in vitro scratch assay is particularly suitable for studies on the effects of cell-matrix and cell-cell interactions on cell migration, mimic cell migration during wound healing in vivo and are compatible with imaging of live cells during migration to monitor intracellular events if desired.  Besides monitoring migration of homogenous cell populations, this method has also been adopted to measure migration of individual cells in the leading edge of the scratch.  Not taking into account the time for transfection of cells, in vitro scratch assay per se usually takes from several hours to overnight.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoteV73OoU6tbVg90H21EOLACvtfcHk0lh-hr5t-cxpVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGntbvI&md5=50b4a72bac9236e14e81af45b547b4c6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.30&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.30%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DC.%2BC.%26aulast%3DPark%26aufirst%3DA.%2BY.%26aulast%3DGuan%26aufirst%3DJ.%2BL.%26atitle%3DIn%2520vitro%2520scratch%2520assay%253A%2520a%2520convenient%2520and%2520inexpensive%2520method%2520for%2520analysis%2520of%2520cell%2520migration%2520in%2520vitro%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26spage%3D329%26epage%3D333%26doi%3D10.1038%2Fnprot.2007.30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremming, B. A.</span></span> <span> </span><span class="NLM_article-title">Rimonabant--a selective CB1 antagonist</span>. <i>Ann. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">684</span>– <span class="NLM_lpage">690</span>, <span class="refDoi"> DOI: 10.1345/aph.1E499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1345%2Faph.1E499" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2005&pages=684-690&author=S.+T.+Boydauthor=B.+A.+Fremming&title=Rimonabant%2D%2Da+selective+CB1+antagonist&doi=10.1345%2Faph.1E499"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1345%2Faph.1E499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1345%252Faph.1E499%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DS.%2BT.%26aulast%3DFremming%26aufirst%3DB.%2BA.%26atitle%3DRimonabant--a%2520selective%2520CB1%2520antagonist%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2005%26volume%3D39%26spage%3D684%26epage%3D690%26doi%3D10.1345%2Faph.1E499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abadji, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taha, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">(R)-Methanandamide - a Chiral Novel Anandamide Possessing Higher Potency and Metabolic Stability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1889</span>– <span class="NLM_lpage">1893</span>, <span class="refDoi"> DOI: 10.1021/jm00038a020</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00038a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1889-1893&author=V.+Abadjiauthor=S.+Y.+Linauthor=G.+Tahaauthor=G.+Griffinauthor=L.+A.+Stevensonauthor=R.+G.+Pertweeauthor=A.+Makriyannis&title=%28R%29-Methanandamide+-+a+Chiral+Novel+Anandamide+Possessing+Higher+Potency+and+Metabolic+Stability&doi=10.1021%2Fjm00038a020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm00038a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00038a020%26sid%3Dliteratum%253Aachs%26aulast%3DAbadji%26aufirst%3DV.%26aulast%3DLin%26aufirst%3DS.%2BY.%26aulast%3DTaha%26aufirst%3DG.%26aulast%3DGriffin%26aufirst%3DG.%26aulast%3DStevenson%26aufirst%3DL.%2BA.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3D%2528R%2529-Methanandamide%2520-%2520a%2520Chiral%2520Novel%2520Anandamide%2520Possessing%2520Higher%2520Potency%2520and%2520Metabolic%2520Stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1889%26epage%3D1893%26doi%3D10.1021%2Fjm00038a020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jarrahian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgemond, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillard, C. J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships among N-arachidonylethanolamine (anandamide) head group analogues for the anandamide transporter</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">2597</span>– <span class="NLM_lpage">2606</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.2000.0742597.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1046%2Fj.1471-4159.2000.0742597.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10820223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsVKrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=2597-2606&author=A.+Jarrahianauthor=S.+Mannaauthor=W.+S.+Edgemondauthor=W.+B.+Campbellauthor=C.+J.+Hillard&title=Structure-activity+relationships+among+N-arachidonylethanolamine+%28anandamide%29+head+group+analogues+for+the+anandamide+transporter&doi=10.1046%2Fj.1471-4159.2000.0742597.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships among N-arachidonylethanolamine (anandamide) head group analogues for the anandamide transporter</span></div><div class="casAuthors">Jarrahian, Abbas; Manna, Sukumar; Edgemond, William S.; Campbell, William B.; Hillard, Cecilia J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2597-2606</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Two putative endocannabinoids, N-arachidonylethanolamine (AEA) and 2-arachidonylglycerol, are inactivated by removal from the extracellular environment by a process that has the features of protein-mediated facilitated diffusion.  The authors have synthesized and studied 22 N-linked analogs of arachidonylamide for the purpose of increasing the authors understanding of the structural requirements for the binding of ligands to the AEA transporter.  The authors have also detd. the affinities of these analogs for both the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH).  The authors have identified several structural features that enhance binding to the AEA transporter in cerebellar granule cells.  The authors have confirmed the findings of others that replacing the ethanolamine head group with 4-hydroxybenzyl results in a high-affinity ligand for the transporter.  However, the authors find that the same mol. is also a competitive inhibitor of FAAH.  Similarly, replacement of the ethanolamine of AEA with 3-pyridinyl also results in a high-affinity inhibitor of both the transporter and FAAH.  The authors conclude that the structural requirements for ligand binding to the CB1 receptor and binding to the transporter are very different; however, the transporter and FAAH share most, but not all, structural requirements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZV4_lBm_zX7Vg90H21EOLACvtfcHk0lh-hr5t-cxpVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsVKrsb8%253D&md5=b0af80e16d8dd2dd362b7973a253198c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0742597.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0742597.x%26sid%3Dliteratum%253Aachs%26aulast%3DJarrahian%26aufirst%3DA.%26aulast%3DManna%26aufirst%3DS.%26aulast%3DEdgemond%26aufirst%3DW.%2BS.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26atitle%3DStructure-activity%2520relationships%2520among%2520N-arachidonylethanolamine%2520%2528anandamide%2529%2520head%2520group%2520analogues%2520for%2520the%2520anandamide%2520transporter%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D74%26spage%3D2597%26epage%3D2606%26doi%3D10.1046%2Fj.1471-4159.2000.0742597.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boring, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilken, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantrell, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howlett, A. C.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid Receptor-Binding and Agonist Activity of Amides and Esters of Arachidonic-Acid</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">516</span>– <span class="NLM_lpage">522</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1994&pages=516-522&author=J.+C.+Pintoauthor=F.+Potieauthor=K.+C.+Riceauthor=D.+Boringauthor=M.+R.+Johnsonauthor=D.+M.+Evansauthor=G.+H.+Wilkenauthor=C.+H.+Cantrellauthor=A.+C.+Howlett&title=Cannabinoid+Receptor-Binding+and+Agonist+Activity+of+Amides+and+Esters+of+Arachidonic-Acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPinto%26aufirst%3DJ.%2BC.%26aulast%3DPotie%26aufirst%3DF.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DBoring%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DM.%2BR.%26aulast%3DEvans%26aufirst%3DD.%2BM.%26aulast%3DWilken%26aufirst%3DG.%2BH.%26aulast%3DCantrell%26aufirst%3DC.%2BH.%26aulast%3DHowlett%26aufirst%3DA.%2BC.%26atitle%3DCannabinoid%2520Receptor-Binding%2520and%2520Agonist%2520Activity%2520of%2520Amides%2520and%2520Esters%2520of%2520Arachidonic-Acid%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D46%26spage%3D516%26epage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheskin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanus, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slager, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span> <span> </span><span class="NLM_article-title">Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1021/jm960752x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960752x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=659-667&author=T.+Sheskinauthor=L.+Hanusauthor=J.+Slagerauthor=Z.+Vogelauthor=R.+Mechoulam&title=Structural+requirements+for+binding+of+anandamide-type+compounds+to+the+brain+cannabinoid+receptor&doi=10.1021%2Fjm960752x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm960752x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960752x%26sid%3Dliteratum%253Aachs%26aulast%3DSheskin%26aufirst%3DT.%26aulast%3DHanus%26aufirst%3DL.%26aulast%3DSlager%26aufirst%3DJ.%26aulast%3DVogel%26aufirst%3DZ.%26aulast%3DMechoulam%26aufirst%3DR.%26atitle%3DStructural%2520requirements%2520for%2520binding%2520of%2520anandamide-type%2520compounds%2520to%2520the%2520brain%2520cannabinoid%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D659%26epage%3D667%26doi%3D10.1021%2Fjm960752x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giang, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Molecular characterization of human and mouse fatty acid amide hydrolases</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">2238</span>– <span class="NLM_lpage">2242</span>, <span class="refDoi"> DOI: 10.1073/pnas.94.6.2238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1073%2Fpnas.94.6.2238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=9122178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADyaK2sXhvF2ltLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=2238-2242&author=D.+K.+Giangauthor=B.+F.+Cravatt&title=Molecular+characterization+of+human+and+mouse+fatty+acid+amide+hydrolases&doi=10.1073%2Fpnas.94.6.2238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization of human and mouse fatty acid amide hydrolases</span></div><div class="casAuthors">Giang, Dan K.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2238-2242</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Recently, we reported the isolation, cloning, and expression of a rat enzyme, fatty acid amide hydrolase (FAAH), that degrades bioactive fatty acid amides like oleamide and anandamide to their corresponding acids, thereby serving to terminate the signaling functions of these mols.  Here, we report the mol. characterization of both a mouse and a human FAAH and compare these enzymes to the rat FAAH.  The enzymes are well conserved in primary structure, with the mouse and rat FAAHs sharing 91% amino acid identity and the human FAAH sharing 82% and 84% identity with the rat FAAH and mouse FAAH, resp.  In addn., the expressed human and rat FAAHs behave biochem. as membrane proteins of comparable mol. size and show similar, but distinguishable, enzymol. properties.  The identification of highly homologous FAAH proteins in rat, mouse, and human supports a general role for the fatty acid amides in mammalian biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU0clJ7pptNLVg90H21EOLACvtfcHk0ljugy9vJXoXEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvF2ltLY%253D&md5=67e8a8f29d8cd60f0ff2510f80fa04d0</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.6.2238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.6.2238%26sid%3Dliteratum%253Aachs%26aulast%3DGiang%26aufirst%3DD.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DMolecular%2520characterization%2520of%2520human%2520and%2520mouse%2520fatty%2520acid%2520amide%2520hydrolases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26spage%3D2238%26epage%3D2242%26doi%3D10.1073%2Fpnas.94.6.2238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goparaju, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span> <span> </span><span class="NLM_article-title">Anandamide amidohydrolase of porcine brain: cDNA cloning, functional expression and site-directed mutagenesis</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>1441</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1016/S1388-1981(99)00143-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2FS1388-1981%2899%2900143-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10526230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADyaK1MXntVGks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1441&publication_year=1999&pages=77-84&author=S.+K.+Goparajuauthor=Y.+Kurahashiauthor=H.+Suzukiauthor=N.+Uedaauthor=S.+Yamamoto&title=Anandamide+amidohydrolase+of+porcine+brain%3A+cDNA+cloning%2C+functional+expression+and+site-directed+mutagenesis&doi=10.1016%2FS1388-1981%2899%2900143-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Anandamide amidohydrolase of porcine brain: cDNA cloning, functional expression and site-directed mutagenesis</span></div><div class="casAuthors">Goparaju, S. K.; Kurahashi, Y.; Suzuki, H.; Ueda, N.; Yamamoto, S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1441</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-84</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Anandamide (arachidonoylethanolamide) is an endogenous ligand for cannabinoid receptors, and its cannabimimetic activities are lost when the compd. is hydrolyzed to arachidonic acid and ethanolamine by an enzyme referred to as anandamide amidohydrolase.  We cloned a cDNA for the enzyme of porcine brain, and the cDNA encoded a protein of 579 amino acids with a mol. mass of 62.9 kDa.  The amino acid sequence was 81, 80 and 85% identical with the enzymes previously cloned from the liver of rat, mouse, and human, resp.  When the enzyme protein was overexpressed in COS-7 cells, the particulate fraction of the cells showed an anandamide hydrolyzing activity and also catalyzed the reverse reaction synthesizing anandamide from arachidonic acid and ethanolamine both with a specific activity of 0.2-0.3 μmol/min/mg protein at 37°.  The brain enzyme exhibited a wide substrate specificity hydrolyzing oleamide, 2-arachidonoylglycerol, and Me arachidonate.  The point mutation of Ser-217, Asp-237, Ser-241, or Cys-249 completely abolished the hydrolysis of all the above-mentioned substrates as well as the synthesis of anandamide in the reverse reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2l38CHaxXDLVg90H21EOLACvtfcHk0lib3z1di6xjKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntVGks7g%253D&md5=5650ac3b562741896a0e532a7ad9061f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS1388-1981%2899%2900143-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1388-1981%252899%252900143-2%26sid%3Dliteratum%253Aachs%26aulast%3DGoparaju%26aufirst%3DS.%2BK.%26aulast%3DKurahashi%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DAnandamide%2520amidohydrolase%2520of%2520porcine%2520brain%253A%2520cDNA%2520cloning%252C%2520functional%2520expression%2520and%2520site-directed%2520mutagenesis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D1999%26volume%3D1441%26spage%3D77%26epage%3D84%26doi%3D10.1016%2FS1388-1981%2899%2900143-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hillard, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkison, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgemond, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span> <span> </span><span class="NLM_article-title">Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain</span>. <i>Biochim. Biophys. Acta, Lipids Lipid Metab.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>1257</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1016/0005-2760(95)00087-S</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2F0005-2760%2895%2900087-S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=7647100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADyaK2MXntl2jtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1257&publication_year=1995&pages=249-256&author=C.+J.+Hillardauthor=D.+M.+Wilkisonauthor=W.+S.+Edgemondauthor=W.+B.+Campbell&title=Characterization+of+the+kinetics+and+distribution+of+N-arachidonylethanolamine+%28anandamide%29+hydrolysis+by+rat+brain&doi=10.1016%2F0005-2760%2895%2900087-S"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain</span></div><div class="casAuthors">Hillard, Cecilia J.; Wilkison, Douglas M.; Edgemond, William S.; Campbell, William B.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Lipids and Lipid Metabolism</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1257</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-56</span>CODEN:
                <span class="NLM_cas:coden">BBLLA6</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Arachidonoylethanolamide or anandamide is a naturally occurring deriv. of arachidonic acid that has been shown to activate cannabinoid receptors in the brain.  Its metabolic inactivation by brain tissue has been investigated.  Anandamide is hydrolyzed by the membrane fraction of rat brain homogenate to arachidonic acid and ethanolamine.  The hydrolysis is temp.- and pH-dependent (pH max. at 8.5) and abolished by boiling.  Anandamide hydrolysis is protein dependent in the range of 25-100 μg protein/mL; does not require calcium and is inhibited by phenylmethylsulfonylfluoride, diisopropylfluorophosphate, thimerosal and arachidonic acid.  Hydrolysis of 10 μM anandamide by brain membranes follows first order kinetics; at 30°, the rate const. for anandamide catabolism is 0.34 min-1 mg protein-1.  The Km for anandamide hydrolysis is 3.4 μM, and the Vmax is 2.2 nmol/min per mg protein.  Hydrolysis occurs in all subcellular fractions except cytosol with the highest specific activity in myelin and microsomes.  The distribution of anandamide hydrolytic activity correlates with the distribution of cannabinoid receptor-binding sites; the hippocampus, cerebellum and cerebral cortex exhibit the highest metabolic activity, while activity is lowest in the striatum, brain stem and white matter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_wuU3uI6dDLVg90H21EOLACvtfcHk0lib3z1di6xjKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntl2jtbo%253D&md5=94968f21405527d140e7c51ee6b265db</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2F0005-2760%2895%2900087-S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2760%252895%252900087-S%26sid%3Dliteratum%253Aachs%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26aulast%3DWilkison%26aufirst%3DD.%2BM.%26aulast%3DEdgemond%26aufirst%3DW.%2BS.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26atitle%3DCharacterization%2520of%2520the%2520kinetics%2520and%2520distribution%2520of%2520N-arachidonylethanolamine%2520%2528anandamide%2529%2520hydrolysis%2520by%2520rat%2520brain%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Lipids%2520Lipid%2520Metab.%26date%3D1995%26volume%3D1257%26spage%3D249%26epage%3D256%26doi%3D10.1016%2F0005-2760%2895%2900087-S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojiro, M.</span></span> <span> </span><span class="NLM_article-title">Angiogenesis in cancer</span>. <i>Vasc Health Risk Manag</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.2147/vhrm.2006.2.3.213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.2147%2Fvhrm.2006.2.3.213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=17326328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlars77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=213-219&author=N.+Nishidaauthor=H.+Yanoauthor=T.+Nishidaauthor=T.+Kamuraauthor=M.+Kojiro&title=Angiogenesis+in+cancer&doi=10.2147%2Fvhrm.2006.2.3.213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis in cancer</span></div><div class="casAuthors">Nishida, Naoyo; Yano, Hirohisa; Nishida, Takashi; Kamura, Toshiharu; Kojiro, Masamichi</div><div class="citationInfo"><span class="NLM_cas:title">Vascular Health and Risk Management</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">213-219</span>CODEN:
                <span class="NLM_cas:coden">VHRMAT</span>;
        ISSN:<span class="NLM_cas:issn">1176-6344</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  New growth in the vascular network is important since the proliferation, as well as metastatic spread, of cancer cells depends on an adequate supply of oxygen and nutrients and the removal of waste products.  New blood and lymphatic vessels form through processes called angiogenesis and lymphangiogenesis, resp.  Angiogenesis is regulated by both activator and inhibitor mols.  More than a dozen different proteins have been identified as angiogenic activators and inhibitors.  Levels of expression of angiogenic factors reflect the aggressiveness of tumor cells.  The discovery of angiogenic inhibitors should help to reduce both morbidity and mortality from carcinomas.  Thousands of patients have received antiangiogenic therapy to date.  Despite their theor. efficacy, antiangiogenic treatments have not proved beneficial in terms of long-term survival.  There is an urgent need for a new comprehensive treatment strategy combining antiangiogenic agents with conventional cytoreductive treatments in the control of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCfY5hNg-E-LVg90H21EOLACvtfcHk0lib3z1di6xjKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlars77L&md5=a63173b323051565266457ca6dcdb242</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.2147%2Fvhrm.2006.2.3.213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252Fvhrm.2006.2.3.213%26sid%3Dliteratum%253Aachs%26aulast%3DNishida%26aufirst%3DN.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DNishida%26aufirst%3DT.%26aulast%3DKamura%26aufirst%3DT.%26aulast%3DKojiro%26aufirst%3DM.%26atitle%3DAngiogenesis%2520in%2520cancer%26jtitle%3DVasc%2520Health%2520Risk%2520Manag%26date%3D2006%26volume%3D2%26spage%3D213%26epage%3D219%26doi%3D10.2147%2Fvhrm.2006.2.3.213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnaoutova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinman, H. K.</span></span> <span> </span><span class="NLM_article-title">In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">628</span>– <span class="NLM_lpage">635</span>, <span class="refDoi"> DOI: 10.1038/nprot.2010.6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1038%2Fnprot.2010.6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=20224563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFSmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=628-635&author=I.+Arnaoutovaauthor=H.+K.+Kleinman&title=In+vitro+angiogenesis%3A+endothelial+cell+tube+formation+on+gelled+basement+membrane+extract&doi=10.1038%2Fnprot.2010.6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract</span></div><div class="casAuthors">Arnaoutova, Irina; Kleinman, Hynda K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">628-635</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A protocol is presented here for a rapid, quant. and reliable in vitro angiogenesis assay that can be adapted for high throughput use.  Endothelial cells are plated on a gelled basement matrix, their natural substrate, and form capillary-like structures with a lumen.  The assay can be used to identify inhibitors or stimulators of angiogenesis, as well as genes and signaling pathways involved in angiogenesis.  It has also been used to identify endothelial progenitor cells.  This assay involves endothelial cell adhesion, migration, protease activity and tubule formation.  This tube formation assay is preferred, as other in vitro assays for angiogenesis, such as cell adhesion, migration and invasion, measure limited steps in the angiogenesis process.  The tube formation assay on basement membrane can be completed in a day because transformed endothelial cells form tubes within 3 h, whereas non-transformed endothelial cells form tubes within 6 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx_ALsj20lJ7Vg90H21EOLACvtfcHk0lis7Gj552GLYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFSmu74%253D&md5=21e5194645ac4076227b687341b19a3b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2010.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2010.6%26sid%3Dliteratum%253Aachs%26aulast%3DArnaoutova%26aufirst%3DI.%26aulast%3DKleinman%26aufirst%3DH.%2BK.%26atitle%3DIn%2520vitro%2520angiogenesis%253A%2520endothelial%2520cell%2520tube%2520formation%2520on%2520gelled%2520basement%2520membrane%2520extract%26jtitle%3DNat.%2520Protoc.%26date%3D2010%26volume%3D5%26spage%3D628%26epage%3D635%26doi%3D10.1038%2Fnprot.2010.6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganju, R. K.</span></span> <span> </span><span class="NLM_article-title">Cannabinoids as therapeutic agents in cancer: current status and future implications</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">5852</span>– <span class="NLM_lpage">5872</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2233</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.18632%2Foncotarget.2233" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=25115386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252Fht1SgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=5852-5872&author=B.+Chakravartiauthor=J.+Raviauthor=R.+K.+Ganju&title=Cannabinoids+as+therapeutic+agents+in+cancer%3A+current+status+and+future+implications&doi=10.18632%2Foncotarget.2233"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoids as therapeutic agents in cancer: current status and future implications</span></div><div class="casAuthors">Chakravarti Bandana; Ravi Janani; Ganju Ramesh K</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5852-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The pharmacological importance of cannabinoids has been in study for several years.  Cannabinoids comprise of (a) the active compounds of the Cannabis sativa plant, (b) endogenous as well as (c) synthetic cannabinoids.  Though cannabinoids are clinically used for anti-palliative effects, recent studies open a promising possibility as anti-cancer agents.  They have been shown to possess anti-proliferative and anti-angiogenic effects in vitro as well as in vivo in different cancer models.  Cannabinoids regulate key cell signaling pathways that are involved in cell survival, invasion, angiogenesis, metastasis, etc.  There is more focus on CB1 and CB2, the two cannabinoid receptors which are activated by most of the cannabinoids.  In this review article, we will focus on a broad range of cannabinoids, their receptor dependent and receptor independent functional roles against various cancer types with respect to growth, metastasis, energy metabolism, immune environment, stemness and future perspectives in exploring new possible therapeutic opportunities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI4t9ZrFEBIXy-c-E1v-fmfW6udTcc2eZ5x1Dqf4uZ1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252Fht1SgtA%253D%253D&md5=a7337b09f46c5df725ab7ce07fd5fee5</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2233%26sid%3Dliteratum%253Aachs%26aulast%3DChakravarti%26aufirst%3DB.%26aulast%3DRavi%26aufirst%3DJ.%26aulast%3DGanju%26aufirst%3DR.%2BK.%26atitle%3DCannabinoids%2520as%2520therapeutic%2520agents%2520in%2520cancer%253A%2520current%2520status%2520and%2520future%2520implications%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D5852%26epage%3D5872%26doi%3D10.18632%2Foncotarget.2233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroeze, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguere, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciaky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">PRESTO–Tango as an open-source resource for interrogation of the druggable human GPCRome</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1038/nsmb.3014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1038%2Fnsmb.3014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=25895059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslOgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=362-369&author=W.+K.+Kroezeauthor=M.+F.+Sassanoauthor=X.+P.+Huangauthor=K.+Lansuauthor=J.+D.+McCorvyauthor=P.+M.+Giguereauthor=N.+Sciakyauthor=B.+L.+Roth&title=PRESTO%E2%80%93Tango+as+an+open-source+resource+for+interrogation+of+the+druggable+human+GPCRome&doi=10.1038%2Fnsmb.3014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome</span></div><div class="casAuthors">Kroeze, Wesley K.; Sassano, Maria F.; Huang, Xi-Ping; Lansu, Katherine; McCorvy, John D.; Giguere, Patrick M.; Sciaky, Noah; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">362-369</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) are essential mediators of cellular signaling and are important targets of drug action.  Of the approx. 350 nonolfactory human GPCRs, more than 100 are still considered to be 'orphans' because their endogenous ligands remain unknown.  Here, we describe a unique open-source resource that allows interrogation of the druggable human GPCRome via a G protein-independent β-arrestin-recruitment assay.  We validate this unique platform at more than 120 nonorphan human GPCR targets, demonstrate its utility for discovering new ligands for orphan human GPCRs and describe a method (parallel receptorome expression and screening via transcriptional output, with transcriptional activation following arrestin translocation (PRESTO-Tango)) for the simultaneous and parallel interrogation of the entire human nonolfactory GPCRome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVbl7caV9gUrVg90H21EOLACvtfcHk0lis7Gj552GLYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslOgtLg%253D&md5=2a78b74a5f1425fa9e8b79b730c16be6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3014%26sid%3Dliteratum%253Aachs%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DLansu%26aufirst%3DK.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DGiguere%26aufirst%3DP.%2BM.%26aulast%3DSciaky%26aufirst%3DN.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DPRESTO%25E2%2580%2593Tango%2520as%2520an%2520open-source%2520resource%2520for%2520interrogation%2520of%2520the%2520druggable%2520human%2520GPCRome%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D362%26epage%3D369%26doi%3D10.1038%2Fnsmb.3014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otero, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. A.</span></span> <span> </span><span class="NLM_article-title">Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">12328</span>– <span class="NLM_lpage">12338</span>, <span class="refDoi"> DOI: 10.1074/jbc.M806516200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1074%2Fjbc.M806516200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=19286662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVClsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=12328-12338&author=H.+Yinauthor=A.+Chuauthor=W.+Liauthor=B.+Wangauthor=F.+Sheltonauthor=F.+Oteroauthor=D.+G.+Nguyenauthor=J.+S.+Caldwellauthor=Y.+A.+Chen&title=Lipid+G+protein-coupled+receptor+ligand+identification+using+beta-arrestin+PathHunter+assay&doi=10.1074%2Fjbc.M806516200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter Assay</span></div><div class="casAuthors">Yin, Hong; Chu, Alan; Li, Wei; Wang, Bin; Shelton, Fabiola; Otero, Francella; Nguyen, Deborah G.; Caldwell, Jeremy S.; Chen, Yu Alice</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">12328-12338</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A growing no. of orphan G-protein-coupled receptors (GPCRs) have been reported to be activated by lipid ligands, such as lysophosphatidic acid, sphingosine 1-phosphate (S1P), and cannabinoids, for which there are already well established receptors.  These new ligand claims are controversial due to either lack of independent confirmations or conflicting reports.  We used the β-arrestin PathHunter assay system, a newly developed, generic GPCR assay format that measures β-arrestin binding to GPCRs, to evaluate lipid receptor and ligand pairing.  This assay eliminates interference from endogenous receptors on the parental cells because it measures a signal that is specifically generated by the tagged receptor and is immediately downstream of receptor activation.  We screened a large no. of newly "deorphaned" receptors (GPR23, GPR92, GPR55, G2A, GPR18, GPR3, GPR6, GPR12, and GPR63) and control receptors against a collection of ∼400 lipid mols. to try to identify the receptor ligand in an unbiased fashion.  GPR92 was confirmed to be a lysophosphatidic acid receptor with weaker responses to farnesyl pyrophosphate and geranylgeranyl diphosphate.  The putative cannabinoid receptor GPR55 responded strongly to AM251, rimonabant, and lysophosphatidylinositol but only very weakly to endocannabinoids.  G2A receptor was confirmed to be an oxidized free fatty acid receptor.  In addn., we discovered that 3,3'-diindolylmethane, a dietary mol. from cruciferous vegetables, which has known anti-cancer properties, to be a CB2 receptor partial agonist, with binding affinity around 1 μM.  The anti-inflammatory effect of 3,3'-diindolylmethane in RAW264.7 cells was shown to be partially mediated by CB2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQnRS1OGXeVrVg90H21EOLACvtfcHk0ljWbCv9Rw8Wrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVClsrw%253D&md5=beb6f1fe11d9dab29329d2a2a85ab051</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M806516200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M806516200%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DH.%26aulast%3DChu%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DShelton%26aufirst%3DF.%26aulast%3DOtero%26aufirst%3DF.%26aulast%3DNguyen%26aufirst%3DD.%2BG.%26aulast%3DCaldwell%26aufirst%3DJ.%2BS.%26aulast%3DChen%26aufirst%3DY.%2BA.%26atitle%3DLipid%2520G%2520protein-coupled%2520receptor%2520ligand%2520identification%2520using%2520beta-arrestin%2520PathHunter%2520assay%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D12328%26epage%3D12338%26doi%3D10.1074%2Fjbc.M806516200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Resolution of Cancer-Promoting Inflammation: A New Approach for Anticancer Therapy</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">71</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2017.00071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.3389%2Ffimmu.2017.00071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=28210259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtl2rsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=71&author=Q.+Zhangauthor=B.+Zhuauthor=Y.+Li&title=Resolution+of+Cancer-Promoting+Inflammation%3A+A+New+Approach+for+Anticancer+Therapy&doi=10.3389%2Ffimmu.2017.00071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Resolution of cancer-promoting inflammation: a new approach for anticancer therapy</span></div><div class="casAuthors">Zhang, Qi; Zhu, Bo; Li, Yongsheng</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">71/1-71/11</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Inflammation is a protective response that eliminates harmful stimuli and restores tissue homeostasis, whereas the failure to resolve inflammation leads to the development of malignancies.  Immune cells in the tumor inflammatory microenvironment endow cancer cells with their specific hallmarks, including mutations, metabolic reprograming, angiogenesis, invasion, and metastasis.  Targeting the inflammatory microenvironment with anti-inflammatory drugs (e.g., aspirin) or by enhancing antitumor immunity (e.g., chimeric antigen receptor T cell therapy) has been extensively investigated and has achieved promising results in many cancers.  Recently, a novel approach promoting antitumor immunity via a dual anti-inflammatory and pro-resolving strategy was proposed based on the discovery of potent, endogenous, specialized pro-resolving mediators, including lipoxins, resolvins, protectins, and maresins.  In this review, we describe the updated principal cellular and mol. mechanisms of inflammation resoln. and cancer immunity and discuss the pro-resoln. strategy in cancer treatment and prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH3pL0BUgEYbVg90H21EOLACvtfcHk0ljWbCv9Rw8Wrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtl2rsr0%253D&md5=253d01cbfe31b2f5e0cf0dc62c80488c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2017.00071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2017.00071%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DResolution%2520of%2520Cancer-Promoting%2520Inflammation%253A%2520A%2520New%2520Approach%2520for%2520Anticancer%2520Therapy%26jtitle%3DFront.%2520Immunol.%26date%3D2017%26volume%3D8%26spage%3D71%26doi%3D10.3389%2Ffimmu.2017.00071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cianchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiavone, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lulli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinci, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messerini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manera, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronconi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perigli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trallori, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanganelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capaccioli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masini, E.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor alpha - Mediated Ceramide De novo Synthesis in Colon Cancer Cells</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">7691</span>– <span class="NLM_lpage">7700</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-08-0799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1158%2F1078-0432.CCR-08-0799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=19047095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVegtrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=7691-7700&author=F.+Cianchiauthor=L.+Papucciauthor=N.+Schiavoneauthor=M.+Lulliauthor=L.+Magnelliauthor=M.+C.+Vinciauthor=L.+Messeriniauthor=C.+Maneraauthor=E.+Ronconiauthor=P.+Romagnaniauthor=M.+Donniniauthor=G.+Perigliauthor=G.+Tralloriauthor=E.+Tanganelliauthor=S.+Capaccioliauthor=E.+Masini&title=Cannabinoid+Receptor+Activation+Induces+Apoptosis+through+Tumor+Necrosis+Factor+alpha+-+Mediated+Ceramide+De+novo+Synthesis+in+Colon+Cancer+Cells&doi=10.1158%2F1078-0432.CCR-08-0799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor α-Mediated Ceramide De novo Synthesis in Colon Cancer Cells</span></div><div class="casAuthors">Cianchi, Fabio; Papucci, Laura; Schiavone, Nicola; Lulli, Matteo; Magnelli, Lucia; Vinci, Maria Cristina; Messerini, Luca; Manera, Clementina; Ronconi, Elisa; Romagnani, Paola; Donnini, Martino; Perigli, Giuliano; Trallori, Giacomo; Tanganelli, Elisabetta; Capaccioli, Sergio; Masini, Emanuela</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7691-7700</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Cannabinoids have been recently proposed as a new family of potential antitumor agents.  The present study was undertaken to investigate the expression of the two cannabinoid receptors, CB1 and CB2, in colorectal cancer and to provide new insight into the mol. pathways underlying the apoptotic activity induced by their activation.  Exptl. Design: Cannabinoid receptor expression was investigated in both human cancer specimens and in the DLD-1 and HT29 colon cancer cell lines.  The effects of the CB1 agonist arachinodyl-2'-chloroethylamide and the CB2 agonist N-cyclopentyl-7-methyl-1-(2-morpholin-4-ylethyl)-1,8-naphthyridin-4(1H)-on-3-carboxamide (CB13) on tumor cell apoptosis and ceramide and tumor necrosis factor (TNF)-α prodn. were evaluated.  The knockdown of TNF-α mRNA was obtained with the use of selective small interfering RNA.  RESULTS: We show that the CB1 receptor was mainly expressed in human normal colonic epithelium whereas tumor tissue was strongly pos. for the CB2 receptor.  The activation of the CB1 and, more efficiently, of the CB2 receptors induced apoptosis and increased ceramide levels in the DLD-1 and HT29 cells.  Apoptosis was prevented by the pharmacol. inhibition of ceramide de novo synthesis.  The CB2 agonist CB13 also reduced the growth of DLD-1 cells in a mouse model of colon cancer.  The knockdown of TNF-α mRNA abrogated the ceramide increase and, therefore, the apoptotic effect induced by cannabinoid receptor activation.  CONCLUSIONS: The present study shows that either CB1 or CB2 receptor activation induces apoptosis through ceramide de novo synthesis in colon cancer cells.  Our data unveiled, for the first time, that TNF-α acts as a link between cannabinoid receptor activation and ceramide prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG5XJOnQBRA7Vg90H21EOLACvtfcHk0ljWbCv9Rw8Wrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVegtrbP&md5=351dcff2b2b2a80adc8c14f2c79cb8d7</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0799%26sid%3Dliteratum%253Aachs%26aulast%3DCianchi%26aufirst%3DF.%26aulast%3DPapucci%26aufirst%3DL.%26aulast%3DSchiavone%26aufirst%3DN.%26aulast%3DLulli%26aufirst%3DM.%26aulast%3DMagnelli%26aufirst%3DL.%26aulast%3DVinci%26aufirst%3DM.%2BC.%26aulast%3DMesserini%26aufirst%3DL.%26aulast%3DManera%26aufirst%3DC.%26aulast%3DRonconi%26aufirst%3DE.%26aulast%3DRomagnani%26aufirst%3DP.%26aulast%3DDonnini%26aufirst%3DM.%26aulast%3DPerigli%26aufirst%3DG.%26aulast%3DTrallori%26aufirst%3DG.%26aulast%3DTanganelli%26aufirst%3DE.%26aulast%3DCapaccioli%26aufirst%3DS.%26aulast%3DMasini%26aufirst%3DE.%26atitle%3DCannabinoid%2520Receptor%2520Activation%2520Induces%2520Apoptosis%2520through%2520Tumor%2520Necrosis%2520Factor%2520alpha%2520-%2520Mediated%2520Ceramide%2520De%2520novo%2520Synthesis%2520in%2520Colon%2520Cancer%2520Cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D7691%26epage%3D7700%26doi%3D10.1158%2F1078-0432.CCR-08-0799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, M.</span></span> <span> </span><span class="NLM_article-title">CB1 cannabinoid receptor-mediated cell migration</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">209</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10871313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksFyhtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2000&pages=204-209&author=Z.+H.+Songauthor=M.+Zhong&title=CB1+cannabinoid+receptor-mediated+cell+migration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">CB1 cannabinoid receptor-mediated cell migration</span></div><div class="casAuthors">Song, Zhao-Hui; Zhong, Miao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">204-209</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Recent studies have suggested that cell migratory responses are often mediated by Gi protein-coupled receptors.  Because it is known that CB1 cannabinoid receptors are coupled to pertussis toxin-sensitive G proteins, we proposed that CB1 may mediate cell migration.  To test this hypothesis, modified Boyden chamber assays were used to investigate cell migration mediated by CB1 cannabinoid receptors.  HU-210, WIN55212-2, and anandamide, three cannabinoid agonists with distinct chem. structures, induced migration of human embryonic kidney 293 cells stably transfected with human CB1 gene, but not 293 cells transfected with an empty expression vector.  These migratory responses were concn.-dependent.  The EC50 values for HU-210, WIN55212-2, and anandamide were 0.19 ± 0.04, 12.2 ± 1.4, and 39.9 ± 3.7 nM, resp.  The maximal migration index for HU-210, WIN55212-2, and anandamide were 8.9 ± 1.6, 9.5 ± 1.6, and 8.8 ± 1.3, resp.  Pretreating cells with 100 ng/mL pertussis toxin eliminated the cannabinoid agonist-induced cell migration.  SR141716A, a selective antagonist for CB1, inhibited the cannabinoid agonist-induced migratory responses in a concn.-dependent manner.  Checkerboard anal. demonstrated that anandamide-induced cell migrations are due to chemotaxis as well as chemokinesis.  Furthermore, anandamide-induced migratory responses were inhibited, in a concn.-dependent manner, by PD098059, an inhibitor of mitogen-activated protein kinase activation, but not by 8-bromoadenosine-3',5'-cyclic monophosphate, a cell-permeable cAMP analog.  These data demonstrate that cannabinoid agonists are able to induce chemotaxis and chemokinesis, and that these migratory responses are mediated by G protein-coupled, CB1 cannabinoid receptors.  In addn., these data suggest that activation of mitogen-activated protein kinase plays an important role, whereas inhibition of adenylate cyclase is probably not involved in the cell migration mediated by CB1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7TiCPM3q9GLVg90H21EOLACvtfcHk0lgDDyZMNkGSPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksFyhtLc%253D&md5=c476acc0e2d1ec323526a4df5f2a5dc0</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DZ.%2BH.%26aulast%3DZhong%26aufirst%3DM.%26atitle%3DCB1%2520cannabinoid%2520receptor-mediated%2520cell%2520migration%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D294%26spage%3D204%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Petrocellis, L.</span></span> <span> </span><span class="NLM_article-title">Why do cannabinoid receptors have more than one endogenous ligand?</span>. <i>Philos. Trans. R. Soc., B</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>367</i></span>,  <span class="NLM_fpage">3216</span>– <span class="NLM_lpage">3228</span>, <span class="refDoi"> DOI: 10.1098/rstb.2011.0382</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1098%2Frstb.2011.0382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=23108541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKgtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=3216-3228&author=V.+Di%0AMarzoauthor=L.+De+Petrocellis&title=Why+do+cannabinoid+receptors+have+more+than+one+endogenous+ligand%3F&doi=10.1098%2Frstb.2011.0382"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Why do cannabinoid receptors have more than one endogenous ligand?</span></div><div class="casAuthors">Di Marzo, Vincenzo; De Petrocellis, Luciano</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical Transactions of the Royal Society, B: Biological Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">1607</span>),
    <span class="NLM_cas:pages">3216-3228</span>CODEN:
                <span class="NLM_cas:coden">PTRBAE</span>;
        ISSN:<span class="NLM_cas:issn">0962-8436</span>.
    
            (<span class="NLM_cas:orgname">Royal Society</span>)
        </div><div class="casAbstract">A review.  The endocannabinoid system was revealed following the understanding of the mechanism of action of marijuana's major psychotropic principle, Δ9-tetrahydrocannabinol, and includes two G-protein-coupled receptors (GPCRs; the cannabinoid CB1 and CB2 receptors), their endogenous ligands (the endocannabinoids, the best studied of which are anandamide and 2-arachidonoylglycerol (2-AG)), and the proteins that regulate the levels and activity of these receptors and ligands.  However, other minor lipid metabolites different from, but chem. similar to, anandamide and 2-AG have also been suggested to act as endocannabinoids.  Thus, unlike most other GPCRs, cannabinoid receptors appear to have more than one endogenous agonist, and it has been often wondered what could be the physiol. meaning of this peculiarity.  In 1999, it was proposed that anandamide might also activate other targets, and in particular the transient receptor potential of vanilloid type-1 (TRPV1) channels.  Over the last decade, this interaction has been shown to occur both in peripheral tissues and brain, during both physiol. and pathol. conditions.  TRPV1 channels can be activated also by another less abundant endocannabinoid, N-arachidonoyldopamine, but not by 2-AG, and have been proposed by some authors to act as ionotropic endocannabinoid receptors.  This article will discuss the latest discoveries on this subject, and discuss, among others, how anandamide and 2-AG differential actions at TRPV1 and cannabinoid receptors contribute to making this signalling system a versatile tool available to organisms to fine-tune homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNDo9Kc33Z6LVg90H21EOLACvtfcHk0lgDDyZMNkGSPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKgtLzK&md5=28a548889dd30baaccf27d66a371d43c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1098%2Frstb.2011.0382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2011.0382%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26atitle%3DWhy%2520do%2520cannabinoid%2520receptors%2520have%2520more%2520than%2520one%2520endogenous%2520ligand%253F%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%252C%2520B%26date%3D2012%26volume%3D367%26spage%3D3216%26epage%3D3228%26doi%3D10.1098%2Frstb.2011.0382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigrahy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahakian, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettersten, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingham, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieran, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">11127</span>– <span class="NLM_lpage">11132</span>, <span class="refDoi"> DOI: 10.1073/pnas.1410432111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1073%2Fpnas.1410432111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=25024195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyqtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=11127-11132&author=G.+Zhangauthor=D.+Panigrahyauthor=S.+H.+Hwangauthor=J.+Yangauthor=L.+M.+Mahakianauthor=H.+I.+Wetterstenauthor=J.+Y.+Liuauthor=Y.+Wangauthor=E.+S.+Inghamauthor=S.+Tamauthor=M.+W.+Kieranauthor=R.+H.+Weissauthor=K.+W.+Ferraraauthor=B.+D.+Hammock&title=Dual+inhibition+of+cyclooxygenase-2+and+soluble+epoxide+hydrolase+synergistically+suppresses+primary+tumor+growth+and+metastasis&doi=10.1073%2Fpnas.1410432111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis</span></div><div class="casAuthors">Zhang, Guodong; Panigrahy, Dipak; Hwang, Sung Hee; Yang, Jun; Mahakian, Lisa M.; Wettersten, Hiromi I.; Liu, Jun-Yan; Wang, Yanru; Ingham, Elizabeth S.; Tam, Sarah; Kieran, Mark W.; Weiss, Robert H.; Ferrara, Katherine W.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">11127-11132</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Prostaglandins derived from the cyclooxygenase (COX) pathway and epoxyeicosatrienoic acids (EETs) from the cytochrome P 450/sol. epoxide hydrolase (sEH) pathway are important eicosanoids that regulate angiogenesis and tumorigenesis.  COX-2 inhibitors, which block the formation of prostaglandins, suppress tumor growth, whereas sEH inhibitors, which increase endogenous EETs, stimulate primary tumor growth and metastasis.  However, the functional interactions of these two pathways in cancer are unknown.  Using pharmacol. inhibitors as probes, we show here that dual inhibition of COX-2 and sEH synergistically inhibits primary tumor growth and metastasis by suppressing tumor angiogenesis.  COX-2/sEH dual pharmacol. inhibitors also potently suppress primary tumor growth and metastasis by inhibiting tumor angiogenesis via selective inhibition of endothelial cell proliferation.  These results demonstrate a crit. interaction of these two lipid metab. pathways on tumorigenesis and suggest dual inhibition of COX-2 and sEH as a potential therapeutic strategy for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq96zPXS3W5_LVg90H21EOLACvtfcHk0lgDDyZMNkGSPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyqtb3J&md5=928fc9973909898ae94dbf2f3e087677</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1410432111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1410432111%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DPanigrahy%26aufirst%3DD.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMahakian%26aufirst%3DL.%2BM.%26aulast%3DWettersten%26aufirst%3DH.%2BI.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DIngham%26aufirst%3DE.%2BS.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DKieran%26aufirst%3DM.%2BW.%26aulast%3DWeiss%26aufirst%3DR.%2BH.%26aulast%3DFerrara%26aufirst%3DK.%2BW.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DDual%2520inhibition%2520of%2520cyclooxygenase-2%2520and%2520soluble%2520epoxide%2520hydrolase%2520synergistically%2520suppresses%2520primary%2520tumor%2520growth%2520and%2520metastasis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D11127%26epage%3D11132%26doi%3D10.1073%2Fpnas.1410432111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dithmer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merkord, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, B.</span></span> <span> </span><span class="NLM_article-title">Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">15047</span>– <span class="NLM_lpage">15064</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.7592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.18632%2Foncotarget.7592" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=15047-15064&author=K.+Winklerauthor=R.+Ramerauthor=S.+Dithmerauthor=I.+Ivanovauthor=J.+Merkordauthor=B.+Hinz&title=Fatty+acid+amide+hydrolase+inhibitors+confer+anti-invasive+and+antimetastatic+effects+on+lung+cancer+cells&doi=10.18632%2Foncotarget.7592"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7592%26sid%3Dliteratum%253Aachs%26aulast%3DWinkler%26aufirst%3DK.%26aulast%3DRamer%26aufirst%3DR.%26aulast%3DDithmer%26aufirst%3DS.%26aulast%3DIvanov%26aufirst%3DI.%26aulast%3DMerkord%26aufirst%3DJ.%26aulast%3DHinz%26aufirst%3DB.%26atitle%3DFatty%2520acid%2520amide%2520hydrolase%2520inhibitors%2520confer%2520anti-invasive%2520and%2520antimetastatic%2520effects%2520on%2520lung%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D15047%26epage%3D15064%26doi%3D10.18632%2Foncotarget.7592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William R.  Arnold</span>, <span class="hlFld-ContribAuthor ">Lauren N.  Carnevale</span>, <span class="hlFld-ContribAuthor ">Zili  Xie</span>, <span class="hlFld-ContribAuthor ">Javier L.  Baylon</span>, <span class="hlFld-ContribAuthor ">Emad  Tajkhorshid</span>, <span class="hlFld-ContribAuthor ">Hongzhen  Hu</span>, <span class="hlFld-ContribAuthor ">Aditi  Das</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-inflammatory dopamine- and serotonin-based endocannabinoid epoxides reciprocally regulate cannabinoid receptors and the TRPV1 channel. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-021-20946-6" title="DOI URL">https://doi.org/10.1038/s41467-021-20946-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-021-20946-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-021-20946-6%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DAnti-inflammatory%252Bdopamine-%252Band%252Bserotonin-based%252Bendocannabinoid%252Bepoxides%252Breciprocally%252Bregulate%252Bcannabinoid%252Breceptors%252Band%252Bthe%252BTRPV1%252Bchannel%26aulast%3DArnold%26aufirst%3DWilliam%2BR.%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Sanfilippo</span>, <span class="hlFld-ContribAuthor ">Angela  Patti</span>. </span><span class="cited-content_cbyCitation_article-title">Biocatalytic regio- and stereoselective access to ω-3 endocannabinoid epoxides with peroxygenase from oat flour. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>113 </em>, 105014. <a href="https://doi.org/10.1016/j.bioorg.2021.105014" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DBiocatalytic%252Bregio-%252Band%252Bstereoselective%252Baccess%252Bto%252B%2525CF%252589-3%252Bendocannabinoid%252Bepoxides%252Bwith%252Bperoxygenase%252Bfrom%252Boat%252Bflour%26aulast%3DSanfilippo%26aufirst%3DClaudia%26date%3D2021%26volume%3D113%26spage%3D105014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ian  de Bus</span>, <span class="hlFld-ContribAuthor ">Sandra  van Krimpen</span>, <span class="hlFld-ContribAuthor ">Guido J.  Hooiveld</span>, <span class="hlFld-ContribAuthor ">Mark V.  Boekschoten</span>, <span class="hlFld-ContribAuthor ">Mieke  Poland</span>, <span class="hlFld-ContribAuthor ">Renger F.  Witkamp</span>, <span class="hlFld-ContribAuthor ">Bauke  Albada</span>, <span class="hlFld-ContribAuthor ">Michiel G.J.  Balvers</span>. </span><span class="cited-content_cbyCitation_article-title">Immunomodulating effects of 13- and 16-hydroxylated docosahexaenoyl ethanolamide in LPS stimulated RAW264.7 macrophages. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids</span><span> <strong>2021,</strong> <em>1866 </em>
                                    (6)
                                     , 158908. <a href="https://doi.org/10.1016/j.bbalip.2021.158908" title="DOI URL">https://doi.org/10.1016/j.bbalip.2021.158908</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbalip.2021.158908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbalip.2021.158908%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520and%2520Cell%2520Biology%2520of%2520Lipids%26atitle%3DImmunomodulating%252Beffects%252Bof%252B13-%252Band%252B16-hydroxylated%252Bdocosahexaenoyl%252Bethanolamide%252Bin%252BLPS%252Bstimulated%252BRAW264.7%252Bmacrophages%26aulast%3Dde%2BBus%26aufirst%3DIan%26date%3D2021%26volume%3D1866%26issue%3D6%26spage%3D158908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Owen M.  Vega</span>, <span class="hlFld-ContribAuthor ">Shaheen  Abkenari</span>, <span class="hlFld-ContribAuthor ">Zhen  Tong</span>, <span class="hlFld-ContribAuthor ">Austin  Tedman</span>, <span class="hlFld-ContribAuthor ">Sara  Huerta-Yepez</span>. </span><span class="cited-content_cbyCitation_article-title">Omega‐3 Polyunsaturated Fatty Acids and Lung Cancer: nutrition or Pharmacology?. </span><span class="cited-content_cbyCitation_journal-name">Nutrition and Cancer</span><span> <strong>2021,</strong> <em>73 </em>
                                    (4)
                                     , 541-561. <a href="https://doi.org/10.1080/01635581.2020.1761408" title="DOI URL">https://doi.org/10.1080/01635581.2020.1761408</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/01635581.2020.1761408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F01635581.2020.1761408%26sid%3Dliteratum%253Aachs%26jtitle%3DNutrition%2520and%2520Cancer%26atitle%3DOmega%2525E2%252580%2525903%252BPolyunsaturated%252BFatty%252BAcids%252Band%252BLung%252BCancer%25253A%252Bnutrition%252Bor%252BPharmacology%25253F%26aulast%3DVega%26aufirst%3DOwen%2BM.%26date%3D2021%26date%3D2020%26volume%3D73%26issue%3D4%26spage%3D541%26epage%3D561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua  Fang</span>, <span class="hlFld-ContribAuthor ">Jianyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Mingtao  Ao</span>, <span class="hlFld-ContribAuthor ">Fengming  He</span>, <span class="hlFld-ContribAuthor ">Weizhu  Chen</span>, <span class="hlFld-ContribAuthor ">Yuqing  Qian</span>, <span class="hlFld-ContribAuthor ">Yuxiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yang  Xu</span>, <span class="hlFld-ContribAuthor ">Meijuan  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and discovery of ω-3 polyunsaturated fatty acid- alkanolamine (PUFA-AA) derivatives as anti-inflammatory agents targeting Nur77. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>105 </em>, 104456. <a href="https://doi.org/10.1016/j.bioorg.2020.104456" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104456</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104456%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bdiscovery%252Bof%252B%2525CF%252589-3%252Bpolyunsaturated%252Bfatty%252Bacid-%252Balkanolamine%252B%252528PUFA-AA%252529%252Bderivatives%252Bas%252Banti-inflammatory%252Bagents%252Btargeting%252BNur77%26aulast%3DFang%26aufirst%3DHua%26date%3D2020%26volume%3D105%26spage%3D104456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aditi  Das</span>, <span class="hlFld-ContribAuthor ">Austin T.  Weigle</span>, <span class="hlFld-ContribAuthor ">William R.  Arnold</span>, <span class="hlFld-ContribAuthor ">Justin S.  Kim</span>, <span class="hlFld-ContribAuthor ">Lauren N.  Carnevale</span>, <span class="hlFld-ContribAuthor ">Hannah C.  Huff</span>. </span><span class="cited-content_cbyCitation_article-title">CYP2J2 Molecular Recognition: A New Axis for Therapeutic Design. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2020,</strong> <em>215 </em>, 107601. <a href="https://doi.org/10.1016/j.pharmthera.2020.107601" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2020.107601</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2020.107601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2020.107601%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DCYP2J2%252BMolecular%252BRecognition%25253A%252BA%252BNew%252BAxis%252Bfor%252BTherapeutic%252BDesign%26aulast%3DDas%26aufirst%3DAditi%26date%3D2020%26volume%3D215%26spage%3D107601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Casati</span>, <span class="hlFld-ContribAuthor ">Chiara  Giannasi</span>, <span class="hlFld-ContribAuthor ">Mauro  Minoli</span>, <span class="hlFld-ContribAuthor ">Stefania  Niada</span>, <span class="hlFld-ContribAuthor ">Alessandro  Ravelli</span>, <span class="hlFld-ContribAuthor ">Ilaria  Angeli</span>, <span class="hlFld-ContribAuthor ">Veronica  Mergenthaler</span>, <span class="hlFld-ContribAuthor ">Roberta  Ottria</span>, <span class="hlFld-ContribAuthor ">Pierangela  Ciuffreda</span>, <span class="hlFld-ContribAuthor ">Marica  Orioli</span>, <span class="hlFld-ContribAuthor ">Anna T.  Brini</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative Lipidomic Analysis of Osteosarcoma Cell-Derived Products by UHPLC-MS/MS. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (9)
                                     , 1302. <a href="https://doi.org/10.3390/biom10091302" title="DOI URL">https://doi.org/10.3390/biom10091302</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10091302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10091302%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DQuantitative%252BLipidomic%252BAnalysis%252Bof%252BOsteosarcoma%252BCell-Derived%252BProducts%252Bby%252BUHPLC-MS%25252FMS%26aulast%3DCasati%26aufirst%3DSara%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D9%26spage%3D1302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ian  de Bus</span>, <span class="hlFld-ContribAuthor ">Han  Zuilhof</span>, <span class="hlFld-ContribAuthor ">Renger  Witkamp</span>, <span class="hlFld-ContribAuthor ">Michiel  Balvers</span>, <span class="hlFld-ContribAuthor ">Bauke  Albada</span>. </span><span class="cited-content_cbyCitation_article-title">Novel COX-2 products of n-3 polyunsaturated fatty acid-ethanolamine-conjugates identified in RAW264.7 macrophages. </span><span class="cited-content_cbyCitation_journal-name">Journal of Lipid Research</span><span> <strong>2019,</strong> <em>60 </em>
                                    (11)
                                     , 1829-1840. <a href="https://doi.org/10.1194/jlr.M094235" title="DOI URL">https://doi.org/10.1194/jlr.M094235</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1194/jlr.M094235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1194%2Fjlr.M094235%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Lipid%2520Research%26atitle%3DNovel%252BCOX-2%252Bproducts%252Bof%252Bn-3%252Bpolyunsaturated%252Bfatty%252Bacid-ethanolamine-conjugates%252Bidentified%252Bin%252BRAW264.7%252Bmacrophages%26aulast%3Dde%2BBus%26aufirst%3DIan%26date%3D2019%26volume%3D60%26issue%3D11%26spage%3D1829%26epage%3D1840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ian  de Bus</span>, <span class="hlFld-ContribAuthor ">Renger  Witkamp</span>, <span class="hlFld-ContribAuthor ">Han  Zuilhof</span>, <span class="hlFld-ContribAuthor ">Bauke  Albada</span>, <span class="hlFld-ContribAuthor ">Michiel  Balvers</span>. </span><span class="cited-content_cbyCitation_article-title">The role of n-3 PUFA-derived fatty acid derivatives and their oxygenated metabolites in the modulation of inflammation. </span><span class="cited-content_cbyCitation_journal-name">Prostaglandins & Other Lipid Mediators</span><span> <strong>2019,</strong> <em>144 </em>, 106351. <a href="https://doi.org/10.1016/j.prostaglandins.2019.106351" title="DOI URL">https://doi.org/10.1016/j.prostaglandins.2019.106351</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.prostaglandins.2019.106351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.prostaglandins.2019.106351%26sid%3Dliteratum%253Aachs%26jtitle%3DProstaglandins%2520%2526%2520Other%2520Lipid%2520Mediators%26atitle%3DThe%252Brole%252Bof%252Bn-3%252BPUFA-derived%252Bfatty%252Bacid%252Bderivatives%252Band%252Btheir%252Boxygenated%252Bmetabolites%252Bin%252Bthe%252Bmodulation%252Bof%252Binflammation%26aulast%3Dde%2BBus%26aufirst%3DIan%26date%3D2019%26volume%3D144%26spage%3D106351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rossi</span>, <span class="hlFld-ContribAuthor ">Tortora</span>, <span class="hlFld-ContribAuthor ">Punzo</span>, <span class="hlFld-ContribAuthor ">Bellini</span>, <span class="hlFld-ContribAuthor ">Argenziano</span>, <span class="hlFld-ContribAuthor ">Di Paola</span>, <span class="hlFld-ContribAuthor ">Torella</span>, <span class="hlFld-ContribAuthor ">Perrotta</span>. </span><span class="cited-content_cbyCitation_article-title">The Endocannabinoid/Endovanilloid System in Bone: From Osteoporosis to Osteosarcoma. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (8)
                                     , 1919. <a href="https://doi.org/10.3390/ijms20081919" title="DOI URL">https://doi.org/10.3390/ijms20081919</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20081919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20081919%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DThe%252BEndocannabinoid%25252FEndovanilloid%252BSystem%252Bin%252BBone%25253A%252BFrom%252BOsteoporosis%252Bto%252BOsteosarcoma%26aulast%3DRossi%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D8%26spage%3D1919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lauren N.  Carnevale</span>, <span class="hlFld-ContribAuthor ">Aditi  Das</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Anti-inflammatory and Vasodilatory ω-3 Endocannabinoid Epoxide Regioisomers. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 219-232. <a href="https://doi.org/10.1007/978-3-030-21735-8_17" title="DOI URL">https://doi.org/10.1007/978-3-030-21735-8_17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-21735-8_17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-21735-8_17%26sid%3Dliteratum%253Aachs%26atitle%3DNovel%252BAnti-inflammatory%252Band%252BVasodilatory%252B%2525CF%252589-3%252BEndocannabinoid%252BEpoxide%252BRegioisomers%26aulast%3DCarnevale%26aufirst%3DLauren%2BN.%26date%3D2019%26date%3D2019%26spage%3D219%26epage%3D232%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DThe%252BRole%252Bof%252BBioactive%252BLipids%252Bin%252BCancer%25252C%252BInflammation%252Band%252BRelated%252BDiseases%26aulast%3DHonn%26aufirst%3DKenneth%2BV.%26date%3D2019%26volume%3D1161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leodevico  Ilag</span>. </span><span class="cited-content_cbyCitation_article-title">Are Long-Chain Polyunsaturated Fatty Acids the Link between the Immune System and the Microbiome towards Modulating Cancer?. </span><span class="cited-content_cbyCitation_journal-name">Medicines</span><span> <strong>2018,</strong> <em>5 </em>
                                    (3)
                                     , 102. <a href="https://doi.org/10.3390/medicines5030102" title="DOI URL">https://doi.org/10.3390/medicines5030102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/medicines5030102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmedicines5030102%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicines%26atitle%3DAre%252BLong-Chain%252BPolyunsaturated%252BFatty%252BAcids%252Bthe%252BLink%252Bbetween%252Bthe%252BImmune%252BSystem%252Band%252Bthe%252BMicrobiome%252Btowards%252BModulating%252BCancer%25253F%26aulast%3DIlag%26aufirst%3DLeodevico%26date%3D2018%26date%3D2018%26volume%3D5%26issue%3D3%26spage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arduino  Mangoni</span>, <span class="hlFld-ContribAuthor ">Tiziano  Tuccinardi</span>, <span class="hlFld-ContribAuthor ">Simona  Collina</span>, <span class="hlFld-ContribAuthor ">Jean  Vanden Eynde</span>, <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>, <span class="hlFld-ContribAuthor ">Rafik  Karaman</span>, <span class="hlFld-ContribAuthor ">Carlo  Siciliano</span>, <span class="hlFld-ContribAuthor ">Maria  De Sousa</span>, <span class="hlFld-ContribAuthor ">Katalin  Prokai-Tatrai</span>, <span class="hlFld-ContribAuthor ">Jarkko  Rautio</span>, <span class="hlFld-ContribAuthor ">Catherine  Guillou</span>, <span class="hlFld-ContribAuthor ">Michael  Gütschow</span>, <span class="hlFld-ContribAuthor ">Stefania  Galdiero</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Luigi  Agrofoglio</span>, <span class="hlFld-ContribAuthor ">Jean-Marc  Sabatier</span>, <span class="hlFld-ContribAuthor ">Christopher  Hulme</span>, <span class="hlFld-ContribAuthor ">George  Kokotos</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>, <span class="hlFld-ContribAuthor ">Paula  Gomes</span>. </span><span class="cited-content_cbyCitation_article-title">Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-3. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (7)
                                     , 1596. <a href="https://doi.org/10.3390/molecules23071596" title="DOI URL">https://doi.org/10.3390/molecules23071596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23071596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23071596%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DBreakthroughs%252Bin%252BMedicinal%252BChemistry%25253A%252BNew%252BTargets%252Band%252BMechanisms%25252C%252BNew%252BDrugs%25252C%252BNew%252BHopes-3%26aulast%3DMangoni%26aufirst%3DArduino%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D7%26spage%3D1596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/medium/jm-2018-002437_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/large/jm-2018-002437_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00243&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/medium/jm-2018-002437_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/large/jm-2018-002437_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Endogenous synthesis of DHEA-epoxide regioisomers (EDP-EAs), 19,20- (<b>5</b>), 16,17- (<b>4</b>), 13,14- (<b>3</b>), 10,11- (<b>2</b>), and 7,8-EDP-EA (<b>1</b>). (B) Levels of endocannabinoid epoxides of DHEA and DHEA in normal lungs and lungs of mice with tumor metastasis. The lungs in the images were infused with India ink, and white lesions represent metastatic-tumor burden. (C) Percentage cell viability as measured by cell-titer blue assay with various regioisomers at 5, 12.5, and 25 μM. (D) Apoptosis induced in HOS, 143B, and MG63 cells by 12.5 μM concentrations of 13,14-EDP-EA (crisscross), 10,11-EDP-EA (checkered), and 7,8-EDP-EA (dots). (E) Wound-healing scratch shown at 0 and 10 h in the 143B cell line with 13,14-EDP-EA, 10,11-EDP-EA, and 7,8-EDP-EA at 5 μM concentrations. (F) Wound healing represented as a ratio of wound remaining in the treatment group to the wound remaining in the control group after 10 h in three cell lines, (i) HOS, (ii) 143B, and (iii) MG63, with 5 μM concentrations of 13,14-EDP-EA (crisscross), 10,11-EDP-EA (checkered), and 7,8-EDP-EA (dots).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/large/jm-2018-002437_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00243&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/medium/jm-2018-002437_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/large/jm-2018-002437_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Synthetic scheme for the EDP-EA analogues (<b>6</b>–<b>8</b>). (B) Fatty acid amide hydrolase (FAAH)-dependent hydrolysis of amide derivatives. (C) Apoptotic potentials of 10,11-EDP-EA (checkered), 10,11-EDP-NA (<b>7</b>, dots), 10,11-EDP-IA (<b>8</b>, horizontal stripes), and 10,11-EDP-CA (<b>6</b>, vertical stripes) compared to the control measured by an annexin V apoptosis assay. (D) Antimigratory properties of 10,11-EDP-EA, 10,11-EDP-NA, 10,11-EDP-IA, and 10,11-EDP-CA compared to the control measured by a wound-healing scratch assay on HOS, 143B, and MG63 cell lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/large/jm-2018-002437_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00243&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/medium/jm-2018-002437_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/large/jm-2018-002437_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Restriction of tube formation in endothelial HUVEC cells on matrigel by 10,11-EDP-EA, 10,11-EDP-NA, 10,11-EDP-IA, and 10,11-EDP-CA at 0.5 and 1 μM. (B) Quantification of angiogenesis reduction by all amide derivatives as represented by number of branches per unit area. (C) PRESTO–Tango-assay measurement of the activation of CB1 and CB2 by the amide derivatives. (D) EC<sub>50</sub> values of all amide derivatives with CB1 and CB2 as determined by the PRESTO–Tango assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.8b00243/20180706/images/large/jm-2018-002437_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00243&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18307" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18307" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 49 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mantovani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allavena, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balkwill, F.</span></span> <span> </span><span class="NLM_article-title">Cancer-related inflammation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>454</i></span>,  <span class="NLM_fpage">436</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1038/nature07205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1038%2Fnature07205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=18650914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovV2mtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=454&publication_year=2008&pages=436-444&author=A.+Mantovaniauthor=P.+Allavenaauthor=A.+Sicaauthor=F.+Balkwill&title=Cancer-related+inflammation&doi=10.1038%2Fnature07205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-related inflammation</span></div><div class="casAuthors">Mantovani, Alberto; Allavena, Paola; Sica, Antonio; Balkwill, Frances</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">454</span>
        (<span class="NLM_cas:issue">7203</span>),
    <span class="NLM_cas:pages">436-444</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mediators and cellular effectors of inflammation are important constituents of the local environment of tumors.  In some types of cancer, inflammatory conditions are present before a malignant change occurs.  Conversely, in other types of cancer, an oncogenic change induces an inflammatory microenvironment that promotes the development of tumors.  Regardless of its origin, 'smoldering' inflammation in the tumor microenvironment has many tumor-promoting effects.  It aids in the proliferation and survival of malignant cells, promotes angiogenesis and metastasis, subverts adaptive immune responses, and alters responses to hormones and chemotherapeutic agents.  The mol. pathways of this cancer-related inflammation are now being unravelled, resulting in the identification of new target mols. that could lead to improved diagnosis and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMShCOkqk0ArVg90H21EOLACvtfcHk0lgNroq9ImTM7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovV2mtbg%253D&md5=488ad8afac066b6330d0468ebb65d941</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnature07205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07205%26sid%3Dliteratum%253Aachs%26aulast%3DMantovani%26aufirst%3DA.%26aulast%3DAllavena%26aufirst%3DP.%26aulast%3DSica%26aufirst%3DA.%26aulast%3DBalkwill%26aufirst%3DF.%26atitle%3DCancer-related%2520inflammation%26jtitle%3DNature%26date%3D2008%26volume%3D454%26spage%3D436%26epage%3D444%26doi%3D10.1038%2Fnature07205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allavena, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantovani, A.</span></span> <span> </span><span class="NLM_article-title">Cancer related inflammation: the macrophage connection</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2008.03.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2Fj.canlet.2008.03.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=18448242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovF2hsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2008&pages=204-215&author=A.+Sicaauthor=P.+Allavenaauthor=A.+Mantovani&title=Cancer+related+inflammation%3A+the+macrophage+connection&doi=10.1016%2Fj.canlet.2008.03.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer related inflammation: The macrophage connection</span></div><div class="casAuthors">Sica, Antonio; Allavena, Paola; Mantovani, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">204-215</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. macrophages (TAM) are key regulators of the link between inflammation and cancer.  In the tumor microenvironment neoplastic cells shape the differentiation and functional orientation of TAM which, in turn, express several pro-tumoral functions, including secretion of growth factors and matrix-proteases, promotion of angiogenesis, and suppression of adaptive immunity.  This review analyzes the current knowledge of TAM and their involvement in tumor development and progression.  The interplay between TAM and neoplastic cells represents a promising target of future therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgrC1ceAH1C7Vg90H21EOLACvtfcHk0lgNroq9ImTM7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovF2hsLk%253D&md5=c780e82b622ace9f918e109ce12c1c6d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2008.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2008.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DSica%26aufirst%3DA.%26aulast%3DAllavena%26aufirst%3DP.%26aulast%3DMantovani%26aufirst%3DA.%26atitle%3DCancer%2520related%2520inflammation%253A%2520the%2520macrophage%2520connection%26jtitle%3DCancer%2520Lett.%26date%3D2008%26volume%3D267%26spage%3D204%26epage%3D215%26doi%3D10.1016%2Fj.canlet.2008.03.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardoll, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jove, R.</span></span> <span> </span><span class="NLM_article-title">STATs in cancer inflammation and immunity: a leading role for STAT3</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">798</span>– <span class="NLM_lpage">809</span>, <span class="refDoi"> DOI: 10.1038/nrc2734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1038%2Fnrc2734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=19851315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSjur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=798-809&author=H.+Yuauthor=D.+Pardollauthor=R.+Jove&title=STATs+in+cancer+inflammation+and+immunity%3A+a+leading+role+for+STAT3&doi=10.1038%2Fnrc2734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">STATs in cancer inflammation and immunity: a leading role for STAT3</span></div><div class="casAuthors">Yu, Hua; Pardoll, Drew; Jove, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">798-809</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Commensurate with their roles in regulating cytokine-dependent inflammation and immunity, signal transducer and activator of transcription (STAT) proteins are central in detg. whether immune responses in the tumor microenvironment promote or inhibit cancer.  Persistently activated STAT3 and, to some extent, STAT5 increase tumor cell proliferation, survival and invasion while suppressing anti-tumor immunity.  The persistent activation of STAT3 also mediates tumor-promoting inflammation.  STAT3 has this dual role in tumor inflammation and immunity by promoting pro-oncogenic inflammatory pathways, including nuclear factor-κB (NF-κB) and interleukin-6 (IL-6)-GP130-Janus kinase (JAK) pathways, and by opposing STAT1- and NF-κB-mediated T helper 1 anti-tumor immune responses.  Consequently, STAT3 is a promising target to redirect inflammation for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYvEMN5YrxbbVg90H21EOLACvtfcHk0ljJ6qdA9vMRMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSjur%252FP&md5=e431d0bd9eabd8f1ef703211be3d5cc9</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc2734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2734%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DPardoll%26aufirst%3DD.%26aulast%3DJove%26aufirst%3DR.%26atitle%3DSTATs%2520in%2520cancer%2520inflammation%2520and%2520immunity%253A%2520a%2520leading%2520role%2520for%2520STAT3%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D798%26epage%3D809%26doi%3D10.1038%2Fnrc2734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaudszus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watzl, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ness, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lochner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahreis, G.</span></span> <span> </span><span class="NLM_article-title">Evaluation of suppressive and pro-resolving effects of EPA and DHA in human primary monocytes and T-helper cells</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">935</span>, <span class="refDoi"> DOI: 10.1194/jlr.P031260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1194%2Fjlr.P031260" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=923-935&author=A.+Jaudszusauthor=M.+Gruenauthor=B.+Watzlauthor=C.+Nessauthor=A.+Rothauthor=A.+Lochnerauthor=D.+Barzauthor=H.+Gabrielauthor=M.+Rotheauthor=G.+Jahreis&title=Evaluation+of+suppressive+and+pro-resolving+effects+of+EPA+and+DHA+in+human+primary+monocytes+and+T-helper+cells&doi=10.1194%2Fjlr.P031260"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1194%2Fjlr.P031260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.P031260%26sid%3Dliteratum%253Aachs%26aulast%3DJaudszus%26aufirst%3DA.%26aulast%3DGruen%26aufirst%3DM.%26aulast%3DWatzl%26aufirst%3DB.%26aulast%3DNess%26aufirst%3DC.%26aulast%3DRoth%26aufirst%3DA.%26aulast%3DLochner%26aufirst%3DA.%26aulast%3DBarz%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DH.%26aulast%3DRothe%26aufirst%3DM.%26aulast%3DJahreis%26aufirst%3DG.%26atitle%3DEvaluation%2520of%2520suppressive%2520and%2520pro-resolving%2520effects%2520of%2520EPA%2520and%2520DHA%2520in%2520human%2520primary%2520monocytes%2520and%2520T-helper%2520cells%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2013%26volume%3D54%26spage%3D923%26epage%3D935%26doi%3D10.1194%2Fjlr.P031260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laviano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rianda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molfino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanelli, F. R.</span></span> <span> </span><span class="NLM_article-title">Omega-3 fatty acids in cancer</span>. <i>Curr. Opin. Clin. Nutr. Metab. Care</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">156</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1097/MCO.0b013e32835d2d99</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1097%2FMCO.0b013e32835d2d99" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=23299701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1egtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2013&pages=156-161&author=A.+Lavianoauthor=S.+Riandaauthor=A.+Molfinoauthor=F.+R.+Fanelli&title=Omega-3+fatty+acids+in+cancer&doi=10.1097%2FMCO.0b013e32835d2d99"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Omega-3 fatty acids in cancer</span></div><div class="casAuthors">Laviano, Alessandro; Rianda, Serena; Molfino, Alessio; Fanelli, Filippo Rossi</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Clinical Nutrition and Metabolic Care</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">156-161</span>CODEN:
                <span class="NLM_cas:coden">COCMF3</span>;
        ISSN:<span class="NLM_cas:issn">1363-1950</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: Significant achievements have been obtained in cancer treatment, but the clin. relevance of drug approach in daily practice remains questionable due to the high costs, limited efficacy, and negligible influence on quality of life.  A new concept is emerging which is based on the early combination of chemotherapy and nutrition therapy.  Recent findings: Inflammation dictates tumor initiation, progression and growth.  Omega-3 fatty acids exert anti-inflammatory effects, and therefore recent studies investigated their role in cancer prevention, in cancer cachexia treatment and in enhancement of antitumor therapies.  Limited evidence suggests a role for omega-3 fatty acid supplementation in cancer prevention, but they have been shown to preserve muscle mass and function in cancer patients even during active treatment.  During chemotherapy, omega-3 fatty acids may contribute to a reduced inflammatory response, but whether cancer treatment toxicity can be prevented remains to be assessed.  Finally, small studies showed that omega-3 fatty acids increase response rate to chemotherapy.  Summary: Combination of chemotherapy and omega-3 supplementation appears an effective strategy to enhance the clin. outcome of cancer patients in their curative and palliative clin. trajectory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJhg1I1lPH9bVg90H21EOLACvtfcHk0ljJ6qdA9vMRMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1egtb0%253D&md5=f9395b88d331289390ebefe80b1c7e16</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1097%2FMCO.0b013e32835d2d99&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMCO.0b013e32835d2d99%26sid%3Dliteratum%253Aachs%26aulast%3DLaviano%26aufirst%3DA.%26aulast%3DRianda%26aufirst%3DS.%26aulast%3DMolfino%26aufirst%3DA.%26aulast%3DFanelli%26aufirst%3DF.%2BR.%26atitle%3DOmega-3%2520fatty%2520acids%2520in%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Clin.%2520Nutr.%2520Metab.%2520Care%26date%3D2013%26volume%3D16%26spage%3D156%26epage%3D161%26doi%3D10.1097%2FMCO.0b013e32835d2d99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rose, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, J. M.</span></span> <span> </span><span class="NLM_article-title">Omega-3 fatty acids as cancer chemopreventive agents</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1016/S0163-7258(99)00026-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2FS0163-7258%2899%2900026-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10576293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADyaK1MXmtVyitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1999&pages=217-244&author=D.+P.+Roseauthor=J.+M.+Connolly&title=Omega-3+fatty+acids+as+cancer+chemopreventive+agents&doi=10.1016%2FS0163-7258%2899%2900026-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Omega-3 fatty acids as cancer chemopreventive agents</span></div><div class="casAuthors">Rose, David P.; Connolly, Jeanne M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">217-244</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 291 refs.  There is both epidemiol. and exptl. evidence that the long-chain ω-3 fatty acids (FAs), which occur at high levels in some fish oils, exert protective effects against some common cancers, notably breast, colon, and prostate cancer.  Multiple mechanisms are involved in this chemopreventive activity, including suppression of neoplastic transformation, cell growth inhibition, enhanced apoptosis, and antiangiogenicity.  A common feature of most of these biol. effects is the inhibition of eicosanoid prodn. from ω-6 FA precursors.  Several risk factors for breast and colon cancer may be favorably modified by dietary ω-3 FA supplementation.  Implementation of clin. chemoprevention trials is now feasible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvzw5ib3DJGbVg90H21EOLACvtfcHk0ljJ6qdA9vMRMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtVyitLY%253D&md5=d6ebfa872f856260fd1e0491c56799c4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2899%2900026-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252899%252900026-1%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DD.%2BP.%26aulast%3DConnolly%26aufirst%3DJ.%2BM.%26atitle%3DOmega-3%2520fatty%2520acids%2520as%2520cancer%2520chemopreventive%2520agents%26jtitle%3DPharmacol.%2520Ther.%26date%3D1999%26volume%3D83%26spage%3D217%26epage%3D244%26doi%3D10.1016%2FS0163-7258%2899%2900026-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Eliseo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velotti, F.</span></span> <span> </span><span class="NLM_article-title">Omega-3 Fatty Acids and Cancer Cell Cytotoxicity: Implications for Multi-Targeted Cancer Therapy</span>. <i>J. Clin. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">15</span>, <span class="refDoi"> DOI: 10.3390/jcm5020015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.3390%2Fjcm5020015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmt1GgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=15&author=D.+D%E2%80%99Eliseoauthor=F.+Velotti&title=Omega-3+Fatty+Acids+and+Cancer+Cell+Cytotoxicity%3A+Implications+for+Multi-Targeted+Cancer+Therapy&doi=10.3390%2Fjcm5020015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Omega-3 fatty acids and cancer cell cytotoxicity: implications for multi-targeted cancer therapy</span></div><div class="casAuthors">D'Eliseo, Donatella; Velotti, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">15/1-15/29</span>CODEN:
                <span class="NLM_cas:coden">JCMOHK</span>;
        ISSN:<span class="NLM_cas:issn">2077-0383</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Cancer is a major disease worldwide.  Despite progress in cancer therapy, conventional cytotoxic therapies lead to unsatisfactory long-term survival, mainly related to development of drug resistance by tumor cells and toxicity towards normal cells. n-3 polyunsatd. fatty acids (PUFAs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), can exert anti-neoplastic activity by inducing apoptotic cell death in human cancer cells either alone or in combination with conventional therapies.  Indeed, n-3 PUFAs potentially increase the sensitivity of tumor cells to conventional therapies, possibly improving their efficacy esp. against cancers resistant to treatment.  Moreover, in contrast to traditional therapies, n-3 PUFAs appear to cause selective cytotoxicity towards cancer cells with little or no toxicity on normal cells.  This review focuses on studies investigating the cytotoxic activity of n-3 PUFAs against cancer cells via apoptosis, analyzing the mol. mechanisms underlying this effective and selective activity.  Here, we highlight the multiple mols. potentially targeted by n-3 PUFAs to trigger cancer cell apoptosis.  This anal. can allow a better comprehension of the potential cytotoxic therapeutic role of n-3 PUFAs against cancer, providing specific information and support to design future pre-clin. and clin. studies for a better use of n-3 PUFAs in cancer therapy, mainly combinational therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHpM3IA5Wv_rVg90H21EOLACvtfcHk0li_1E7-jn1yeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmt1GgsLc%253D&md5=6f0c1a747d3112158c37313958f30ff7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3390%2Fjcm5020015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcm5020015%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Eliseo%26aufirst%3DD.%26aulast%3DVelotti%26aufirst%3DF.%26atitle%3DOmega-3%2520Fatty%2520Acids%2520and%2520Cancer%2520Cell%2520Cytotoxicity%253A%2520Implications%2520for%2520Multi-Targeted%2520Cancer%2520Therapy%26jtitle%3DJ.%2520Clin.%2520Med.%26date%3D2016%26volume%3D5%26spage%3D15%26doi%3D10.3390%2Fjcm5020015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, M.</span></span> <span> </span><span class="NLM_article-title">The omega-3 epoxide of eicosapentaenoic acid inhibits endothelial cell proliferation by p38 MAP kinase activation and cyclin D1/CDK4 down-regulation</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">1143</span>– <span class="NLM_lpage">1155</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.01113.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1111%2Fj.1476-5381.2010.01113.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=21077851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhslWgs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2011&pages=1143-1155&author=P.+H.+Cuiauthor=N.+Petrovicauthor=M.+Murray&title=The+omega-3+epoxide+of+eicosapentaenoic+acid+inhibits+endothelial+cell+proliferation+by+p38+MAP+kinase+activation+and+cyclin+D1%2FCDK4+down-regulation&doi=10.1111%2Fj.1476-5381.2010.01113.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The ω-3 epoxide of eicosapentaenoic acid inhibits endothelial cell proliferation by p38 MAP kinase activation and cyclin D1/CDK4 down-regulation</span></div><div class="casAuthors">Cui, Pei H.; Petrovic, Nenad; Murray, Michael</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1143-1155</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Dietary intake of ω-3 polyunsatd. fatty acids (ω-3 PUFAs) like eicosapentaenoic acid (EPA) decreases cancer risk, while arachidonic acid and other ω-6 PUFAs increase risk, but the underlying mechanisms are unclear.  Cytochrome P 450 (CYP)-derived epoxides contribute to enhanced tumorigenesis due to ω-6 PUFA intake.  Thus, ω-6 arachidonic acid epoxides (EETs) inhibit apoptosis and stimulate proliferation by up-regulating cyclin D1 expression in cells.  The present study evaluated the corresponding ω-3 PUFA epoxides and assessed their role in the regulation of cell proliferation.  Four chem. stable EPA epoxides (formed at the 8,9-, 11,12-, 14,15- and 17,18-olefinic bonds) were synthesized and tested against growth-related signaling pathways in brain microvascular endothelial bEND.3 cells.  Cell cycle distribution was detd. by flow cytometry and cyclin gene expression by immunoblotting and real-time PCR.  The role of the p38 mitogen-activated protein (MAP) kinase in cyclin D1 dysregulation was assessed using specific inhibitors and dominant-neg. expression plasmids.  The ω-3 17,18-epoxide of EPA decreased cell proliferation, interrupted the cell cycle in S-phase and down-regulated the cyclin D1/cyclin-dependent kinase (CDK)-4 complex, whereas the 8,9-, 11,12-, and 14,15-epoxides were either inactive or enhanced proliferation.  Cyclin D1 down-regulation by 17,18-epoxy-EPA was mediated by activation of the growth-suppressing p38 MAP kinase, but the alternate EPA-epoxides were inactive.  The present findings suggest that the epoxide formed by CYP enzymes at the ω-3 olefinic bond may contribute to the beneficial effects of ω-3 PUFA by down-regulating cyclin D1 and suppressing cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpp3uX9jlKaLVg90H21EOLACvtfcHk0li_1E7-jn1yeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhslWgs7o%253D&md5=67e943c96c12a2371ceab81be6b64aa5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.01113.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.01113.x%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DP.%2BH.%26aulast%3DPetrovic%26aufirst%3DN.%26aulast%3DMurray%26aufirst%3DM.%26atitle%3DThe%2520omega-3%2520epoxide%2520of%2520eicosapentaenoic%2520acid%2520inhibits%2520endothelial%2520cell%2520proliferation%2520by%2520p38%2520MAP%2520kinase%2520activation%2520and%2520cyclin%2520D1%252FCDK4%2520down-regulation%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D162%26spage%3D1143%26epage%3D1155%26doi%3D10.1111%2Fj.1476-5381.2010.01113.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigrahy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahakian, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephen
Lee, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettersten, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingham, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieran, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">6530</span>– <span class="NLM_lpage">6535</span>, <span class="refDoi"> DOI: 10.1073/pnas.1304321110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1073%2Fpnas.1304321110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=6530-6535&author=G.+Zhangauthor=D.+Panigrahyauthor=L.+M.+Mahakianauthor=J.+Yangauthor=J.+Y.+Liuauthor=K.+S.+Stephen%0ALeeauthor=H.+I.+Wetterstenauthor=A.+Uluauthor=X.+Huauthor=S.+Tamauthor=S.+H.+Hwangauthor=E.+S.+Inghamauthor=M.+W.+Kieranauthor=R.+H.+Weissauthor=K.+W.+Ferraraauthor=B.+D.+Hammock&title=Epoxy+metabolites+of+docosahexaenoic+acid+%28DHA%29+inhibit+angiogenesis%2C+tumor+growth%2C+and+metastasis&doi=10.1073%2Fpnas.1304321110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1304321110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1304321110%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DPanigrahy%26aufirst%3DD.%26aulast%3DMahakian%26aufirst%3DL.%2BM.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DStephen%2BLee%26aufirst%3DK.%2BS.%26aulast%3DWettersten%26aufirst%3DH.%2BI.%26aulast%3DUlu%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DIngham%26aufirst%3DE.%2BS.%26aulast%3DKieran%26aufirst%3DM.%2BW.%26aulast%3DWeiss%26aufirst%3DR.%2BH.%26aulast%3DFerrara%26aufirst%3DK.%2BW.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DEpoxy%2520metabolites%2520of%2520docosahexaenoic%2520acid%2520%2528DHA%2529%2520inhibit%2520angiogenesis%252C%2520tumor%2520growth%252C%2520and%2520metastasis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D6530%26epage%3D6535%26doi%3D10.1073%2Fpnas.1304321110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascio, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotondo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heys, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahle, K. W.</span></span> <span> </span><span class="NLM_article-title">Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators</span>. <i>Prog. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1016/j.plipres.2012.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2Fj.plipres.2012.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=23103355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFensg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=80-109&author=I.+Brownauthor=M.+G.+Cascioauthor=D.+Rotondoauthor=R.+G.+Pertweeauthor=S.+D.+Heysauthor=K.+W.+Wahle&title=Cannabinoids+and+omega-3%2F6+endocannabinoids+as+cell+death+and+anticancer+modulators&doi=10.1016%2Fj.plipres.2012.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators</span></div><div class="casAuthors">Brown, Iain; Cascio, Maria G.; Rotondo, Dino; Pertwee, Roger G.; Heys, Steven D.; Wahle, Klaus W. J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-109</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Cannabinoids-endocannaboids are possible preventatives of common diseases including cancers.  Cannabinoid receptors (CB1/2, TRPV1) are central components of the system.  Many disease-ameliorating effects of cannabinoids-endocannabinoids are receptor mediated, but many are not, indicating non-CBR signaling pathways.  Cannabinoids-endocannabinoids are anti-inflammatory, anti-proliferative, anti-invasive, anti-metastatic and pro-apoptotic in most cancers, in vitro and in vivo in animals.  They signal through p38, MAPK, JUN, PI3, AKT, ceramide, caspases, MMPs, PPARs, VEGF, NF-κB, p8, CHOP, TRB3 and pro-apoptotic oncogenes (p53,p21 waf1/cip1) to induce cell cycle arrest, autophagy, apoptosis and tumor inhibition.  Paradoxically they are pro-proliferative and anti-apoptotic in some cancers.  Differences in receptor expression and concns. of cannabinoids in cancer and immune cells can elicit anti- or pro-cancer effects through different signal cascades (p38MAPK or PI3/AKT).  Similarities between effects of cannabinoids-endocannabinoids, omega-3 LCPUFA and CLAs/CLnAs as anti-inflammatory, antiangiogenic, anti-invasive anti-cancer agents indicate common signaling pathways.  Evidence in vivo and in vitro shows EPA and DHA can form endocannabinoids that: (i) are ligands for CB1/2 receptors and possibly TRPV-1, (ii) have non-receptor mediated bioactivity, (iii) induce cell cycle arrest, (iii) increase autophagy and apoptosis, and (iv) augment chemotherapeutic actions in vitro.  They can also form bioactive, eicosanoid-like products that appear to be non-CBR ligands but have effects on PPARs and NF-kB transcription factors.  The use of cannabinoids in cancer treatment is currently limited to chemo- and radio-therapy-assocd. nausea and cancer-assocd. pain apart from one trial on brain tumors in patients.  Further clin. studies are urgently required to det. the true potential of these intriguing, low toxicity compds. in cancer therapy.  Particularly in view of their synergistic effects with chemotherapeutic agents similar to that obsd. for n-3 LCPUFA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0MNRYHO3XzLVg90H21EOLACvtfcHk0lihNQoZfducSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFensg%253D%253D&md5=faf1b468db28bb0d84c1df1be7e7cbbe</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2012.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2012.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DI.%26aulast%3DCascio%26aufirst%3DM.%2BG.%26aulast%3DRotondo%26aufirst%3DD.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DHeys%26aufirst%3DS.%2BD.%26aulast%3DWahle%26aufirst%3DK.%2BW.%26atitle%3DCannabinoids%2520and%2520omega-3%252F6%2520endocannabinoids%2520as%2520cell%2520death%2520and%2520anticancer%2520modulators%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2013%26volume%3D52%26spage%3D80%26epage%3D109%26doi%3D10.1016%2Fj.plipres.2012.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascio, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahle, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smoum, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heys, S. D.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1584</span>– <span class="NLM_lpage">1591</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgq151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1093%2Fcarcin%2Fbgq151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=20660502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaitLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=1584-1591&author=I.+Brownauthor=M.+G.+Cascioauthor=K.+W.+Wahleauthor=R.+Smoumauthor=R.+Mechoulamauthor=R.+A.+Rossauthor=R.+G.+Pertweeauthor=S.+D.+Heys&title=Cannabinoid+receptor-dependent+and+-independent+anti-proliferative+effects+of+omega-3+ethanolamides+in+androgen+receptor-positive+and+-negative+prostate+cancer+cell+lines&doi=10.1093%2Fcarcin%2Fbgq151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines</span></div><div class="casAuthors">Brown, Iain; Cascio, Maria G.; Wahle, Klaus W. J.; Smoum, Reem; Mechoulam, Raphael; Ross, Ruth A.; Pertwee, Roger G.; Heys, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1584-1591</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The omega-3 fatty acid ethanolamides, docosahexaenoyl ethanolamide (DHEA) and eicosapentaenoyl ethanolamide (EPEA), displayed greater anti-proliferative potency than their parent omega-3 fatty acids, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), in LNCaP and PC3 prostate cancer cells.  DHEA and EPEA activated cannabinoid CB1 and CB2 receptors in vitro with significant potency, suggesting that they are endocannabinoids.  Both LNCaP and PC3 cells expressed CB1 and CB2 receptors, and the CB1- and CB2-selective antagonists, AM281 and AM630, administered sep. or together, reduced the anti-proliferative potencies of EPEA and EPA but not of DHEA or DHA in PC3 cells and of EPA but not of EPEA, DHEA or DHA in LNCaP cells.  Even so, EPEA and EPA may not have inhibited PC3 or LNCaP cell proliferation via cannabinoid receptors since the anti-proliferative potency of EPEA was well below the potency it displayed as a CB1 or CB2 receptor agonist.  Indeed, these receptors may mediate a protective effect because the anti-proliferative potency of DHEA in LNCaP and PC3 cells was increased by sep. or combined administration of AM281 and AM630.  The anandamide-metabolizing enzyme, fatty acid amide hydrolase (FAAH), was highly expressed in LNCaP but not PC3 cells.  Evidence was obtained that FAAH metabolizes EPEA and DHEA and that the anti-proliferative potencies of these ethanolamides in LNCaP cells can be enhanced by inhibiting this enzyme.  Our findings suggest that the expression of cannabinoid receptors and of FAAH in some tumor cells could well influence the effectiveness of DHA and EPA or their ethanolamide derivs. as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXVmDGbUYUjbVg90H21EOLACvtfcHk0lihNQoZfducSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaitLvO&md5=782181896032c0d8fce5f0252c67c4fc</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgq151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgq151%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DI.%26aulast%3DCascio%26aufirst%3DM.%2BG.%26aulast%3DWahle%26aufirst%3DK.%2BW.%26aulast%3DSmoum%26aufirst%3DR.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DRoss%26aufirst%3DR.%2BA.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DHeys%26aufirst%3DS.%2BD.%26atitle%3DCannabinoid%2520receptor-dependent%2520and%2520-independent%2520anti-proliferative%2520effects%2520of%2520omega-3%2520ethanolamides%2520in%2520androgen%2520receptor-positive%2520and%2520-negative%2520prostate%2520cancer%2520cell%2520lines%26jtitle%3DCarcinogenesis%26date%3D2010%26volume%3D31%26spage%3D1584%26epage%3D1591%26doi%3D10.1093%2Fcarcin%2Fbgq151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Marzo, V.</span></span> <span> </span><span class="NLM_article-title">Endocannabinoids: synthesis and degradation</span>. <i>Rev. Physiol., Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1007/112_0505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1007%2F112_0505" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2006&pages=1-24&author=V.+Di%0AMarzo&title=Endocannabinoids%3A+synthesis+and+degradation&doi=10.1007%2F112_0505"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2F112_0505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F112_0505%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DEndocannabinoids%253A%2520synthesis%2520and%2520degradation%26jtitle%3DRev.%2520Physiol.%252C%2520Biochem.%2520Pharmacol.%26date%3D2006%26volume%3D160%26spage%3D1%26epage%3D24%26doi%3D10.1007%2F112_0505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skaper, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span> <span> </span><span class="NLM_article-title">Endocannabinoids in nervous system health and disease: the big picture in a nutshell</span>. <i>Philos. Trans. R. Soc., B</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>367</i></span>,  <span class="NLM_fpage">3193</span>– <span class="NLM_lpage">3200</span>, <span class="refDoi"> DOI: 10.1098/rstb.2012.0313</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1098%2Frstb.2012.0313" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=23108539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKgtLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=3193-3200&author=S.+D.+Skaperauthor=V.+Di+Marzo&title=Endocannabinoids+in+nervous+system+health+and+disease%3A+the+big+picture+in+a+nutshell&doi=10.1098%2Frstb.2012.0313"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoids in nervous system health and disease: the big picture in a nutshell</span></div><div class="casAuthors">Skaper, Stephen D.; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical Transactions of the Royal Society, B: Biological Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">1607</span>),
    <span class="NLM_cas:pages">3193-3200</span>CODEN:
                <span class="NLM_cas:coden">PTRBAE</span>;
        ISSN:<span class="NLM_cas:issn">0962-8436</span>.
    
            (<span class="NLM_cas:orgname">Royal Society</span>)
        </div><div class="casAbstract">A review.  The psychoactive component of the cannabis resin and flowers, delta9-tetrahydrocannabinol (THC), was first isolated in 1964, and at least 70 other structurally related 'phytocannabinoid' compds. have since been identified.  The serendipitous identification of a G-protein-coupled cannabinoid receptor at which THC is active in the brain heralded an explosion in cannabinoid research.  Elements of the endocannabinoid system (ECS) comprise the cannabinoid receptors, a family of nascent lipid ligands, the 'endocannabinoids' and the machinery for their biosynthesis and metab.  The function of the ECS is thus defined by modulation of these receptors, in particular, by two of the best-described ligands, 2-arachidonoyl glycerol and anandamide (arachidonylethanolamide).  Research on the ECS has recently aroused enormous interest not only for the physiol. functions, but also for the promising therapeutic potentials of drugs interfering with the activity of cannabinoid receptors.  Many of the former relate to stress-recovery systems and to the maintenance of homeostatic balance.  Among other functions, the ECS is involved in neuroprotection, modulation of nociception, regulation of motor activity, neurogenesis, synaptic plasticity and the control of certain phases of memory processing.  In addn., the ECS acts to modulate the immune and inflammatory responses and to maintain a pos. energy balance.  This theme issue aims to provide the reader with an overview of ECS pharmacol., followed by discussions on the pivotal role of this system in the modulation of neurogenesis in the developing and adult organism, memory processes and synaptic plasticity, as well as in pathol. pain and brain ageing.  The vol. will conclude with discussions that address the proposed therapeutic applications of targeting the ECS for the treatment of neurodegeneration, pain and mental illness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqytAYy2FAN-LVg90H21EOLACvtfcHk0lihNQoZfducSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKgtLzI&md5=dc601d67ca629e093ff1d85b422be36a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1098%2Frstb.2012.0313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2012.0313%26sid%3Dliteratum%253Aachs%26aulast%3DSkaper%26aufirst%3DS.%2BD.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DEndocannabinoids%2520in%2520nervous%2520system%2520health%2520and%2520disease%253A%2520the%2520big%2520picture%2520in%2520a%2520nutshell%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%252C%2520B%26date%3D2012%26volume%3D367%26spage%3D3193%26epage%3D3200%26doi%3D10.1098%2Frstb.2012.0313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correia-da-Silva, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixeira, N. A.</span></span> <span> </span><span class="NLM_article-title">Endogenous cannabinoids revisited: a biochemistry perspective</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>102–103</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2013.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2Fj.prostaglandins.2013.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkt12qurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102%E2%80%93103&publication_year=2013&pages=13-30&author=B.+M.+Fonsecaauthor=M.+A.+Costaauthor=M.+Almadaauthor=G.+Correia-da-Silvaauthor=N.+A.+Teixeira&title=Endogenous+cannabinoids+revisited%3A+a+biochemistry+perspective&doi=10.1016%2Fj.prostaglandins.2013.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous cannabinoids revisited: A biochemistry perspective</span></div><div class="casAuthors">Fonseca, B. M.; Costa, M. A.; Almada, M.; Correia-da-Silva, G.; Teixeira, N. A.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins and Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">102-103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-30</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Marijuana is the most commonly used illegal drug, particularly in Western societies.  The discovery of an endogenous cannabinoid system (ECS) highlighted new mols. in various physiol. processes.  The ECS consists of G-protein-coupled cannabinoid receptors that can be activated by small lipid mediators, termed endocannabinoids (eCBs) and cannabis-derived drugs, plus the assocd. biochem. machinery (precursors, synthesis and degradative enzymes, and transporters).  Several biochem., pharmacol. and physiol. studies have shown that endocannabinoid system elements are widely distributed throughout the body, with regional variations and organ-specific actions.  This review portrays the endocannabinoid "family" on new studies concerning eCB storage, release and functional roles and on the growing importance of its bioactive metabolites.  Those findings reinforce and confirm the importance of ECS.  Strategies for manipulating the system for the treatment of human disease will require a thorough understanding of the roles of the different eCBs and their sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWoSuyAKTrl7Vg90H21EOLACvtfcHk0lgXhhOLuWttKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkt12qurk%253D&md5=d069aa267e2de467a1ae2a86c901fc6a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2013.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2013.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca%26aufirst%3DB.%2BM.%26aulast%3DCosta%26aufirst%3DM.%2BA.%26aulast%3DAlmada%26aufirst%3DM.%26aulast%3DCorreia-da-Silva%26aufirst%3DG.%26aulast%3DTeixeira%26aufirst%3DN.%2BA.%26atitle%3DEndogenous%2520cannabinoids%2520revisited%253A%2520a%2520biochemistry%2520perspective%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2013%26volume%3D102%25E2%2580%2593103%26spage%3D13%26epage%3D30%26doi%3D10.1016%2Fj.prostaglandins.2013.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, M.</span></span> <span> </span><span class="NLM_article-title">The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration</span>. <i>Current Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.2174/157015907780866884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.2174%2F157015907780866884" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=73-80&author=J.+C.+Ashtonauthor=M.+Glass&title=The+cannabinoid+CB2+receptor+as+a+target+for+inflammation-dependent+neurodegeneration&doi=10.2174%2F157015907780866884"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F157015907780866884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157015907780866884%26sid%3Dliteratum%253Aachs%26aulast%3DAshton%26aufirst%3DJ.%2BC.%26aulast%3DGlass%26aufirst%3DM.%26atitle%3DThe%2520cannabinoid%2520CB2%2520receptor%2520as%2520a%2520target%2520for%2520inflammation-dependent%2520neurodegeneration%26jtitle%3DCurrent%2520Neuropharmacology%26date%3D2007%26volume%3D5%26spage%3D73%26epage%3D80%26doi%3D10.2174%2F157015907780866884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Onaivi, E. S.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications</span>. <i>Int. Rev. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1016/S0074-7742(09)88012-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2FS0074-7742%2809%2988012-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=19897083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt1Omsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2009&pages=335-369&author=E.+S.+Onaivi&title=Cannabinoid+receptors+in+brain%3A+pharmacogenetics%2C+neuropharmacology%2C+neurotoxicology%2C+and+potential+therapeutic+applications&doi=10.1016%2FS0074-7742%2809%2988012-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications</span></div><div class="casAuthors">Onaivi, Emmanuel S.</div><div class="citationInfo"><span class="NLM_cas:title">International Review of Neurobiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">New Concepts of Psychostimulants Induced Neurotoxicity</span>),
    <span class="NLM_cas:pages">335-369</span>CODEN:
                <span class="NLM_cas:coden">IRNEAE</span>;
        ISSN:<span class="NLM_cas:issn">0074-7742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Much progress has been achieved in cannabinoid research.  A major breakthrough in marijuana-cannabinoid research has been the discovery of a previously unknown but elaborate endogenous endocannabinoid system (ECS), complete with endocannabinoids and enzymes for their biosynthesis and degrdn. with genes; encoding two distinct cannabinoid (CB1 and CB2) receptors (CBRs) that are activated by endocannabinoids, cannabinoids, and marijuana use.  Phys. and genetic localization of the CBR genes CNR1 and CNR2 have been mapped to chromosome 6 and 1, resp.  A no. of variations in CBR genes have been assocd. with human disorders including osteoporosis, attention deficit hyperactivity disorder (ADHD), posttraumatic stress disorder (PTSD), drug dependency, obesity, and depression.  Other family of lipid receptors including vanilloid (VR1) and lysophosphatidic acid (LPA) receptors appear to be related to the CBRs at the phylogenetic level.  The ubiquitous abundance and differential distribution of the ECS in the human body and brain along with the coupling to many signal transduction pathways may explain the effects in most biol. system and the myriad behavioral effects assocd. with smoking marijuana.  The neuropharmacol. and neuroprotective features of phytocannabinoids and endocannabinoid assocd. neurogenesis have revealed roles for the use of cannabinoids in neurodegenerative pathologies with less neurotoxicity.  The remarkable progress in understanding the biol. actions of marijuana and cannabinoids have provided much richer results than previously appreciated cannabinoid genomics and raised a no. of crit. issues on the mol. mechanisms of cannabinoid induced behavioral and biochem. alterations.  These advances will allow specific therapeutic targeting of the different components of the ECS in health and disease.  This review focuses on these recent advances in cannabinoid genomics and the surprising new fundamental roles that the ECS plays in the retrograde signaling assocd. with cannabinoid inhibition of neurotransmitter release to the genetic basis of the effects of marijuana use and pharmacotherpeutic applications and limitations.  Much evidence is provided for the complex GNR1 and CNR2 gene structures and their assocd. regulatory elements.  Thus, understanding the ECS in the human body and brain will contribute to elucidating this natural regulatory mechanism in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Ei-jnghXtLVg90H21EOLACvtfcHk0lgXhhOLuWttKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt1Omsg%253D%253D&md5=bb945ecc35b936bd0de1edfa0588103d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0074-7742%2809%2988012-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0074-7742%252809%252988012-4%26sid%3Dliteratum%253Aachs%26aulast%3DOnaivi%26aufirst%3DE.%2BS.%26atitle%3DCannabinoid%2520receptors%2520in%2520brain%253A%2520pharmacogenetics%252C%2520neuropharmacology%252C%2520neurotoxicology%252C%2520and%2520potential%2520therapeutic%2520applications%26jtitle%3DInt.%2520Rev.%2520Neurobiol.%26date%3D2009%26volume%3D88%26spage%3D335%26epage%3D369%26doi%3D10.1016%2FS0074-7742%2809%2988012-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salazar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olea-Herrero, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Laviada, I.</span></span> <span> </span><span class="NLM_article-title">Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1099</span>– <span class="NLM_lpage">1111</span>, <span class="refDoi"> DOI: 10.1038/cdd.2011.32</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1038%2Fcdd.2011.32" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=21475304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVShtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1099-1111&author=D.+Varaauthor=M.+Salazarauthor=N.+Olea-Herreroauthor=M.+Guzmanauthor=G.+Velascoauthor=I.+Diaz-Laviada&title=Anti-tumoral+action+of+cannabinoids+on+hepatocellular+carcinoma%3A+role+of+AMPK-dependent+activation+of+autophagy&doi=10.1038%2Fcdd.2011.32"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy</span></div><div class="casAuthors">Vara, D.; Salazar, M.; Olea-Herrero, N.; Guzman, M.; Velasco, G.; Diaz-Laviada, I.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1099-1111</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is the third cause of cancer-related death worldwide.  When these tumors are in advanced stages, few therapeutic options are available.  Therefore, it is essential to search for new treatments to fight this disease.  In this study, we investigated the effects of cannabinoids - a novel family of potential anticancer agents - on the growth of HCC.  We found that Δ9-tetrahydrocannabinol (Δ9-THC, the main active component of Cannabis sativa) and JWH-015 (a cannabinoid receptor 2 (CB2) cannabinoid receptor-selective agonist) reduced the viability of the human HCC cell lines HepG2 (human hepatocellular liver carcinoma cell line) and HuH-7 (hepatocellular carcinoma cells), an effect that relied on the stimulation of CB2 receptor.  We also found that Δ9-THC- and JWH-015-induced autophagy relies on tribbles homolog 3 (TRB3) upregulation, and subsequent inhibition of the serine-threonine kinase Akt/mammalian target of rapamycin C1 axis and adenosine monophosphate-activated kinase (AMPK) stimulation.  Pharmacol. and genetic inhibition of AMPK upstream kinases supported that calmodulin-activated kinase kinase β was responsible for cannabinoid-induced AMPK activation and autophagy.  In vivo studies revealed that Δ9-THC and JWH-015 reduced the growth of HCC s.c. xenografts, an effect that was not evident when autophagy was genetically of pharmacol. inhibited in those tumors.  Moreover, cannabinoids were also able to inhibit tumor growth and ascites in an orthotopic model of HCC xenograft.  Our findings may contribute to the design of new therapeutic strategies for the management of HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUstctG4ZkZbVg90H21EOLACvtfcHk0lgXhhOLuWttKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVShtLg%253D&md5=670cf2a3687e9ea926f9ec346c9ae009</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2011.32&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2011.32%26sid%3Dliteratum%253Aachs%26aulast%3DVara%26aufirst%3DD.%26aulast%3DSalazar%26aufirst%3DM.%26aulast%3DOlea-Herrero%26aufirst%3DN.%26aulast%3DGuzman%26aufirst%3DM.%26aulast%3DVelasco%26aufirst%3DG.%26aulast%3DDiaz-Laviada%26aufirst%3DI.%26atitle%3DAnti-tumoral%2520action%2520of%2520cannabinoids%2520on%2520hepatocellular%2520carcinoma%253A%2520role%2520of%2520AMPK-dependent%2520activation%2520of%2520autophagy%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2011%26volume%3D18%26spage%3D1099%26epage%3D1111%26doi%3D10.1038%2Fcdd.2011.32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ladin, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soliman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dross, R.</span></span> <span> </span><span class="NLM_article-title">Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">361</span>, <span class="refDoi"> DOI: 10.3389/fphar.2016.00361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.3389%2Ffphar.2016.00361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=27774065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptl2lsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=361&author=D.+A.+Ladinauthor=E.+Solimanauthor=L.+Griffinauthor=R.+Van+Dross&title=Preclinical+and+Clinical+Assessment+of+Cannabinoids+as+Anti-Cancer+Agents&doi=10.3389%2Ffphar.2016.00361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical and clinical assessment of cannabinoids as anti-cancer agents</span></div><div class="casAuthors">Ladin, Daniel A.; Soliman, Eman; Griffin, LaToya; Van Dross, Rukiyah</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">361/1-361/18</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Cancer is the second leading cause of death in the United States with 1.7 million new cases estd. to be diagnosed in 2016.  This disease remains a formidable clin. challenge and represents a substantial financial burden to the US health care system.  Therefore, research and development of novel therapeutics for the treatment of cancer is of high priority.  Cannabinoids and their derivs. have been utilized for their medicinal and therapeutic properties throughout history.  Cannabinoid activity is regulated by the endocannabinoid system (ECS), which is comprised of cannabinoid receptors, transporters, and enzymes involved in cannabinoid synthesis and breakdown.  More recently, cannabinoids have gained special attention for their role in cancer cell proliferation and death.  However, many studies investigated these effects using in vitro models which may not adequately mimic tumor growth and metastasis.  As such, this article aims to review study results which evaluated effects of cannabinoids from plant, synthetic and endogenous origins on cancer development in preclin. animal models and to examine the current standing of cannabinoids that are being tested in human cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3Nc9bhtVzW7Vg90H21EOLACvtfcHk0li5FuKZMSdErw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptl2lsQ%253D%253D&md5=46fb9ae53781f1a50ea578ceddc28560</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2016.00361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2016.00361%26sid%3Dliteratum%253Aachs%26aulast%3DLadin%26aufirst%3DD.%2BA.%26aulast%3DSoliman%26aufirst%3DE.%26aulast%3DGriffin%26aufirst%3DL.%26aulast%3DVan%2BDross%26aufirst%3DR.%26atitle%3DPreclinical%2520and%2520Clinical%2520Assessment%2520of%2520Cannabinoids%2520as%2520Anti-Cancer%2520Agents%26jtitle%3DFront.%2520Pharmacol.%26date%3D2016%26volume%3D7%26spage%3D361%26doi%3D10.3389%2Ffphar.2016.00361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guindon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, A. G.</span></span> <span> </span><span class="NLM_article-title">The endocannabinoid system and cancer: therapeutic implication</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">1447</span>– <span class="NLM_lpage">1463</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01327.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1111%2Fj.1476-5381.2011.01327.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=21410463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC3MXps1Sju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2011&pages=1447-1463&author=J.+Guindonauthor=A.+G.+Hohmann&title=The+endocannabinoid+system+and+cancer%3A+therapeutic+implication&doi=10.1111%2Fj.1476-5381.2011.01327.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The endocannabinoid system and cancer: therapeutic implication</span></div><div class="casAuthors">Guindon, Josee; Hohmann, Andrea G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1447-1463</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The endocannabinoid system is implicated in a variety of physiol. and pathol. conditions (inflammation, immunomodulation, analgesia, cancer and others).  The main active ingredient of cannabis, Δ9-tetrahydrocannabinol (Δ9-THC), produces its effects through activation of CB1 and CB2 receptors.  CB1 receptors are expressed at high levels in the central nervous system (CNS), whereas CB2 receptors are concd. predominantly, although not exclusively, in cells of the immune system.  Endocannabinoids are endogenous lipid-signaling mols. that are generated in the cell membrane from phospholipid precursors.  The 2 best characterized endocannabinoids identified to date are anandamide (AEA) and 2-arachidonoylglycerol (2-AG).  Here we review the relationship between the endocannabinoid system and anti-tumor actions (inhibition of cell proliferation and migration, induction of apoptosis, redn. of tumor growth) of the cannabinoids in different types of cancer.  This review will focus on examg. how activation of the endocannabinoid system impacts breast, prostate and bone cancers in both in vitro and in vivo systems.  The therapeutic potential of cannabinoids for cancer, as identified in clin. trials, is also discussed.  Identification of safe and effective treatments to manage and improve cancer therapy is crit. to improve quality of life and reduce unnecessary suffering in cancer patients.  In this regard, cannabis-like compds. offer therapeutic potential for the treatment of breast, prostate and bone cancer in patients.  Further basic research on anti-cancer properties of cannabinoids as well as clin. trials of cannabinoid therapeutic efficacy in breast, prostate and bone cancer is therefore warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_omB4D6NVN7Vg90H21EOLACvtfcHk0li5FuKZMSdErw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXps1Sju7g%253D&md5=fb5ec332b401d12e51c229d291c1909d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01327.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01327.x%26sid%3Dliteratum%253Aachs%26aulast%3DGuindon%26aufirst%3DJ.%26aulast%3DHohmann%26aufirst%3DA.%2BG.%26atitle%3DThe%2520endocannabinoid%2520system%2520and%2520cancer%253A%2520therapeutic%2520implication%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D163%26spage%3D1447%26epage%3D1463%26doi%3D10.1111%2Fj.1476-5381.2011.01327.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, B.</span></span> <span> </span><span class="NLM_article-title">Targeting the endocannabinoid system as a potential anticancer approach</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1080/03602532.2018.1428344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1080%2F03602532.2018.1428344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=29390896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1aiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2018&pages=26-53&author=R.+Schwarzauthor=R.+Ramerauthor=B.+Hinz&title=Targeting+the+endocannabinoid+system+as+a+potential+anticancer+approach&doi=10.1080%2F03602532.2018.1428344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the endocannabinoid system as a potential anticancer approach</span></div><div class="casAuthors">Schwarz, Rico; Ramer, Robert; Hinz, Burkhard</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-53</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The endocannabinoid system is currently under intense investigation due to the therapeutic potential of cannabinoid-based drugs as treatment options for a broad variety of diseases including cancer.  Besides the canonical endocannabinoid system that includes the cannabinoid receptors CB1 and CB2 and the endocannabinoids N-arachidonoylethanolamine (anandamide) and 2-arachidonoylglycerol, recent investigations suggest that other fatty acid derivs., receptors, enzymes, and lipid transporters likewise orchestrate this system as components of the endocannabinoid system when defined as an extended signaling network.  As such, fatty acids acting at cannabinoid receptors (e.g. 2-arachidonoyl glyceryl ether [noladin ether], N-arachidonoyldopamine) as well as endocannabinoid-like substances that do not elicit cannabinoid receptor activation (e.g. N-palmitoylethanolamine, N-oleoylethanolamine) have raised interest as anticancerogenic substances.  Furthermore, the endocannabinoid-degrading enzymes fatty acid amide hydrolase and monoacylglycerol lipase, lipid transport proteins of the fatty acid binding protein family, addnl. cannabinoid-activated G protein-coupled receptors, members of the transient receptor potential family as well as peroxisome proliferator-activated receptors have been considered as targets of antitumoral cannabinoid activity.  Therefore, this review focused on the antitumorigenic effects induced upon modulation of this extended endocannabinoid network.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6gqyQZreVWrVg90H21EOLACvtfcHk0li5FuKZMSdErw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1aiur0%253D&md5=2a17e53ac39a2a376a82098d3e1aae01</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1080%2F03602532.2018.1428344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F03602532.2018.1428344%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarz%26aufirst%3DR.%26aulast%3DRamer%26aufirst%3DR.%26aulast%3DHinz%26aufirst%3DB.%26atitle%3DTargeting%2520the%2520endocannabinoid%2520system%2520as%2520a%2520potential%2520anticancer%2520approach%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2018%26volume%3D50%26spage%3D26%26epage%3D53%26doi%3D10.1080%2F03602532.2018.1428344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jan, C. R.</span></span> <span> </span><span class="NLM_article-title">Anandamide-induced Ca2+ elevation leading to p38 MAPK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells</span>. <i>Toxicology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>231</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/j.tox.2006.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2Fj.tox.2006.11.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=2007&pages=21-29&author=S.+S.+Hsuauthor=C.+J.+Huangauthor=H.+H.+Chengauthor=C.+T.+Chouauthor=H.+Y.+Leeauthor=J.+L.+Wangauthor=I.+S.+Chenauthor=S.+I.+Liuauthor=Y.+C.+Luauthor=H.+T.+Changauthor=J.+K.+Huangauthor=J.+S.+Chenauthor=C.+R.+Jan&title=Anandamide-induced+Ca2%2B+elevation+leading+to+p38+MAPK+phosphorylation+and+subsequent+cell+death+via+apoptosis+in+human+osteosarcoma+cells&doi=10.1016%2Fj.tox.2006.11.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.tox.2006.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tox.2006.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DHsu%26aufirst%3DS.%2BS.%26aulast%3DHuang%26aufirst%3DC.%2BJ.%26aulast%3DCheng%26aufirst%3DH.%2BH.%26aulast%3DChou%26aufirst%3DC.%2BT.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DWang%26aufirst%3DJ.%2BL.%26aulast%3DChen%26aufirst%3DI.%2BS.%26aulast%3DLiu%26aufirst%3DS.%2BI.%26aulast%3DLu%26aufirst%3DY.%2BC.%26aulast%3DChang%26aufirst%3DH.%2BT.%26aulast%3DHuang%26aufirst%3DJ.%2BK.%26aulast%3DChen%26aufirst%3DJ.%2BS.%26aulast%3DJan%26aufirst%3DC.%2BR.%26atitle%3DAnandamide-induced%2520Ca2%252B%2520elevation%2520leading%2520to%2520p38%2520MAPK%2520phosphorylation%2520and%2520subsequent%2520cell%2520death%2520via%2520apoptosis%2520in%2520human%2520osteosarcoma%2520cells%26jtitle%3DToxicology%26date%3D2007%26volume%3D231%26spage%3D21%26epage%3D29%26doi%3D10.1016%2Fj.tox.2006.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Petrocellis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmisano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisogno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laezza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bifulco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span> <span> </span><span class="NLM_article-title">The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">8375</span>– <span class="NLM_lpage">8380</span>, <span class="refDoi"> DOI: 10.1073/pnas.95.14.8375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1073%2Fpnas.95.14.8375" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=8375-8380&author=L.+De%0APetrocellisauthor=D.+Melckauthor=A.+Palmisanoauthor=T.+Bisognoauthor=C.+Laezzaauthor=M.+Bifulcoauthor=V.+Di+Marzo&title=The+endogenous+cannabinoid+anandamide+inhibits+human+breast+cancer+cell+proliferation&doi=10.1073%2Fpnas.95.14.8375"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.14.8375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.14.8375%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26aulast%3DMelck%26aufirst%3DD.%26aulast%3DPalmisano%26aufirst%3DA.%26aulast%3DBisogno%26aufirst%3DT.%26aulast%3DLaezza%26aufirst%3DC.%26aulast%3DBifulco%26aufirst%3DM.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DThe%2520endogenous%2520cannabinoid%2520anandamide%2520inhibits%2520human%2520breast%2520cancer%2520cell%2520proliferation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D8375%26epage%3D8380%26doi%3D10.1073%2Fpnas.95.14.8375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patsos, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenhough, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paraskeva, C.</span></span> <span> </span><span class="NLM_article-title">The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1741</span>– <span class="NLM_lpage">1750</span>, <span class="refDoi"> DOI: 10.1136/gut.2005.073403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1136%2Fgut.2005.073403" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=1741-1750&author=H.+A.+Patsosauthor=D.+J.+Hicksauthor=R.+R.+Dobsonauthor=A.+Greenhoughauthor=N.+Woodmanauthor=J.+D.+Laneauthor=A.+C.+Williamsauthor=C.+Paraskeva&title=The+endogenous+cannabinoid%2C+anandamide%2C+induces+cell+death+in+colorectal+carcinoma+cells%3A+a+possible+role+for+cyclooxygenase+2&doi=10.1136%2Fgut.2005.073403"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1136%2Fgut.2005.073403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgut.2005.073403%26sid%3Dliteratum%253Aachs%26aulast%3DPatsos%26aufirst%3DH.%2BA.%26aulast%3DHicks%26aufirst%3DD.%2BJ.%26aulast%3DDobson%26aufirst%3DR.%2BR.%26aulast%3DGreenhough%26aufirst%3DA.%26aulast%3DWoodman%26aufirst%3DN.%26aulast%3DLane%26aufirst%3DJ.%2BD.%26aulast%3DWilliams%26aufirst%3DA.%2BC.%26aulast%3DParaskeva%26aufirst%3DC.%26atitle%3DThe%2520endogenous%2520cannabinoid%252C%2520anandamide%252C%2520induces%2520cell%2520death%2520in%2520colorectal%2520carcinoma%2520cells%253A%2520a%2520possible%2520role%2520for%2520cyclooxygenase%25202%26jtitle%3DGut%26date%3D2005%26volume%3D54%26spage%3D1741%26epage%3D1750%26doi%3D10.1136%2Fgut.2005.073403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nithipatikom, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endsley, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isbell, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillard, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span> <span> </span><span class="NLM_article-title">2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">8826</span>– <span class="NLM_lpage">8830</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-3136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1158%2F0008-5472.CAN-04-3136" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=8826-8830&author=K.+Nithipatikomauthor=M.+P.+Endsleyauthor=M.+A.+Isbellauthor=J.+R.+Falckauthor=Y.+Iwamotoauthor=C.+J.+Hillardauthor=W.+B.+Campbell&title=2-arachidonoylglycerol%3A+a+novel+inhibitor+of+androgen-independent+prostate+cancer+cell+invasion&doi=10.1158%2F0008-5472.CAN-04-3136"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-3136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-3136%26sid%3Dliteratum%253Aachs%26aulast%3DNithipatikom%26aufirst%3DK.%26aulast%3DEndsley%26aufirst%3DM.%2BP.%26aulast%3DIsbell%26aufirst%3DM.%2BA.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DIwamoto%26aufirst%3DY.%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26atitle%3D2-arachidonoylglycerol%253A%2520a%2520novel%2520inhibitor%2520of%2520androgen-independent%2520prostate%2520cancer%2520cell%2520invasion%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D8826%26epage%3D8830%26doi%3D10.1158%2F0008-5472.CAN-04-3136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDougle, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdeen, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adili, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caputo, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krapf, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilian, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holinstat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, A.</span></span> <span> </span><span class="NLM_article-title">Anti-inflammatory omega-3 endocannabinoid epoxides</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E6034</span>, <span class="refDoi"> DOI: 10.1073/pnas.1610325114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1073%2Fpnas.1610325114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E6034&author=D.+R.+McDougleauthor=J.+E.+Watsonauthor=A.+A.+Abdeenauthor=R.+Adiliauthor=M.+P.+Caputoauthor=J.+E.+Krapfauthor=R.+W.+Johnsonauthor=K.+A.+Kilianauthor=M.+Holinstatauthor=A.+Das&title=Anti-inflammatory+omega-3+endocannabinoid+epoxides&doi=10.1073%2Fpnas.1610325114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1610325114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1610325114%26sid%3Dliteratum%253Aachs%26aulast%3DMcDougle%26aufirst%3DD.%2BR.%26aulast%3DWatson%26aufirst%3DJ.%2BE.%26aulast%3DAbdeen%26aufirst%3DA.%2BA.%26aulast%3DAdili%26aufirst%3DR.%26aulast%3DCaputo%26aufirst%3DM.%2BP.%26aulast%3DKrapf%26aufirst%3DJ.%2BE.%26aulast%3DJohnson%26aufirst%3DR.%2BW.%26aulast%3DKilian%26aufirst%3DK.%2BA.%26aulast%3DHolinstat%26aufirst%3DM.%26aulast%3DDas%26aufirst%3DA.%26atitle%3DAnti-inflammatory%2520omega-3%2520endocannabinoid%2520epoxides%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3DE6034%26doi%3D10.1073%2Fpnas.1610325114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sha, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nie, T. H.</span></span> <span> </span><span class="NLM_article-title">Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212–2</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2415</span>– <span class="NLM_lpage">2421</span>, <span class="refDoi"> DOI: 10.3892/ol.2015.3525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.3892%2Fol.2015.3525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=26622862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltlGksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=2415-2421&author=F.+Niuauthor=S.+Zhaoauthor=C.+Y.+Xuauthor=H.+Shaauthor=G.+B.+Biauthor=L.+Chenauthor=L.+Yeauthor=P.+Gongauthor=T.+H.+Nie&title=Potentiation+of+the+antitumor+activity+of+adriamycin+against+osteosarcoma+by+cannabinoid+WIN-55%2C212%E2%80%932&doi=10.3892%2Fol.2015.3525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2</span></div><div class="casAuthors">Niu, Feng; Zhao, Song; Xu, Chang-Yan; Sha, Hui; Bi, Gui-Bin; Chen, Lin; Ye, Long; Gong, Ping; Nie, Tian-Hong</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2415-2421</span>CODEN:
                <span class="NLM_cas:coden">OLNEB5</span>;
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Osteosarcoma is the most frequent primary malignant bone tumor that occurs in children and adolescents.  The present study aimed to identify novel therapeutic strategies for osteosarcoma, by assessing the antitumor activity of the cannabinoid WIN-55,212-2 and its combined effect with adriamycin (ADM) against the MG-63 human osteosarcoma cell line.  To evaluate the antiproliferative action of these mols., a Cell Counting kit-8 (CCK-8) assay was used.  The ability of cannabinoid to inhibit the migration, invasion and angiogenic activity of MG-63 cells were assessed by scratch, Transwell chamber and angiogenesis assays, resp., in vitro.  To examine the alterations in expression of targeted genes, quant. polymerase chain reaction and western blot anal. were used.  The administration of cannabinoid combined with ADM was demonstrated to inhibit the growth of MG-63 cells, resulting in a cell viability of 32.12 ± 3.13%, which was significantly lower (P<0.05) compared with the cell viability following treatment with cannabinoid (70.86 ± 7.55%) and ADM (62.87 ± 5.98%) alone.  Greater antimetastasis and antiangiogenic activities were also obsd. following the coadministration of the two agents compared with individual treatments and controls.  In addn., the expression levels of Notch-1, matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in MG-63 cells were downregulated following the treatments with cannabinoid alone or in combination with ADM.  In conclusion, the present findings demonstrated that cannabinoid WIN-55,212-2 may significantly potentiate the antiproliferative, antimetastasis and antiangiogenic effects of ADM against MG-63 cells via the downregulation of Notch-1, MMP-2 and VEGF.  These findings may offer a novel strategy for the treatment of osteosarcoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1RaPlUUcAnrVg90H21EOLACvtfcHk0lgUH4oT1exGHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltlGksbs%253D&md5=162b54a5116cf2ad8d190b879cfe0175</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3892%2Fol.2015.3525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2015.3525%26sid%3Dliteratum%253Aachs%26aulast%3DNiu%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DC.%2BY.%26aulast%3DSha%26aufirst%3DH.%26aulast%3DBi%26aufirst%3DG.%2BB.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DGong%26aufirst%3DP.%26aulast%3DNie%26aufirst%3DT.%2BH.%26atitle%3DPotentiation%2520of%2520the%2520antitumor%2520activity%2520of%2520adriamycin%2520against%2520osteosarcoma%2520by%2520cannabinoid%2520WIN-55%252C212%25E2%2580%25932%26jtitle%3DOncol.%2520Lett.%26date%3D2015%26volume%3D10%26spage%3D2415%26epage%3D2421%26doi%3D10.3892%2Fol.2015.3525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hald, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egerod, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konradsen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atalay, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjerrum, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heegaard, A. M.</span></span> <span> </span><span class="NLM_article-title">Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212–2 in experimental models of bone cancer pain and neuropathic pain</span>. <i>Pharmacol., Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1016/j.pbb.2008.04.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2Fj.pbb.2008.04.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2008&pages=38-46&author=A.+Haldauthor=M.+Dingauthor=K.+Egerodauthor=R.+R.+Hansenauthor=D.+Konradsenauthor=S.+G.+Jorgensenauthor=B.+Atalayauthor=A.+Nasserauthor=O.+J.+Bjerrumauthor=A.+M.+Heegaard&title=Differential+effects+of+repeated+low+dose+treatment+with+the+cannabinoid+agonist+WIN+55%2C212%E2%80%932+in+experimental+models+of+bone+cancer+pain+and+neuropathic+pain&doi=10.1016%2Fj.pbb.2008.04.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2008.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2008.04.021%26sid%3Dliteratum%253Aachs%26aulast%3DHald%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DM.%26aulast%3DEgerod%26aufirst%3DK.%26aulast%3DHansen%26aufirst%3DR.%2BR.%26aulast%3DKonradsen%26aufirst%3DD.%26aulast%3DJorgensen%26aufirst%3DS.%2BG.%26aulast%3DAtalay%26aufirst%3DB.%26aulast%3DNasser%26aufirst%3DA.%26aulast%3DBjerrum%26aufirst%3DO.%2BJ.%26aulast%3DHeegaard%26aufirst%3DA.%2BM.%26atitle%3DDifferential%2520effects%2520of%2520repeated%2520low%2520dose%2520treatment%2520with%2520the%2520cannabinoid%2520agonist%2520WIN%252055%252C212%25E2%2580%25932%2520in%2520experimental%2520models%2520of%2520bone%2520cancer%2520pain%2520and%2520neuropathic%2520pain%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2008%26volume%3D91%26spage%3D38%26epage%3D46%26doi%3D10.1016%2Fj.pbb.2008.04.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lozano-Ondoua, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vardanyan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Largent-Milnes, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Andrade, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantyh, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderah, T. W.</span></span> <span> </span><span class="NLM_article-title">A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">653</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2010.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2Fj.lfs.2010.02.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2010&pages=646-653&author=A.+N.+Lozano-Ondouaauthor=C.+Wrightauthor=A.+Vardanyanauthor=T.+Kingauthor=T.+M.+Largent-Milnesauthor=M.+Nelsonauthor=J.+M.+Jimenez-Andradeauthor=P.+W.+Mantyhauthor=T.+W.+Vanderah&title=A+cannabinoid+2+receptor+agonist+attenuates+bone+cancer-induced+pain+and+bone+loss&doi=10.1016%2Fj.lfs.2010.02.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2010.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2010.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DLozano-Ondoua%26aufirst%3DA.%2BN.%26aulast%3DWright%26aufirst%3DC.%26aulast%3DVardanyan%26aufirst%3DA.%26aulast%3DKing%26aufirst%3DT.%26aulast%3DLargent-Milnes%26aufirst%3DT.%2BM.%26aulast%3DNelson%26aufirst%3DM.%26aulast%3DJimenez-Andrade%26aufirst%3DJ.%2BM.%26aulast%3DMantyh%26aufirst%3DP.%2BW.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26atitle%3DA%2520cannabinoid%25202%2520receptor%2520agonist%2520attenuates%2520bone%2520cancer-induced%2520pain%2520and%2520bone%2520loss%26jtitle%3DLife%2520Sci.%26date%3D2010%26volume%3D86%26spage%3D646%26epage%3D653%26doi%3D10.1016%2Fj.lfs.2010.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luu, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montag, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peabody, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haydon, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinker-Schaeffer, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, T. C.</span></span> <span> </span><span class="NLM_article-title">An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis</span>. <i>Clin. Exp. Metastasis</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.1007/s10585-005-0365-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1007%2Fs10585-005-0365-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=16170668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A280%3ADC%252BD2Mvps12gsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2005&pages=319-329&author=H.+H.+Luuauthor=Q.+Kangauthor=J.+K.+Parkauthor=W.+Siauthor=Q.+Luoauthor=W.+Jiangauthor=H.+Yinauthor=A.+G.+Montagauthor=M.+A.+Simonauthor=T.+D.+Peabodyauthor=R.+C.+Haydonauthor=C.+W.+Rinker-Schaefferauthor=T.+C.+He&title=An+orthotopic+model+of+human+osteosarcoma+growth+and+spontaneous+pulmonary+metastasis&doi=10.1007%2Fs10585-005-0365-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis</span></div><div class="casAuthors">Luu Hue H; Kang Quan; Park Jong Kyung; Si Weike; Luo Qing; Jiang Wei; Yin Hong; Montag Anthony G; Simon Michael A; Peabody Terrance D; Haydon Rex C; Rinker-Schaeffer Carrie W; He Tong-Chuan</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & experimental metastasis</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">319-29</span>
        ISSN:<span class="NLM_cas:issn">0262-0898</span>.
    </div><div class="casAbstract">Osteosarcoma is the most common primary malignancy of bone and patients often develop pulmonary metastases.  In order to investigate the pathogenesis of human osteosarcoma, there is a great need to develop a clinically relevant animal model.  Here we report the development of an osteosarcoma animal model using three related human osteosarcoma lines, the parental TE-85 and two derivative lines MNNG/HOS and 143B.  In vitro characterization demonstrated that the 143B line had the greatest cell migration and the least cell adhesion activities among the three lines.  The 143B line also exhibited the greatest ability for anchorage independent growth.  When GFP-tagged osteosarcoma cells were injected into the proximal tibia of athymic mice, we found that 143B cells were highly tumorigenic and metastatic, and MNNG/HOS cells were tumorigenic but significantly less metastatic.  TE85 cells were neither tumorigenic nor metastatic.  The number of pulmonary metastases was found 50-fold higher in 143B injected animals than that in MNNG/HOS injected mice.  No pulmonary metastases were detected in TE85 injected animals for up to 8 weeks.  Primary tumors formed by MNNG/HOS and 143B cells could be visualized by whole body fluorescence imaging, while the pulmonary metastases were visualized on the necropsied samples.  The GFP tagged 143B cells (and to a lesser extent, MNNG/HOS cells) were readily recovered from lung metastases.  This clinically relevant model of human osteosarcoma provides varying degrees of tumor growth at the primary site and metastatic potential.  Thus, this orthotopic model should be a valuable tool to investigate factors that promote or inhibit osteosarcoma growth and/or metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXRi-dKHz0zkh5eUSa2oe_fW6udTcc2ebM7Nqw5PC9mrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mvps12gsQ%253D%253D&md5=3bc41704831cd6b329d783262bac338e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs10585-005-0365-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10585-005-0365-9%26sid%3Dliteratum%253Aachs%26aulast%3DLuu%26aufirst%3DH.%2BH.%26aulast%3DKang%26aufirst%3DQ.%26aulast%3DPark%26aufirst%3DJ.%2BK.%26aulast%3DSi%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DMontag%26aufirst%3DA.%2BG.%26aulast%3DSimon%26aufirst%3DM.%2BA.%26aulast%3DPeabody%26aufirst%3DT.%2BD.%26aulast%3DHaydon%26aufirst%3DR.%2BC.%26aulast%3DRinker-Schaeffer%26aufirst%3DC.%2BW.%26aulast%3DHe%26aufirst%3DT.%2BC.%26atitle%3DAn%2520orthotopic%2520model%2520of%2520human%2520osteosarcoma%2520growth%2520and%2520spontaneous%2520pulmonary%2520metastasis%26jtitle%3DClin.%2520Exp.%2520Metastasis%26date%3D2005%26volume%3D22%26spage%3D319%26epage%3D329%26doi%3D10.1007%2Fs10585-005-0365-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, J. L.</span></span> <span> </span><span class="NLM_article-title">In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.1038/nprot.2007.30</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1038%2Fnprot.2007.30" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=17406593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGntbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=329-333&author=C.+C.+Liangauthor=A.+Y.+Parkauthor=J.+L.+Guan&title=In+vitro+scratch+assay%3A+a+convenient+and+inexpensive+method+for+analysis+of+cell+migration+in+vitro&doi=10.1038%2Fnprot.2007.30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro</span></div><div class="casAuthors">Liang, Chun-Chi; Park, Ann Y.; Guan, Jun-Lin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">329-333</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The in vitro scratch assay is an easy, low-cost and well-developed method to measure cell migration in vitro.  The basic steps involve creating a "scratch" in a cell monolayer, capturing the images at the beginning and at regular intervals during cell migration to close the scratch, and comparing the images to quantify the migration rate of the cells.  Compared to other methods, the in vitro scratch assay is particularly suitable for studies on the effects of cell-matrix and cell-cell interactions on cell migration, mimic cell migration during wound healing in vivo and are compatible with imaging of live cells during migration to monitor intracellular events if desired.  Besides monitoring migration of homogenous cell populations, this method has also been adopted to measure migration of individual cells in the leading edge of the scratch.  Not taking into account the time for transfection of cells, in vitro scratch assay per se usually takes from several hours to overnight.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoteV73OoU6tbVg90H21EOLACvtfcHk0lir9wYpihVGUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGntbvI&md5=50b4a72bac9236e14e81af45b547b4c6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.30&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.30%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DC.%2BC.%26aulast%3DPark%26aufirst%3DA.%2BY.%26aulast%3DGuan%26aufirst%3DJ.%2BL.%26atitle%3DIn%2520vitro%2520scratch%2520assay%253A%2520a%2520convenient%2520and%2520inexpensive%2520method%2520for%2520analysis%2520of%2520cell%2520migration%2520in%2520vitro%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26spage%3D329%26epage%3D333%26doi%3D10.1038%2Fnprot.2007.30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremming, B. A.</span></span> <span> </span><span class="NLM_article-title">Rimonabant--a selective CB1 antagonist</span>. <i>Ann. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">684</span>– <span class="NLM_lpage">690</span>, <span class="refDoi"> DOI: 10.1345/aph.1E499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1345%2Faph.1E499" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2005&pages=684-690&author=S.+T.+Boydauthor=B.+A.+Fremming&title=Rimonabant%2D%2Da+selective+CB1+antagonist&doi=10.1345%2Faph.1E499"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1345%2Faph.1E499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1345%252Faph.1E499%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DS.%2BT.%26aulast%3DFremming%26aufirst%3DB.%2BA.%26atitle%3DRimonabant--a%2520selective%2520CB1%2520antagonist%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2005%26volume%3D39%26spage%3D684%26epage%3D690%26doi%3D10.1345%2Faph.1E499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abadji, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taha, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">(R)-Methanandamide - a Chiral Novel Anandamide Possessing Higher Potency and Metabolic Stability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1889</span>– <span class="NLM_lpage">1893</span>, <span class="refDoi"> DOI: 10.1021/jm00038a020</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00038a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1889-1893&author=V.+Abadjiauthor=S.+Y.+Linauthor=G.+Tahaauthor=G.+Griffinauthor=L.+A.+Stevensonauthor=R.+G.+Pertweeauthor=A.+Makriyannis&title=%28R%29-Methanandamide+-+a+Chiral+Novel+Anandamide+Possessing+Higher+Potency+and+Metabolic+Stability&doi=10.1021%2Fjm00038a020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm00038a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00038a020%26sid%3Dliteratum%253Aachs%26aulast%3DAbadji%26aufirst%3DV.%26aulast%3DLin%26aufirst%3DS.%2BY.%26aulast%3DTaha%26aufirst%3DG.%26aulast%3DGriffin%26aufirst%3DG.%26aulast%3DStevenson%26aufirst%3DL.%2BA.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3D%2528R%2529-Methanandamide%2520-%2520a%2520Chiral%2520Novel%2520Anandamide%2520Possessing%2520Higher%2520Potency%2520and%2520Metabolic%2520Stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1889%26epage%3D1893%26doi%3D10.1021%2Fjm00038a020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jarrahian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgemond, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillard, C. J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships among N-arachidonylethanolamine (anandamide) head group analogues for the anandamide transporter</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">2597</span>– <span class="NLM_lpage">2606</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.2000.0742597.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1046%2Fj.1471-4159.2000.0742597.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10820223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsVKrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=2597-2606&author=A.+Jarrahianauthor=S.+Mannaauthor=W.+S.+Edgemondauthor=W.+B.+Campbellauthor=C.+J.+Hillard&title=Structure-activity+relationships+among+N-arachidonylethanolamine+%28anandamide%29+head+group+analogues+for+the+anandamide+transporter&doi=10.1046%2Fj.1471-4159.2000.0742597.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships among N-arachidonylethanolamine (anandamide) head group analogues for the anandamide transporter</span></div><div class="casAuthors">Jarrahian, Abbas; Manna, Sukumar; Edgemond, William S.; Campbell, William B.; Hillard, Cecilia J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2597-2606</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Two putative endocannabinoids, N-arachidonylethanolamine (AEA) and 2-arachidonylglycerol, are inactivated by removal from the extracellular environment by a process that has the features of protein-mediated facilitated diffusion.  The authors have synthesized and studied 22 N-linked analogs of arachidonylamide for the purpose of increasing the authors understanding of the structural requirements for the binding of ligands to the AEA transporter.  The authors have also detd. the affinities of these analogs for both the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH).  The authors have identified several structural features that enhance binding to the AEA transporter in cerebellar granule cells.  The authors have confirmed the findings of others that replacing the ethanolamine head group with 4-hydroxybenzyl results in a high-affinity ligand for the transporter.  However, the authors find that the same mol. is also a competitive inhibitor of FAAH.  Similarly, replacement of the ethanolamine of AEA with 3-pyridinyl also results in a high-affinity inhibitor of both the transporter and FAAH.  The authors conclude that the structural requirements for ligand binding to the CB1 receptor and binding to the transporter are very different; however, the transporter and FAAH share most, but not all, structural requirements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZV4_lBm_zX7Vg90H21EOLACvtfcHk0lir9wYpihVGUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsVKrsb8%253D&md5=b0af80e16d8dd2dd362b7973a253198c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0742597.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0742597.x%26sid%3Dliteratum%253Aachs%26aulast%3DJarrahian%26aufirst%3DA.%26aulast%3DManna%26aufirst%3DS.%26aulast%3DEdgemond%26aufirst%3DW.%2BS.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26atitle%3DStructure-activity%2520relationships%2520among%2520N-arachidonylethanolamine%2520%2528anandamide%2529%2520head%2520group%2520analogues%2520for%2520the%2520anandamide%2520transporter%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D74%26spage%3D2597%26epage%3D2606%26doi%3D10.1046%2Fj.1471-4159.2000.0742597.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boring, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilken, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantrell, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howlett, A. C.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid Receptor-Binding and Agonist Activity of Amides and Esters of Arachidonic-Acid</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">516</span>– <span class="NLM_lpage">522</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1994&pages=516-522&author=J.+C.+Pintoauthor=F.+Potieauthor=K.+C.+Riceauthor=D.+Boringauthor=M.+R.+Johnsonauthor=D.+M.+Evansauthor=G.+H.+Wilkenauthor=C.+H.+Cantrellauthor=A.+C.+Howlett&title=Cannabinoid+Receptor-Binding+and+Agonist+Activity+of+Amides+and+Esters+of+Arachidonic-Acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPinto%26aufirst%3DJ.%2BC.%26aulast%3DPotie%26aufirst%3DF.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DBoring%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DM.%2BR.%26aulast%3DEvans%26aufirst%3DD.%2BM.%26aulast%3DWilken%26aufirst%3DG.%2BH.%26aulast%3DCantrell%26aufirst%3DC.%2BH.%26aulast%3DHowlett%26aufirst%3DA.%2BC.%26atitle%3DCannabinoid%2520Receptor-Binding%2520and%2520Agonist%2520Activity%2520of%2520Amides%2520and%2520Esters%2520of%2520Arachidonic-Acid%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D46%26spage%3D516%26epage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheskin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanus, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slager, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span> <span> </span><span class="NLM_article-title">Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1021/jm960752x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960752x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=659-667&author=T.+Sheskinauthor=L.+Hanusauthor=J.+Slagerauthor=Z.+Vogelauthor=R.+Mechoulam&title=Structural+requirements+for+binding+of+anandamide-type+compounds+to+the+brain+cannabinoid+receptor&doi=10.1021%2Fjm960752x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm960752x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960752x%26sid%3Dliteratum%253Aachs%26aulast%3DSheskin%26aufirst%3DT.%26aulast%3DHanus%26aufirst%3DL.%26aulast%3DSlager%26aufirst%3DJ.%26aulast%3DVogel%26aufirst%3DZ.%26aulast%3DMechoulam%26aufirst%3DR.%26atitle%3DStructural%2520requirements%2520for%2520binding%2520of%2520anandamide-type%2520compounds%2520to%2520the%2520brain%2520cannabinoid%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D659%26epage%3D667%26doi%3D10.1021%2Fjm960752x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giang, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Molecular characterization of human and mouse fatty acid amide hydrolases</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">2238</span>– <span class="NLM_lpage">2242</span>, <span class="refDoi"> DOI: 10.1073/pnas.94.6.2238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1073%2Fpnas.94.6.2238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=9122178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADyaK2sXhvF2ltLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=2238-2242&author=D.+K.+Giangauthor=B.+F.+Cravatt&title=Molecular+characterization+of+human+and+mouse+fatty+acid+amide+hydrolases&doi=10.1073%2Fpnas.94.6.2238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization of human and mouse fatty acid amide hydrolases</span></div><div class="casAuthors">Giang, Dan K.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2238-2242</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Recently, we reported the isolation, cloning, and expression of a rat enzyme, fatty acid amide hydrolase (FAAH), that degrades bioactive fatty acid amides like oleamide and anandamide to their corresponding acids, thereby serving to terminate the signaling functions of these mols.  Here, we report the mol. characterization of both a mouse and a human FAAH and compare these enzymes to the rat FAAH.  The enzymes are well conserved in primary structure, with the mouse and rat FAAHs sharing 91% amino acid identity and the human FAAH sharing 82% and 84% identity with the rat FAAH and mouse FAAH, resp.  In addn., the expressed human and rat FAAHs behave biochem. as membrane proteins of comparable mol. size and show similar, but distinguishable, enzymol. properties.  The identification of highly homologous FAAH proteins in rat, mouse, and human supports a general role for the fatty acid amides in mammalian biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU0clJ7pptNLVg90H21EOLACvtfcHk0liw6AICgX3Bag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvF2ltLY%253D&md5=67e8a8f29d8cd60f0ff2510f80fa04d0</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.6.2238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.6.2238%26sid%3Dliteratum%253Aachs%26aulast%3DGiang%26aufirst%3DD.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DMolecular%2520characterization%2520of%2520human%2520and%2520mouse%2520fatty%2520acid%2520amide%2520hydrolases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26spage%3D2238%26epage%3D2242%26doi%3D10.1073%2Fpnas.94.6.2238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goparaju, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span> <span> </span><span class="NLM_article-title">Anandamide amidohydrolase of porcine brain: cDNA cloning, functional expression and site-directed mutagenesis</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>1441</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1016/S1388-1981(99)00143-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2FS1388-1981%2899%2900143-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10526230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADyaK1MXntVGks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1441&publication_year=1999&pages=77-84&author=S.+K.+Goparajuauthor=Y.+Kurahashiauthor=H.+Suzukiauthor=N.+Uedaauthor=S.+Yamamoto&title=Anandamide+amidohydrolase+of+porcine+brain%3A+cDNA+cloning%2C+functional+expression+and+site-directed+mutagenesis&doi=10.1016%2FS1388-1981%2899%2900143-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Anandamide amidohydrolase of porcine brain: cDNA cloning, functional expression and site-directed mutagenesis</span></div><div class="casAuthors">Goparaju, S. K.; Kurahashi, Y.; Suzuki, H.; Ueda, N.; Yamamoto, S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1441</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-84</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Anandamide (arachidonoylethanolamide) is an endogenous ligand for cannabinoid receptors, and its cannabimimetic activities are lost when the compd. is hydrolyzed to arachidonic acid and ethanolamine by an enzyme referred to as anandamide amidohydrolase.  We cloned a cDNA for the enzyme of porcine brain, and the cDNA encoded a protein of 579 amino acids with a mol. mass of 62.9 kDa.  The amino acid sequence was 81, 80 and 85% identical with the enzymes previously cloned from the liver of rat, mouse, and human, resp.  When the enzyme protein was overexpressed in COS-7 cells, the particulate fraction of the cells showed an anandamide hydrolyzing activity and also catalyzed the reverse reaction synthesizing anandamide from arachidonic acid and ethanolamine both with a specific activity of 0.2-0.3 μmol/min/mg protein at 37°.  The brain enzyme exhibited a wide substrate specificity hydrolyzing oleamide, 2-arachidonoylglycerol, and Me arachidonate.  The point mutation of Ser-217, Asp-237, Ser-241, or Cys-249 completely abolished the hydrolysis of all the above-mentioned substrates as well as the synthesis of anandamide in the reverse reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2l38CHaxXDLVg90H21EOLACvtfcHk0liw6AICgX3Bag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntVGks7g%253D&md5=5650ac3b562741896a0e532a7ad9061f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS1388-1981%2899%2900143-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1388-1981%252899%252900143-2%26sid%3Dliteratum%253Aachs%26aulast%3DGoparaju%26aufirst%3DS.%2BK.%26aulast%3DKurahashi%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DAnandamide%2520amidohydrolase%2520of%2520porcine%2520brain%253A%2520cDNA%2520cloning%252C%2520functional%2520expression%2520and%2520site-directed%2520mutagenesis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D1999%26volume%3D1441%26spage%3D77%26epage%3D84%26doi%3D10.1016%2FS1388-1981%2899%2900143-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hillard, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkison, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgemond, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span> <span> </span><span class="NLM_article-title">Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain</span>. <i>Biochim. Biophys. Acta, Lipids Lipid Metab.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>1257</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1016/0005-2760(95)00087-S</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1016%2F0005-2760%2895%2900087-S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=7647100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADyaK2MXntl2jtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1257&publication_year=1995&pages=249-256&author=C.+J.+Hillardauthor=D.+M.+Wilkisonauthor=W.+S.+Edgemondauthor=W.+B.+Campbell&title=Characterization+of+the+kinetics+and+distribution+of+N-arachidonylethanolamine+%28anandamide%29+hydrolysis+by+rat+brain&doi=10.1016%2F0005-2760%2895%2900087-S"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain</span></div><div class="casAuthors">Hillard, Cecilia J.; Wilkison, Douglas M.; Edgemond, William S.; Campbell, William B.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Lipids and Lipid Metabolism</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1257</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-56</span>CODEN:
                <span class="NLM_cas:coden">BBLLA6</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Arachidonoylethanolamide or anandamide is a naturally occurring deriv. of arachidonic acid that has been shown to activate cannabinoid receptors in the brain.  Its metabolic inactivation by brain tissue has been investigated.  Anandamide is hydrolyzed by the membrane fraction of rat brain homogenate to arachidonic acid and ethanolamine.  The hydrolysis is temp.- and pH-dependent (pH max. at 8.5) and abolished by boiling.  Anandamide hydrolysis is protein dependent in the range of 25-100 μg protein/mL; does not require calcium and is inhibited by phenylmethylsulfonylfluoride, diisopropylfluorophosphate, thimerosal and arachidonic acid.  Hydrolysis of 10 μM anandamide by brain membranes follows first order kinetics; at 30°, the rate const. for anandamide catabolism is 0.34 min-1 mg protein-1.  The Km for anandamide hydrolysis is 3.4 μM, and the Vmax is 2.2 nmol/min per mg protein.  Hydrolysis occurs in all subcellular fractions except cytosol with the highest specific activity in myelin and microsomes.  The distribution of anandamide hydrolytic activity correlates with the distribution of cannabinoid receptor-binding sites; the hippocampus, cerebellum and cerebral cortex exhibit the highest metabolic activity, while activity is lowest in the striatum, brain stem and white matter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_wuU3uI6dDLVg90H21EOLACvtfcHk0lhGIpNz1SAilQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntl2jtbo%253D&md5=94968f21405527d140e7c51ee6b265db</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2F0005-2760%2895%2900087-S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2760%252895%252900087-S%26sid%3Dliteratum%253Aachs%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26aulast%3DWilkison%26aufirst%3DD.%2BM.%26aulast%3DEdgemond%26aufirst%3DW.%2BS.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26atitle%3DCharacterization%2520of%2520the%2520kinetics%2520and%2520distribution%2520of%2520N-arachidonylethanolamine%2520%2528anandamide%2529%2520hydrolysis%2520by%2520rat%2520brain%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Lipids%2520Lipid%2520Metab.%26date%3D1995%26volume%3D1257%26spage%3D249%26epage%3D256%26doi%3D10.1016%2F0005-2760%2895%2900087-S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojiro, M.</span></span> <span> </span><span class="NLM_article-title">Angiogenesis in cancer</span>. <i>Vasc Health Risk Manag</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.2147/vhrm.2006.2.3.213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.2147%2Fvhrm.2006.2.3.213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=17326328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlars77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=213-219&author=N.+Nishidaauthor=H.+Yanoauthor=T.+Nishidaauthor=T.+Kamuraauthor=M.+Kojiro&title=Angiogenesis+in+cancer&doi=10.2147%2Fvhrm.2006.2.3.213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis in cancer</span></div><div class="casAuthors">Nishida, Naoyo; Yano, Hirohisa; Nishida, Takashi; Kamura, Toshiharu; Kojiro, Masamichi</div><div class="citationInfo"><span class="NLM_cas:title">Vascular Health and Risk Management</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">213-219</span>CODEN:
                <span class="NLM_cas:coden">VHRMAT</span>;
        ISSN:<span class="NLM_cas:issn">1176-6344</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  New growth in the vascular network is important since the proliferation, as well as metastatic spread, of cancer cells depends on an adequate supply of oxygen and nutrients and the removal of waste products.  New blood and lymphatic vessels form through processes called angiogenesis and lymphangiogenesis, resp.  Angiogenesis is regulated by both activator and inhibitor mols.  More than a dozen different proteins have been identified as angiogenic activators and inhibitors.  Levels of expression of angiogenic factors reflect the aggressiveness of tumor cells.  The discovery of angiogenic inhibitors should help to reduce both morbidity and mortality from carcinomas.  Thousands of patients have received antiangiogenic therapy to date.  Despite their theor. efficacy, antiangiogenic treatments have not proved beneficial in terms of long-term survival.  There is an urgent need for a new comprehensive treatment strategy combining antiangiogenic agents with conventional cytoreductive treatments in the control of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCfY5hNg-E-LVg90H21EOLACvtfcHk0lgUDVnTP21sPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlars77L&md5=a63173b323051565266457ca6dcdb242</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.2147%2Fvhrm.2006.2.3.213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252Fvhrm.2006.2.3.213%26sid%3Dliteratum%253Aachs%26aulast%3DNishida%26aufirst%3DN.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DNishida%26aufirst%3DT.%26aulast%3DKamura%26aufirst%3DT.%26aulast%3DKojiro%26aufirst%3DM.%26atitle%3DAngiogenesis%2520in%2520cancer%26jtitle%3DVasc%2520Health%2520Risk%2520Manag%26date%3D2006%26volume%3D2%26spage%3D213%26epage%3D219%26doi%3D10.2147%2Fvhrm.2006.2.3.213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnaoutova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinman, H. K.</span></span> <span> </span><span class="NLM_article-title">In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">628</span>– <span class="NLM_lpage">635</span>, <span class="refDoi"> DOI: 10.1038/nprot.2010.6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1038%2Fnprot.2010.6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=20224563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFSmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=628-635&author=I.+Arnaoutovaauthor=H.+K.+Kleinman&title=In+vitro+angiogenesis%3A+endothelial+cell+tube+formation+on+gelled+basement+membrane+extract&doi=10.1038%2Fnprot.2010.6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract</span></div><div class="casAuthors">Arnaoutova, Irina; Kleinman, Hynda K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">628-635</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A protocol is presented here for a rapid, quant. and reliable in vitro angiogenesis assay that can be adapted for high throughput use.  Endothelial cells are plated on a gelled basement matrix, their natural substrate, and form capillary-like structures with a lumen.  The assay can be used to identify inhibitors or stimulators of angiogenesis, as well as genes and signaling pathways involved in angiogenesis.  It has also been used to identify endothelial progenitor cells.  This assay involves endothelial cell adhesion, migration, protease activity and tubule formation.  This tube formation assay is preferred, as other in vitro assays for angiogenesis, such as cell adhesion, migration and invasion, measure limited steps in the angiogenesis process.  The tube formation assay on basement membrane can be completed in a day because transformed endothelial cells form tubes within 3 h, whereas non-transformed endothelial cells form tubes within 6 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx_ALsj20lJ7Vg90H21EOLACvtfcHk0lgUDVnTP21sPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFSmu74%253D&md5=21e5194645ac4076227b687341b19a3b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2010.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2010.6%26sid%3Dliteratum%253Aachs%26aulast%3DArnaoutova%26aufirst%3DI.%26aulast%3DKleinman%26aufirst%3DH.%2BK.%26atitle%3DIn%2520vitro%2520angiogenesis%253A%2520endothelial%2520cell%2520tube%2520formation%2520on%2520gelled%2520basement%2520membrane%2520extract%26jtitle%3DNat.%2520Protoc.%26date%3D2010%26volume%3D5%26spage%3D628%26epage%3D635%26doi%3D10.1038%2Fnprot.2010.6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganju, R. K.</span></span> <span> </span><span class="NLM_article-title">Cannabinoids as therapeutic agents in cancer: current status and future implications</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">5852</span>– <span class="NLM_lpage">5872</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2233</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.18632%2Foncotarget.2233" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=25115386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252Fht1SgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=5852-5872&author=B.+Chakravartiauthor=J.+Raviauthor=R.+K.+Ganju&title=Cannabinoids+as+therapeutic+agents+in+cancer%3A+current+status+and+future+implications&doi=10.18632%2Foncotarget.2233"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoids as therapeutic agents in cancer: current status and future implications</span></div><div class="casAuthors">Chakravarti Bandana; Ravi Janani; Ganju Ramesh K</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5852-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The pharmacological importance of cannabinoids has been in study for several years.  Cannabinoids comprise of (a) the active compounds of the Cannabis sativa plant, (b) endogenous as well as (c) synthetic cannabinoids.  Though cannabinoids are clinically used for anti-palliative effects, recent studies open a promising possibility as anti-cancer agents.  They have been shown to possess anti-proliferative and anti-angiogenic effects in vitro as well as in vivo in different cancer models.  Cannabinoids regulate key cell signaling pathways that are involved in cell survival, invasion, angiogenesis, metastasis, etc.  There is more focus on CB1 and CB2, the two cannabinoid receptors which are activated by most of the cannabinoids.  In this review article, we will focus on a broad range of cannabinoids, their receptor dependent and receptor independent functional roles against various cancer types with respect to growth, metastasis, energy metabolism, immune environment, stemness and future perspectives in exploring new possible therapeutic opportunities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI4t9ZrFEBIXy-c-E1v-fmfW6udTcc2eYzCvVCT_E647ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252Fht1SgtA%253D%253D&md5=a7337b09f46c5df725ab7ce07fd5fee5</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2233%26sid%3Dliteratum%253Aachs%26aulast%3DChakravarti%26aufirst%3DB.%26aulast%3DRavi%26aufirst%3DJ.%26aulast%3DGanju%26aufirst%3DR.%2BK.%26atitle%3DCannabinoids%2520as%2520therapeutic%2520agents%2520in%2520cancer%253A%2520current%2520status%2520and%2520future%2520implications%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D5852%26epage%3D5872%26doi%3D10.18632%2Foncotarget.2233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroeze, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguere, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciaky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">PRESTO–Tango as an open-source resource for interrogation of the druggable human GPCRome</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1038/nsmb.3014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1038%2Fnsmb.3014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=25895059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslOgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=362-369&author=W.+K.+Kroezeauthor=M.+F.+Sassanoauthor=X.+P.+Huangauthor=K.+Lansuauthor=J.+D.+McCorvyauthor=P.+M.+Giguereauthor=N.+Sciakyauthor=B.+L.+Roth&title=PRESTO%E2%80%93Tango+as+an+open-source+resource+for+interrogation+of+the+druggable+human+GPCRome&doi=10.1038%2Fnsmb.3014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome</span></div><div class="casAuthors">Kroeze, Wesley K.; Sassano, Maria F.; Huang, Xi-Ping; Lansu, Katherine; McCorvy, John D.; Giguere, Patrick M.; Sciaky, Noah; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">362-369</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) are essential mediators of cellular signaling and are important targets of drug action.  Of the approx. 350 nonolfactory human GPCRs, more than 100 are still considered to be 'orphans' because their endogenous ligands remain unknown.  Here, we describe a unique open-source resource that allows interrogation of the druggable human GPCRome via a G protein-independent β-arrestin-recruitment assay.  We validate this unique platform at more than 120 nonorphan human GPCR targets, demonstrate its utility for discovering new ligands for orphan human GPCRs and describe a method (parallel receptorome expression and screening via transcriptional output, with transcriptional activation following arrestin translocation (PRESTO-Tango)) for the simultaneous and parallel interrogation of the entire human nonolfactory GPCRome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVbl7caV9gUrVg90H21EOLACvtfcHk0ljT2BKGf1cckQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslOgtLg%253D&md5=2a78b74a5f1425fa9e8b79b730c16be6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3014%26sid%3Dliteratum%253Aachs%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DLansu%26aufirst%3DK.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DGiguere%26aufirst%3DP.%2BM.%26aulast%3DSciaky%26aufirst%3DN.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DPRESTO%25E2%2580%2593Tango%2520as%2520an%2520open-source%2520resource%2520for%2520interrogation%2520of%2520the%2520druggable%2520human%2520GPCRome%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D362%26epage%3D369%26doi%3D10.1038%2Fnsmb.3014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otero, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. A.</span></span> <span> </span><span class="NLM_article-title">Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">12328</span>– <span class="NLM_lpage">12338</span>, <span class="refDoi"> DOI: 10.1074/jbc.M806516200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1074%2Fjbc.M806516200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=19286662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVClsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=12328-12338&author=H.+Yinauthor=A.+Chuauthor=W.+Liauthor=B.+Wangauthor=F.+Sheltonauthor=F.+Oteroauthor=D.+G.+Nguyenauthor=J.+S.+Caldwellauthor=Y.+A.+Chen&title=Lipid+G+protein-coupled+receptor+ligand+identification+using+beta-arrestin+PathHunter+assay&doi=10.1074%2Fjbc.M806516200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter Assay</span></div><div class="casAuthors">Yin, Hong; Chu, Alan; Li, Wei; Wang, Bin; Shelton, Fabiola; Otero, Francella; Nguyen, Deborah G.; Caldwell, Jeremy S.; Chen, Yu Alice</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">12328-12338</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A growing no. of orphan G-protein-coupled receptors (GPCRs) have been reported to be activated by lipid ligands, such as lysophosphatidic acid, sphingosine 1-phosphate (S1P), and cannabinoids, for which there are already well established receptors.  These new ligand claims are controversial due to either lack of independent confirmations or conflicting reports.  We used the β-arrestin PathHunter assay system, a newly developed, generic GPCR assay format that measures β-arrestin binding to GPCRs, to evaluate lipid receptor and ligand pairing.  This assay eliminates interference from endogenous receptors on the parental cells because it measures a signal that is specifically generated by the tagged receptor and is immediately downstream of receptor activation.  We screened a large no. of newly "deorphaned" receptors (GPR23, GPR92, GPR55, G2A, GPR18, GPR3, GPR6, GPR12, and GPR63) and control receptors against a collection of ∼400 lipid mols. to try to identify the receptor ligand in an unbiased fashion.  GPR92 was confirmed to be a lysophosphatidic acid receptor with weaker responses to farnesyl pyrophosphate and geranylgeranyl diphosphate.  The putative cannabinoid receptor GPR55 responded strongly to AM251, rimonabant, and lysophosphatidylinositol but only very weakly to endocannabinoids.  G2A receptor was confirmed to be an oxidized free fatty acid receptor.  In addn., we discovered that 3,3'-diindolylmethane, a dietary mol. from cruciferous vegetables, which has known anti-cancer properties, to be a CB2 receptor partial agonist, with binding affinity around 1 μM.  The anti-inflammatory effect of 3,3'-diindolylmethane in RAW264.7 cells was shown to be partially mediated by CB2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQnRS1OGXeVrVg90H21EOLACvtfcHk0ljT2BKGf1cckQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVClsrw%253D&md5=beb6f1fe11d9dab29329d2a2a85ab051</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M806516200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M806516200%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DH.%26aulast%3DChu%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DShelton%26aufirst%3DF.%26aulast%3DOtero%26aufirst%3DF.%26aulast%3DNguyen%26aufirst%3DD.%2BG.%26aulast%3DCaldwell%26aufirst%3DJ.%2BS.%26aulast%3DChen%26aufirst%3DY.%2BA.%26atitle%3DLipid%2520G%2520protein-coupled%2520receptor%2520ligand%2520identification%2520using%2520beta-arrestin%2520PathHunter%2520assay%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D12328%26epage%3D12338%26doi%3D10.1074%2Fjbc.M806516200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Resolution of Cancer-Promoting Inflammation: A New Approach for Anticancer Therapy</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">71</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2017.00071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.3389%2Ffimmu.2017.00071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=28210259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtl2rsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=71&author=Q.+Zhangauthor=B.+Zhuauthor=Y.+Li&title=Resolution+of+Cancer-Promoting+Inflammation%3A+A+New+Approach+for+Anticancer+Therapy&doi=10.3389%2Ffimmu.2017.00071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Resolution of cancer-promoting inflammation: a new approach for anticancer therapy</span></div><div class="casAuthors">Zhang, Qi; Zhu, Bo; Li, Yongsheng</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">71/1-71/11</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Inflammation is a protective response that eliminates harmful stimuli and restores tissue homeostasis, whereas the failure to resolve inflammation leads to the development of malignancies.  Immune cells in the tumor inflammatory microenvironment endow cancer cells with their specific hallmarks, including mutations, metabolic reprograming, angiogenesis, invasion, and metastasis.  Targeting the inflammatory microenvironment with anti-inflammatory drugs (e.g., aspirin) or by enhancing antitumor immunity (e.g., chimeric antigen receptor T cell therapy) has been extensively investigated and has achieved promising results in many cancers.  Recently, a novel approach promoting antitumor immunity via a dual anti-inflammatory and pro-resolving strategy was proposed based on the discovery of potent, endogenous, specialized pro-resolving mediators, including lipoxins, resolvins, protectins, and maresins.  In this review, we describe the updated principal cellular and mol. mechanisms of inflammation resoln. and cancer immunity and discuss the pro-resoln. strategy in cancer treatment and prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH3pL0BUgEYbVg90H21EOLACvtfcHk0ljT2BKGf1cckQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtl2rsr0%253D&md5=253d01cbfe31b2f5e0cf0dc62c80488c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2017.00071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2017.00071%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DResolution%2520of%2520Cancer-Promoting%2520Inflammation%253A%2520A%2520New%2520Approach%2520for%2520Anticancer%2520Therapy%26jtitle%3DFront.%2520Immunol.%26date%3D2017%26volume%3D8%26spage%3D71%26doi%3D10.3389%2Ffimmu.2017.00071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cianchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiavone, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lulli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinci, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messerini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manera, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronconi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perigli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trallori, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanganelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capaccioli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masini, E.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor alpha - Mediated Ceramide De novo Synthesis in Colon Cancer Cells</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">7691</span>– <span class="NLM_lpage">7700</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-08-0799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1158%2F1078-0432.CCR-08-0799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=19047095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVegtrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=7691-7700&author=F.+Cianchiauthor=L.+Papucciauthor=N.+Schiavoneauthor=M.+Lulliauthor=L.+Magnelliauthor=M.+C.+Vinciauthor=L.+Messeriniauthor=C.+Maneraauthor=E.+Ronconiauthor=P.+Romagnaniauthor=M.+Donniniauthor=G.+Perigliauthor=G.+Tralloriauthor=E.+Tanganelliauthor=S.+Capaccioliauthor=E.+Masini&title=Cannabinoid+Receptor+Activation+Induces+Apoptosis+through+Tumor+Necrosis+Factor+alpha+-+Mediated+Ceramide+De+novo+Synthesis+in+Colon+Cancer+Cells&doi=10.1158%2F1078-0432.CCR-08-0799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor α-Mediated Ceramide De novo Synthesis in Colon Cancer Cells</span></div><div class="casAuthors">Cianchi, Fabio; Papucci, Laura; Schiavone, Nicola; Lulli, Matteo; Magnelli, Lucia; Vinci, Maria Cristina; Messerini, Luca; Manera, Clementina; Ronconi, Elisa; Romagnani, Paola; Donnini, Martino; Perigli, Giuliano; Trallori, Giacomo; Tanganelli, Elisabetta; Capaccioli, Sergio; Masini, Emanuela</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7691-7700</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Cannabinoids have been recently proposed as a new family of potential antitumor agents.  The present study was undertaken to investigate the expression of the two cannabinoid receptors, CB1 and CB2, in colorectal cancer and to provide new insight into the mol. pathways underlying the apoptotic activity induced by their activation.  Exptl. Design: Cannabinoid receptor expression was investigated in both human cancer specimens and in the DLD-1 and HT29 colon cancer cell lines.  The effects of the CB1 agonist arachinodyl-2'-chloroethylamide and the CB2 agonist N-cyclopentyl-7-methyl-1-(2-morpholin-4-ylethyl)-1,8-naphthyridin-4(1H)-on-3-carboxamide (CB13) on tumor cell apoptosis and ceramide and tumor necrosis factor (TNF)-α prodn. were evaluated.  The knockdown of TNF-α mRNA was obtained with the use of selective small interfering RNA.  RESULTS: We show that the CB1 receptor was mainly expressed in human normal colonic epithelium whereas tumor tissue was strongly pos. for the CB2 receptor.  The activation of the CB1 and, more efficiently, of the CB2 receptors induced apoptosis and increased ceramide levels in the DLD-1 and HT29 cells.  Apoptosis was prevented by the pharmacol. inhibition of ceramide de novo synthesis.  The CB2 agonist CB13 also reduced the growth of DLD-1 cells in a mouse model of colon cancer.  The knockdown of TNF-α mRNA abrogated the ceramide increase and, therefore, the apoptotic effect induced by cannabinoid receptor activation.  CONCLUSIONS: The present study shows that either CB1 or CB2 receptor activation induces apoptosis through ceramide de novo synthesis in colon cancer cells.  Our data unveiled, for the first time, that TNF-α acts as a link between cannabinoid receptor activation and ceramide prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG5XJOnQBRA7Vg90H21EOLACvtfcHk0lhtC2Yenc7aeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVegtrbP&md5=351dcff2b2b2a80adc8c14f2c79cb8d7</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0799%26sid%3Dliteratum%253Aachs%26aulast%3DCianchi%26aufirst%3DF.%26aulast%3DPapucci%26aufirst%3DL.%26aulast%3DSchiavone%26aufirst%3DN.%26aulast%3DLulli%26aufirst%3DM.%26aulast%3DMagnelli%26aufirst%3DL.%26aulast%3DVinci%26aufirst%3DM.%2BC.%26aulast%3DMesserini%26aufirst%3DL.%26aulast%3DManera%26aufirst%3DC.%26aulast%3DRonconi%26aufirst%3DE.%26aulast%3DRomagnani%26aufirst%3DP.%26aulast%3DDonnini%26aufirst%3DM.%26aulast%3DPerigli%26aufirst%3DG.%26aulast%3DTrallori%26aufirst%3DG.%26aulast%3DTanganelli%26aufirst%3DE.%26aulast%3DCapaccioli%26aufirst%3DS.%26aulast%3DMasini%26aufirst%3DE.%26atitle%3DCannabinoid%2520Receptor%2520Activation%2520Induces%2520Apoptosis%2520through%2520Tumor%2520Necrosis%2520Factor%2520alpha%2520-%2520Mediated%2520Ceramide%2520De%2520novo%2520Synthesis%2520in%2520Colon%2520Cancer%2520Cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D7691%26epage%3D7700%26doi%3D10.1158%2F1078-0432.CCR-08-0799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, M.</span></span> <span> </span><span class="NLM_article-title">CB1 cannabinoid receptor-mediated cell migration</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">209</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10871313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksFyhtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2000&pages=204-209&author=Z.+H.+Songauthor=M.+Zhong&title=CB1+cannabinoid+receptor-mediated+cell+migration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">CB1 cannabinoid receptor-mediated cell migration</span></div><div class="casAuthors">Song, Zhao-Hui; Zhong, Miao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">204-209</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Recent studies have suggested that cell migratory responses are often mediated by Gi protein-coupled receptors.  Because it is known that CB1 cannabinoid receptors are coupled to pertussis toxin-sensitive G proteins, we proposed that CB1 may mediate cell migration.  To test this hypothesis, modified Boyden chamber assays were used to investigate cell migration mediated by CB1 cannabinoid receptors.  HU-210, WIN55212-2, and anandamide, three cannabinoid agonists with distinct chem. structures, induced migration of human embryonic kidney 293 cells stably transfected with human CB1 gene, but not 293 cells transfected with an empty expression vector.  These migratory responses were concn.-dependent.  The EC50 values for HU-210, WIN55212-2, and anandamide were 0.19 ± 0.04, 12.2 ± 1.4, and 39.9 ± 3.7 nM, resp.  The maximal migration index for HU-210, WIN55212-2, and anandamide were 8.9 ± 1.6, 9.5 ± 1.6, and 8.8 ± 1.3, resp.  Pretreating cells with 100 ng/mL pertussis toxin eliminated the cannabinoid agonist-induced cell migration.  SR141716A, a selective antagonist for CB1, inhibited the cannabinoid agonist-induced migratory responses in a concn.-dependent manner.  Checkerboard anal. demonstrated that anandamide-induced cell migrations are due to chemotaxis as well as chemokinesis.  Furthermore, anandamide-induced migratory responses were inhibited, in a concn.-dependent manner, by PD098059, an inhibitor of mitogen-activated protein kinase activation, but not by 8-bromoadenosine-3',5'-cyclic monophosphate, a cell-permeable cAMP analog.  These data demonstrate that cannabinoid agonists are able to induce chemotaxis and chemokinesis, and that these migratory responses are mediated by G protein-coupled, CB1 cannabinoid receptors.  In addn., these data suggest that activation of mitogen-activated protein kinase plays an important role, whereas inhibition of adenylate cyclase is probably not involved in the cell migration mediated by CB1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7TiCPM3q9GLVg90H21EOLACvtfcHk0lhtC2Yenc7aeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksFyhtLc%253D&md5=c476acc0e2d1ec323526a4df5f2a5dc0</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DZ.%2BH.%26aulast%3DZhong%26aufirst%3DM.%26atitle%3DCB1%2520cannabinoid%2520receptor-mediated%2520cell%2520migration%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D294%26spage%3D204%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Petrocellis, L.</span></span> <span> </span><span class="NLM_article-title">Why do cannabinoid receptors have more than one endogenous ligand?</span>. <i>Philos. Trans. R. Soc., B</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>367</i></span>,  <span class="NLM_fpage">3216</span>– <span class="NLM_lpage">3228</span>, <span class="refDoi"> DOI: 10.1098/rstb.2011.0382</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1098%2Frstb.2011.0382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=23108541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKgtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=3216-3228&author=V.+Di%0AMarzoauthor=L.+De+Petrocellis&title=Why+do+cannabinoid+receptors+have+more+than+one+endogenous+ligand%3F&doi=10.1098%2Frstb.2011.0382"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Why do cannabinoid receptors have more than one endogenous ligand?</span></div><div class="casAuthors">Di Marzo, Vincenzo; De Petrocellis, Luciano</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical Transactions of the Royal Society, B: Biological Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">1607</span>),
    <span class="NLM_cas:pages">3216-3228</span>CODEN:
                <span class="NLM_cas:coden">PTRBAE</span>;
        ISSN:<span class="NLM_cas:issn">0962-8436</span>.
    
            (<span class="NLM_cas:orgname">Royal Society</span>)
        </div><div class="casAbstract">A review.  The endocannabinoid system was revealed following the understanding of the mechanism of action of marijuana's major psychotropic principle, Δ9-tetrahydrocannabinol, and includes two G-protein-coupled receptors (GPCRs; the cannabinoid CB1 and CB2 receptors), their endogenous ligands (the endocannabinoids, the best studied of which are anandamide and 2-arachidonoylglycerol (2-AG)), and the proteins that regulate the levels and activity of these receptors and ligands.  However, other minor lipid metabolites different from, but chem. similar to, anandamide and 2-AG have also been suggested to act as endocannabinoids.  Thus, unlike most other GPCRs, cannabinoid receptors appear to have more than one endogenous agonist, and it has been often wondered what could be the physiol. meaning of this peculiarity.  In 1999, it was proposed that anandamide might also activate other targets, and in particular the transient receptor potential of vanilloid type-1 (TRPV1) channels.  Over the last decade, this interaction has been shown to occur both in peripheral tissues and brain, during both physiol. and pathol. conditions.  TRPV1 channels can be activated also by another less abundant endocannabinoid, N-arachidonoyldopamine, but not by 2-AG, and have been proposed by some authors to act as ionotropic endocannabinoid receptors.  This article will discuss the latest discoveries on this subject, and discuss, among others, how anandamide and 2-AG differential actions at TRPV1 and cannabinoid receptors contribute to making this signalling system a versatile tool available to organisms to fine-tune homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNDo9Kc33Z6LVg90H21EOLACvtfcHk0lhtC2Yenc7aeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKgtLzK&md5=28a548889dd30baaccf27d66a371d43c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1098%2Frstb.2011.0382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2011.0382%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26atitle%3DWhy%2520do%2520cannabinoid%2520receptors%2520have%2520more%2520than%2520one%2520endogenous%2520ligand%253F%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%252C%2520B%26date%3D2012%26volume%3D367%26spage%3D3216%26epage%3D3228%26doi%3D10.1098%2Frstb.2011.0382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigrahy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahakian, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettersten, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingham, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieran, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">11127</span>– <span class="NLM_lpage">11132</span>, <span class="refDoi"> DOI: 10.1073/pnas.1410432111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.1073%2Fpnas.1410432111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=25024195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyqtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=11127-11132&author=G.+Zhangauthor=D.+Panigrahyauthor=S.+H.+Hwangauthor=J.+Yangauthor=L.+M.+Mahakianauthor=H.+I.+Wetterstenauthor=J.+Y.+Liuauthor=Y.+Wangauthor=E.+S.+Inghamauthor=S.+Tamauthor=M.+W.+Kieranauthor=R.+H.+Weissauthor=K.+W.+Ferraraauthor=B.+D.+Hammock&title=Dual+inhibition+of+cyclooxygenase-2+and+soluble+epoxide+hydrolase+synergistically+suppresses+primary+tumor+growth+and+metastasis&doi=10.1073%2Fpnas.1410432111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis</span></div><div class="casAuthors">Zhang, Guodong; Panigrahy, Dipak; Hwang, Sung Hee; Yang, Jun; Mahakian, Lisa M.; Wettersten, Hiromi I.; Liu, Jun-Yan; Wang, Yanru; Ingham, Elizabeth S.; Tam, Sarah; Kieran, Mark W.; Weiss, Robert H.; Ferrara, Katherine W.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">11127-11132</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Prostaglandins derived from the cyclooxygenase (COX) pathway and epoxyeicosatrienoic acids (EETs) from the cytochrome P 450/sol. epoxide hydrolase (sEH) pathway are important eicosanoids that regulate angiogenesis and tumorigenesis.  COX-2 inhibitors, which block the formation of prostaglandins, suppress tumor growth, whereas sEH inhibitors, which increase endogenous EETs, stimulate primary tumor growth and metastasis.  However, the functional interactions of these two pathways in cancer are unknown.  Using pharmacol. inhibitors as probes, we show here that dual inhibition of COX-2 and sEH synergistically inhibits primary tumor growth and metastasis by suppressing tumor angiogenesis.  COX-2/sEH dual pharmacol. inhibitors also potently suppress primary tumor growth and metastasis by inhibiting tumor angiogenesis via selective inhibition of endothelial cell proliferation.  These results demonstrate a crit. interaction of these two lipid metab. pathways on tumorigenesis and suggest dual inhibition of COX-2 and sEH as a potential therapeutic strategy for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq96zPXS3W5_LVg90H21EOLACvtfcHk0lhtC2Yenc7aeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyqtb3J&md5=928fc9973909898ae94dbf2f3e087677</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1410432111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1410432111%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DPanigrahy%26aufirst%3DD.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMahakian%26aufirst%3DL.%2BM.%26aulast%3DWettersten%26aufirst%3DH.%2BI.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DIngham%26aufirst%3DE.%2BS.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DKieran%26aufirst%3DM.%2BW.%26aulast%3DWeiss%26aufirst%3DR.%2BH.%26aulast%3DFerrara%26aufirst%3DK.%2BW.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DDual%2520inhibition%2520of%2520cyclooxygenase-2%2520and%2520soluble%2520epoxide%2520hydrolase%2520synergistically%2520suppresses%2520primary%2520tumor%2520growth%2520and%2520metastasis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D11127%26epage%3D11132%26doi%3D10.1073%2Fpnas.1410432111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dithmer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merkord, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, B.</span></span> <span> </span><span class="NLM_article-title">Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">15047</span>– <span class="NLM_lpage">15064</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.7592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;key=10.18632%2Foncotarget.7592" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=15047-15064&author=K.+Winklerauthor=R.+Ramerauthor=S.+Dithmerauthor=I.+Ivanovauthor=J.+Merkordauthor=B.+Hinz&title=Fatty+acid+amide+hydrolase+inhibitors+confer+anti-invasive+and+antimetastatic+effects+on+lung+cancer+cells&doi=10.18632%2Foncotarget.7592"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7592%26sid%3Dliteratum%253Aachs%26aulast%3DWinkler%26aufirst%3DK.%26aulast%3DRamer%26aufirst%3DR.%26aulast%3DDithmer%26aufirst%3DS.%26aulast%3DIvanov%26aufirst%3DI.%26aulast%3DMerkord%26aufirst%3DJ.%26aulast%3DHinz%26aufirst%3DB.%26atitle%3DFatty%2520acid%2520amide%2520hydrolase%2520inhibitors%2520confer%2520anti-invasive%2520and%2520antimetastatic%2520effects%2520on%2520lung%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D15047%26epage%3D15064%26doi%3D10.18632%2Foncotarget.7592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i39"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00243">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_33380"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00243">10.1021/acs.jmedchem.8b00243</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Endocannabinoid fold change in normal versus metastatic lungs; full-range CTB assay; apoptosis assay with parent fatty acids, 7,8-EDP-EA, 10,11-EDP-EA, and 13,14-EDP-EA in the presence of CB1 and CB2 inhibitors in all three cell lines; scratch assay in 143B cells; CTB assay with HUVEC cells; qRT-PCR for CB1 and CB2; NMR spectra of 10,11-EDP-NA, 10,11-EDP-IA, and 10,11-EDP-CA; scratch assay of 10,11-EDP-CA in 143B cells with CB1 and CB2 antagonists; and angiogenesis assay with 10,11-EDP-EA and its analogues in HUVEC cells (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES strings and the corresponding biological data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_002.csv">CSV</a>)</p></li><li><p class="inline">EDP-EA regioisomers (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_003.cdx">CDX</a>)</p></li><li><p class="inline">10,11-EDP-NA, 10,11-EDP-CA, and 10,11-EDP-IA (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_004.cdx">CDX</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_001.pdf">jm8b00243_si_001.pdf (1.31 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_002.csv">jm8b00243_si_002.csv (1.57 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_003.cdx">jm8b00243_si_003.cdx (15.72 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00243/suppl_file/jm8b00243_si_004.cdx">jm8b00243_si_004.cdx (8.47 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00243&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-13%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00243" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00243" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992ba468143dd7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
